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Summary 
 
Herpes viruses adapted successfully during their evolution in order to reproduce 
themselves in a variety of hosts. After initial infection they can establish a state of 
viral latency in their host organism. The assembly of herpes virus capsids takes place 
in the cell nucleus. As these capsids exceed the size limit of nuclear pore complexes, 
they are transported by a virus-mediated vesicular transport through the nuclear 
membranes into the cytoplasm.  
This transport involves the induction of membrane deformation, followed by capsid 
integration and subsequent scission of membrane vesicles at the inner nuclear 
membrane into the periplasm. This process is known as primary envelopment. The 
enveloped capsids fuse with the outer nuclear membrane and are released for further 
maturation into the cytoplasm. 
It is believed that envelopment of capsids at the inner nuclear membrane is mediated 
by only two viral proteins, conserved among all herpes viruses. These essential 
proteins termed pUL31 and pUL34, interact at the inner nuclear membrane and form 
the so-called nuclear egress complex (NEC). The direction of the nuclear envelope 
passage is defined by a pUL31 and pUL34 gradient between the nucleus and 
cytoplasm and thus, might be the reason for maintaining the conserved two 
component nuclear egress complex. 
The involvement of cellular proteins in primary envelopment, as well as the 
underlying mechanism is not known. 
By employing a minimal artificial membrane test system I was able to demonstrate 
that the interaction of these two viral proteins is sufficient to mediate membrane 
invagination and scission. Strikingly, this process required no additional cellular 
factors. My further characterization of pUL31 revealed that artificial membrane 
tethering is sufficient to mediate membrane restructuring. The initial binding and 
subsequent oligomerization of pUL31 to membranes induces the formation of a 
protein coat in the absence of the interaction partner pUL34 that drives membrane 
budding and scission. 
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My results confirm that this complex of two viral proteins is sufficient to deform 
membranes in a minimal system. The important features of this complex, namely 
membrane deformation and membrane scission are mediated most interestingly only 
by the viral protein pUL31. Thus, pUL34 acts as a recruitment factor for pUL31.  
Nevertheless, essential functions of the conserved protein pUL34 and its 
homologues in the replication cycle of herpesviruses cannot be excluded. 
Taken together this study demonstrates how in contrast to the complexity of cellular 
membrane deformation and scission processes, a single viral protein combines these 
essential functions. Additionally, the presented results further emphasize the 
advantage of in vitro systems to investigate molecular mechanisms of membrane 
related processes.  
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Zusammenfassung 
 
Um sich in einer Vielzahl von Wirten vermehren zu können, haben sich Herpesviren 
im Laufe ihrer Evolution erfolgreich angepasst. Sie sind die bisher einzig bekannten 
Viren, die nach einer Erstinfektion ein Leben lang in ihrem Wirtsorganismus 
persistieren, indem sie in eine Art Ruhezustand (Latenz) übergehen. Eine weitere 
Besonderheit von Herpesviren, ist der im Zellkern erfolgende Zusammenbau von 
Viruskapsiden. Diese werden aufgrund ihrer Größe die das Größenlimit von 
Kernporenkomplexen übersteigen, durch einen virusvermittelten, vesikulären 
Transport durch die Kernhülle in das Zytoplasma transportiert. 
Dieser Transport umfasst die Induktion von Membrandeformation, sowie darauf 
folgende Membranabschnürungen der inneren Kernmembran. In diese werden 
Kapside integriert und liegen im periplasmatischen Raum vor. Dieser Prozess wird 
als primäre Umhüllung bezeichnet. Im weiteren Verlauf fusionieren die umhüllten, 
periplasmatischen Kapside mit der äußeren Kernmembran und geben diese zum 
weiteren Transport in das Zytoplasma frei.  
Es wird angenommen, dass für diesen Einschnürungsprozess an der inneren 
Kernmembran zwei in allen Herpesviren konservierte, virale Proteine entscheidend 
sind. Diese essentiellen Proteine sind pUL31 und pUL34. Sie interagieren 
miteinander an der inneren Kernmembran und formen den sogenannten Kern-
Austritts-Komplex. Konzentrationsunterschiede von pUL31 und pUL34 zwischen 
Zellkern und Zytoplasma, definieren die Richtung des Kerndurchtritts und sind 
vermutlich der Grund für die Beibehaltung eines konservierten Zwei-Komponenten 
Kern-Austritt-Komplexes. 
Die Beteiligung zellulärer Proteine an der Umhüllung, sowie der zugrunde liegende 
Mechanismus sind bisher nicht bekannt. 
Mit Hilfe eines minimalen, artifiziellen Membranvesikel Testsystems konnte ich 
nachweisen, dass die Interaktion der beiden viralen Proteine ausreichend ist, um 
Membraneinstülpungen und deren Fusion zu vermitteln. Dies erfordert keine weiteren 
zellulären Faktoren. Weiterhin konnte ich zeigen, dass das virale Protein pUL31 
künstlich an Membranen gebunden, ausreichend ist, um deren Umstrukturierung 
 XVI 
 
hervorzurufen. Die initiale Bindung und folgende Oligomerisierung von pUL31 an 
Membranen, induziert die Ausbildung einer Hülle in Abwesenheit des 
Interaktionspartners pUL34, was zu Membrandeformation und Abschnürungen führt. 
Meine Ergebnisse legen nahe, dass lediglich der Komplex aus zwei viralen Proteinen 
in einem minimalen System ausreichend ist, um Membranen zu deformieren. Die 
wichtigen Funktionen dieses Komplexes: Membrandeformation und Membran-
abschürung vermittelt lediglich das virale Protein pUL31. pUL34 fungiert somit in dem 
minimalen Vesikelsystem als Rekrutierungsfaktor für pUL31. Weitere, mitunter 
essentielle Funktionen des konservierten Proteins pUL34 und seiner Homologen im 
Vermehrungszyklus der Herpesviren können jedoch nicht ausgeschlossen werden. 
Zusammenfassend demonstriert diese Arbeit, dass im Gegensatz zur Komplexität 
zellulärer Membrandeformations- und Abschnürungs-Prozesse, ein einzelnes virales 
Protein diese grundlegenden Funktionen vereint. Die weiteren vorgestellten 
Ergebnisse unterstreichen zudem den Vorteil von in-vitro-Systemen, um molekulare 
Mechanismen membranbezogener Prozesse zu untersuchen. 
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1 Introduction 
1.1 Herpesviruses 
 
Herpes viruses are enveloped DNA viruses with a double-stranded linear genome. 
The virus family of Herpesviridae is part of the order Herpesvirales, according to „The 
International Committee on Taxonomy of Viruses“ (ICTV) and is categorized in three 
families, three subfamilies, 17 genera and 90 species in total (Davison et al., 2009). 
The family of the herpesviridae is divided in three subfamilies, the alpha-, beta- and 
gamma-herpesviridae and further into several genera. In total, until to today 90 
categorized and at least 48 unassigned species are known among the Herpesvirales 
(Davison, 2010). 
Herpesviruses are characterized by the same basic structure and replication cycle 
(Fig. 1.1 - Fig. 1.3). One main property of herpes viruses is their ability to establish 
latent infections in dividing and non-dividing cells dependent on the cell tropism 
(Block & Hill, 2007). In the latent phase, the viral genome is circularized, located in 
the nucleoplasm and genes encoding factors involved in the lytic (replicative) cycle 
are transcriptionally and functionally repressed (Roizman & Knipe, 2001; Preston, 
2000). Thus, no infectious viral particles are produced, resulting in suspended virus 
dissemination and appears thereby clinical inapparent. Latent infections last the 
lifespan of the host and can undergo reactivation anytime. Stimuli resulting in 
reactivation can be physical or psychological and induce viral gene expression and 
entry in the lytic cycle. The underlying mechanisms regulating establishment, 
maintenance and reactivation of latent infections are highly complex. 
Alpha-herpesviruses are the “prototypes” of the Herpesviridae, including several 
human pathogenic herpes viruses such as human herpes virus I (HHV-1, HSV-1), 
human herpes virus II (HHV-2, HSV-2), and the human herpes virus 3 (HHV-3, VZV). 
In addition, several animal pathogenic species, e.g. suid herpesvirus-I (SuHV-1, 
PRV) are assigned to the subfamily.  
Alpha-herpesviruses are commonly used to study virus related processes, as they 
can infect a broad range of cell types, accompanied by a high infectivity. Interestingly, 
many of the viral genes are not essential and can be replaced by genes of interest for 
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the creation of virus vectors (Burton et al., 2002). For this, the human not pathogenic 
suid herpesvirus-I (PRV) was the selected as model organism. 
Unless otherwise indicated, the alpha-herpesviruses shall be examined more detailed 
in the following. Furthermore, herpesviral genes are designated to their location in the 
viral genome which consist of a long and short region as unique long (UL) or unique 
short (US) and corresponding, viral proteins as pUL or pUS. 
1.1.1 Structure of herpesviruses 
 
The overall morphology of herpesviruses is conserved. The main structural features 
of this family are the viral capsid of a typical viral particle. It comprises the viral DNA 
genome of about 152 kbp (HSV-I) and is of toroidal shape. The genome of 
herpesviruses is described as containing a unique long (UL) and a unique short (US) 
region, each flanked by inverted repeat sequences (McGeoch et al., 1988; Furlong et 
al., 1972).   
The viral capsid, a main structural element, is assembled in the nucleoplasm from 
about seven viral proteins (pUL6, pUL17, pUL18, pUL19, pUL25, pUL35, pUL38) 
(Brown & William, 2011; Loret et al., 2008; Rozen et al., 2008; Zhu et al., 2005; 
Johannsen et al., 2004). Capids have an icosahedral shape and are composed of 
162 capsomers. These represent the smallest subunits of all herpesviruses and can 
be subdivided in 150 hexons and 12 pentons interconnected by triplexes (Fig. 1.1) 
 
 
 
 
 
 
 
 
Figure 1.1: Structure of the HSV-1 capsid  
Surface-shaded representation of a Cryo-EM reconstruction of a 125 nm HSV-1 capsid. One 
capsid face is coulored, highlighting hexons, pentons and triplexes (red, orange and blue). 
Adapted and modified from Brown & Newcomb (2011). 
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The layer between the viral capsid and the viral envelope is termed as the tegument, 
composed of a multitude of proteins (at least 20 to 23 for HHV-1) (Kelly et al., 2009; 
Loret et al., 2008; Zhu et al., 2005; Mettenleiter, 2004; Grünewald et al., 2003). 
Multiple roles are assigned to individual tegument proteins during viral entry and exit 
as well as in regulation of viral transcription and host translation (Kelly et al., 2009). 
The viral envelope represents the outer layer of herpes virions. The membrane 
originates from infected hosts and is aquired by secondary envelopement at the 
trans-Golgi network. The membrane is modified with serveral viral encoded 
glycoproteins playing an important role in viral attachment and fusion upon infection 
(Eisenberg et al., 2012; Farnsworth & Johnson, 2006; Turcotte et al., 2005; Wisner & 
Johnson, 2004). Additionally, viral glycoproteins are also found in budded virions and 
the inner nuclear membrane in HHV-I infected cells (Baines et al., 2007; Farnsworth 
et al., 2007; Stannard et al., 1996). Interestingly, viral glycoproteins are not present in 
budded virions of suid herpes virus-I (Klupp et al., 2008) and thus, appear not to be 
involved in budding at the inner nuclear membrane. 
 
Figure 1.2: The structure of herpesviruses 
The main structural components of herpesviruses are indicated in a 3D illustration (right) and 
in an electron microscopical image (left) for a single herpesviral particle. Adapted and 
modified from Gruenewald et al. (2003). Dp - distal pole, pp - proximale pole 
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1.1.2 Replication of herpesviruses 
 
The initial steps of viral attachment to the surface of the target cell are the binding of 
viral glycoproteins to the target cell membrane receptors, including heparan sulfate 
proteoglycans (Bender et al., 2005), chondroitin sulfate proteoglycans (Banfield et al., 
1995), as well as cellular integrins (Cheshenko et al., 2014) and presumably other 
cell surface receptors. Four membrane glycoproteins (gD, gB, and a heterodimer, 
gH/gL) are required for HHV-1 entry into cells (Forrester et al., 1992; Cai et al., 1987; 
Ligas & Johnson, 1988). These initial interactions are followed by fusion of the target 
cell membrane with the virus envelope, after which the nucleocapsid and tegument 
are released into the cytoplasm. Subsequently, the viral capsid is transported to the 
nucleus mediated by dynein and dynactin (Döhner et al., 2002).  Interactions 
between the tegument protein pUL36 and NPC protein Nup358, mediate capsid 
binding to nuclear pore complexes (Copeland et al., 2009). This binding is thought to 
iniiate the release of the viral DNA bound to viral core proteins into the nucleoplasm 
(Pasdeloup et al., 2009). 
Viral DNA translation is divided into three temporal phases (Honess & Roizman, 
1974) immediately early (IE), early (E) and late (L) gene expression. The immediately 
early (IE) genes are the first viral genes being expressed, encoding mainly for non-
structural proteins and further regulate gene expression of the (delayed) early (E) and 
late (L) genes. 
After fusion of the viral envelope with the cell membrane, liberated tegument proteins 
pUL48 (VP16) and pUL41 (VHS) are of particular importance for viral progression. 
The binding of the viral protein pUL48 (α-TIF, α-trans inducing factor) to the cellular 
transcription factor oct-1 and the cellular protein hcf-1 (host cell factor-1) are 
assumed to be important for the initiation of transcription of the early genes (Nogueira 
et al., 2004; Liu et al., 1999;  Kristie et al., 1989; Stern et al., 1989; Gerster & Roeder, 
1988). 
In addition, pUL41 (virion host shutoff protein, UL41) a viral protein with   
ribonuclease activity (Taddeo & Roizman, 2006; Matis & Kúdelová, 2001) degrades 
cellular mRNA, as well as to some extend viral mRNA, causing polysome breakdown. 
Thus, aquisition of the cellular translation machinery for the expression of viral early 
and late gene products is promoted.  
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How herpesviruses enter the lytic cycle from latency, after application of reactivation 
stimuli, is still not well understood. So far the viral protein pUL48 (VP16) appears to 
be crucial for reactivation (Kim et al., 2012) and entry into the lytic cycle (Sawtell et 
al., 2011; Thompson & Sawtell, 2010; Campbell et al., 1984; Batterson & Roizman, 
1983; Post et al., 1981). 
Reactivation is assumed to begin by expression of regulatory early gene products, 
inducing replication of viral DNA, present in the cell nucleus according to the "rolling 
circle" principle (Boehmer & Lehman, 1997).  
Regulatory early gene expression induces the expression of the late gene, encoding 
mainly structural proteins, necessary for the production of new virus particles. These 
are synthesized in the cytosol and imported into the nucleus. Structural proteins allow 
the assembly of new capsids, by spontaneous aggregation of viral major capsid 
proteins and minor capsid proteins in the nucleoplasm (Newcomb et al., 1996). The 
viral concatemeric DNA is cleaved and packed into newly formed capsids by a yet ill 
defined mechanism. This involves the HHV-1 viral proteins pUL6, pUL15, pUL17, 
pUL25, pUL28, pUL32, and pUL33 (Heming et al., 2014; Conway & Homa, 2011; 
Toropova et al., 2011; White et al., 2003; Boehmer & Lehman, 1997).  
Since newly formed capsids with a diameter of about 125 nm exceed the nuclear 
pore size limit (Panté & Kann, 2002), herpes viruses have developed a unique and 
yet not fully understood mechanism in order to egress from the nucleus via 
translocation through the inner (INM) and outer (ONM) nuclear membrane. 
Capsids bud at the nucleoplasmic site of the inner nuclear membrane into the 
perinuclear space, resulting in fully enwrappment by the inner nuclear membrane 
(Fig. 1.4). In this process, termed primary envelopement, viral proteins as well as 
cellular proteins become part of the tegument layer, surrounding the capsid (Padula 
et al., 2009; Read & Patterson, 2007; Naldinho-Souto, 2006; Baines et al., 1995). In 
order to acquire the primary envelope two viral proteins, pUL31 and UL34, are 
essential and conserved among the herpesvirales (Reynolds et al., 2001; Roller et 
al., 2000; Chang et al., 1997). After full enwrappment of capsids by the inner nuclear 
membrane, these vesicles reside in the perinuclear space (Fig. 1.4B, Fig. 1.5). 
The fusion process of enveloped virions with the outer nuclear membrane is ill 
defined and is assumed to involve viral glycoproteins, initially involved in fusion of the 
viral envelope with the cell membrane (Farnsworth et al., 2007; Stannard et al., 
1996). In addition, the not conserved but essential viral US3 kinase plays an 
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important role in fusion of capsids with the outer nuclear membrane since a lack of 
US3 results in accumulation of enveloped capsids in the perinuclear space (Klupp et 
al., 2001). 
After the release of the capsids into the cytoplasm they are actively transported via 
the microtubule plus end motor kinesin-1 towards the cell periphery (Radtke et al., 
2010; Miranda-Saksena et al., 2009). The final viral envelope is aquired by budding 
through Golgi, trans-Golgi and endosomal membranes. This process is termed 
secondary envelopment and respresents a maturation step, as viral capsids aquire 
tegument proteins and glycoproteins, important for cell to cell transmission. 
Enveloped capsids are finally released into the extracellular space after vesicle 
transport to the plasma membrane. This transport to the cell periphery is assumed to 
involve actin-based motor protein Myosin Va, but the underlying mechanism is not 
yet defined (Roberts & Baines, 2010). 
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Figure 1.3: Illustration of the general herpesviral lifecycle 
Infectious herpes viruses fuse with the cell membrane releasing the viral capsid into the 
cytoplasm. The capsid is transported to the nucleus were it interacts with NPC proteins 
releasing the viral DNA into the nucleoplasm where viral DNA is replicated and transcribed. 
Messenger RNA is exported into the cytoplasm and new structural viral proteins are 
synthesized which are imported in the nucleus. Assembly of new capids is performed in the 
nucleoplasm. Capsids are engulfed by the inner nuclear membrane resulting in periplasmatic 
enveloped particles which subsequently fuse with the outer nuclear membrane releasing the 
capsids into the cytoplasm. Cytoplasmic capsids are transported to the Golgi apparatus 
where a second budding step is performed, acquiring membranes to fuse with the cell 
membrane to release the new virus in the extracellular space. 
 
1.1.3 The role of the nuclear egress complex in passing the nuclear envelope  
 
 
 
Figure 1.4: Transport of herpesviral capsids through the nuclear envelope 
Herpesviral capsids aquire a primary envelope at in the inner nuclear membrane (A). 
Completely enveloped capsids reside in the perinuclear space (B) and subequently fuse with 
the outer nuclear membrane releasing the capsid into the cytoplasm (C). Budding direction 
(arrow), as well as nucleoplasm (N) and cytoplasm (C) are indicated. Bars: 150 nm, adapted 
and modified from Mettenleiter (2002). 
 
Viral capsids acquire a primary envelope by constrictions at the inner nuclear 
membrane. How exactly capsids are transported and attracted to local accessible 
areas is unclear. In the process of the primary envelopment, two viral proteins pUL31 
and pUL34 are essential and form the hetero-dimeric nuclear egress complex (NEC) 
(Loetzerich et al., 2006; Schnee et al., 2006; Mettenleiter, 2002) at the nucleoplasmic 
side of the inner nuclear membrane.  
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Both proteins are conserved among the herpesvirales. pUL31 is nucleoplasmic 
localized protein, interacting with the tail anchored  viral protein pUL34, an integral 
type-II membrane protein, residing in the endoplasmic reticulum and nuclear 
envelope. 
Infection experiments with viruses lacking either the UL31- and UL34 genes or both 
resulted in accumulation of non-enveloped capsids in the nucleoplasm (Liang & 
Baines, 2005).  
The formed nuclear egress complex at the inner nuclear membrane is assumed to be 
involved in several ways during nuclear egress. Viral capsids need to access the 
inner nuclear membrane in order to cross the nuclear envelope covered at the 
nucleoplasmic site by the lamina, a dense meshwork consisting mainly of the 
proteins lamin A/C and lamin B. The pUL31/pUL34 complex locally disrupts the 
nuclear lamina (Bjerke & Roller, 2006; Reynolds et al., 2004; Simpson-Holley et al., 
2004). This is mediated by recruiting additional viral and cellular factors to the 
membrane. Factors shown to be involved are cellular protein kinase C isoforms 
(PKC) (Leach & Roller, 2010; Park & Baines, 2006; Muranyi et al., 2002) and the viral 
kinases pUS3 (Mou et al., 2007; Kato et al., 2005; Reynolds et al., 2001; Purves & 
Roizman, 1991), conserved only in alphaherpesviruses, and pUL13 (Cano-Monreal 
et al., 2009; Romaker et al., 2006), as well as their homologues in all herpesviruses. 
The cellular and viral kinases phosphorylate components of the nuclear lamina: lamin 
A/C (Mou et al., 2007), lamin B1/B2 (Scott & O'Hare, 2001) and lamin interacting 
proteins e.g. lamin B receptor (LBR) (Scott & O'Hare, 2001; Cano-Monreal et al., 
2009) and emerin (Leach et al., 2007).  
Interestingly, also the NEC by itself can interact directly with lamin A/C in vitro 
(Reynolds et al., 2004). Thus, NEC-lamin interaction can interfere with lamin-lamin-
interaction and additionally weakens the local integrity of the nuclear lamina 
(Reynolds et al., 2004).   
Another important function of the NEC is implied in selecting capsids containing viral 
DNA (C-capsids) over immature capsids (A and B capsids) (Brown & Newcomb, 
2011; Homa, 1997). This selection was assumed to include the viral proteins pUL17 
and pUL25, two minor capsid assocciated proteins (Cockrell et al., 2011; Toropova et 
al., 2011) forming a complex, termed C-capsid-specific complex (CCSC) (Yang & 
Baines, 2011). As the C-capsid-specific complex was also found on immature 
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capsids, it was renamed to capsids vertex specific component (CVSC) (Toropova et 
al., 2011). 
Most importantly, pUL31 and pUL34, forming the nuclear egress complex, are the 
main factors mediating capsid envelopment at the inner nuclear membrane (Bigalke 
et al., 2014; Roller et al., 2010; Mou et al., 2009; Klupp et al., 2007).  
The NEC is assumed to remodel the inner nuclear membrane, preferentially around 
the viral capsids, but the precise mechanism, how pUL31 and pUL34 mediate inner 
nuclear membrane deformation remains enigmatic. Interestingly, in transfected cells 
the NEC is sufficient to induce perinuclear vesicle formation in the absence of other 
viral proteins (Klupp et al., 2007; Luitweiler et al., 2013). However, the key question 
remains, whether the NEC mediated membrane deformation requires additional 
cellular proteins as well as their potential involvment in scission of enveloped vesicles 
into the perinuclear space.  
Recent findings indicate that the NEC only is indeed sufficient in mediating herpes 
viral primary envelopement (Bigalke et al., 2014).  
In further respects, interactions between pUL31 and the pUL17-pUL25 complex may 
provide the physical link between attraction and attachment of capsids with the 
nuclear egress complex (Yang & Baines, 2011). 
After complete enclosure of capsids by the inner nuclear membrane these vesicles 
have to fuse with the outer nuclear membrane. A direct role of the NEC in fusion of 
perinuclear vesicles is so far unknown. As pUL31 and pUL34 are found only 
associated with perinuclear enveloped capsids (Reynolds et al., 2002) and the C-
terminus of pUL34 extends only three aminoacids into the periplasm, a potential 
interaction with soluble periplasmic or integral outer nuclear membrane proteins is 
uncertain, but cannot be excluded. Interestingly, overexpression of a cellular AAA+ 
ATPase in the lumen of the endoplasmic reticulum, torsinA, results in production and 
accumulation of enveloped vesicles in the cytoplasm and impaires HHV-I 
reproduction in infection experiments (Maric et al., 2011). TorsinA is implied to be 
involved in nuclear envelope maintenance (Ozelius et al., 1997). However, upon 
fusion of periplasmic vesicles with the outer nuclear membrane the fate of pUL31 and 
pUL34 is not defined. Both proteins are either degraded or reimported into the 
nucleus to promote another round of budding at the inner nuclear membrane. 
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Figure 1.5: Illustration of inner nuclear membrane budding 
Assembly of new capids is performed in the nucleoplasm with incorporation of viral 
DNA. Capsids are recruited and engulfed at the inner nuclear membrane (INM). The 
main factors for budding of viral capsids are the soluble protein pUL31 (green) and 
the viral membrane protein pUL34 (red). Complex formation of pUL31 and pUL34 
results in constriction of capsids completely sheathed by the INM and scission of the 
vesicle with subsequent location in the perinuclear space. Enveloped viral particles 
fuse with the outer nuclear membrane releasing the capsids into the cytoplasm. 
 
1.1.4 GUVs – a versatile tool to study membrane associated processes 
 
Giant unilamellar vesicles provide a powerful, versatile tool for quantitative and 
qualitative biochemically analysis of membrane related processes. GUVs allow, due 
to their size, direct observation by light microscopy and enable simple manipulation of 
physical factors e.g. lipid composition, pH values or temperature. Thus, GUVs 
provide a tool to study membrane properties in terms of lipid dynamics, membrane 
budding, fission or fusion as well as lipid domain formation. In addition, GUVs can 
serve as a model system to test the interplay between proteins and lipids as well as 
integral membrane or membrane-associated proteins with soluble interactors. 
Countless cellular processes involve integral membrane proteins. Thus, GUVs can 
be used to address and understand the interplay of factors or individual functions. 
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Some integral membrane proteins were successfully integrated in GUVs and 
demonstrated functionality. These included the sarcoplasmic reticulum Ca2+-ATPase 
and the H+ pump bacteriorhodopsin (Girard et al., 2004) or voltage-dependent anion 
channels (VDAC) (Betaneli et al., 2012; Aimon et al., 2011).  
GUV generation can be performed in many ways (Walde et al., 2010). The 
rehydration of dried lipid films provides an easy, although time consuming, way for 
generation of large quantities of GUVs. Applying an alternating field can assist the 
underlying natural swelling process (Angelova & Dimitrov, 1986) and is performed 
between conductive glass electrodes (ITOs) or platinum wires. Many adaptations and 
variations for the electroformation protocol exist reflecting the individually addressed 
issues. 
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1.2 The nucleus and the nuclear envelope 
 
The nuclear envelope is composed of two membranes: the inner nuclear membrane 
and the outer nuclear membrane continuous with the endoplasmic reticulum. They 
are part of the most prominent structure of the cell: the cell nucleus, a compartment 
having a multitude of functions (Dulz & Ellenberg, 2007).  The nuclear membranes do 
not form an impermeable barrier surrounding the chromatin. This membrane 
structure is interrupted by nuclear pore complexes (NPCs). NPCs are large protein 
assemblies and are composed of about 30 different proteins termed nucleoporins 
(Nups) arranged in an eightfold symmetry (Fig. 1.2.1). They are integrated at sites 
where the inner and outer nuclear membranes fuse. NPCs mediate and regulate the 
bidirectional transport of factors across the nuclear envelope and are able to perform 
hundreds of transport events every minute (Gorlich & Mattaj, 1996). 
 
 
Figure 1.2.1: Nuclear pore complex structure and components  
Nuclear pore complexes (NPCs) are comprised nucleoporins (Nups) arranged in an eight 
fold symmetry surrounding a central channel, connecting the nucleoplasm and cytoplasm. 
The NPC is anchored to the nuclear envelope by a transmembrane ring structure that 
connects to the core scaffold and comprises inner ring and outer ring elements. Linker Nups 
assist in anchoring the FG (phenylalanine-glycine)-repeat-Nups, filling the central tube. 
Peripheral structures are the cytoplasmic filaments, the nuclear basket with a distal ring. 
Yeast and vertebrate homologues are shown. Adapted from Strambio-De-Castillia (2010). 
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1.2.1 NPC assembly at the end of mitosis 
 
In mitosis the nuclear envelope and integrated nuclear pore complexes undergo 
dramatic morphological changes. NPC reassembly in the reforming nuclear envelope 
starts by recruitment of the nucleoporin Mel28/ELYS to the decondensing chromatin 
depending on the AT hook binding motif to AT rich areas on the chromatin, followed 
by recruitment of the Nup107-160 complex (Franz et al., 2007; Rasala et al., 2008). 
The GEF RCC1 bound on chromatin generates a spatial ran-GTP gradient around 
the chromatin, releasing Importin-β bound factors crucial for further NPC assembly 
(Chen et al., 2007; Hutchins et al., 2004; Li et al., 2004; Walther et al., 2003; Hetzer 
et al., 2000). Subsequently, membranes are attracted containing the transmembrane 
nucleoporin Ndc1, interacting with Nup53 and thereby recruiting Nup155 to the 
assembling NPCs (Franz et al., 2005; Eisenhardt et al., 2014). Additionally, 
membranes containing the transmembrane nucleoporin Pom121 are recruited to 
assembly sites, interacting with the Nup107/Nup160 complex. Nup93 is recruited via 
Nup53 and strengthens the interaction between Nup53 and Nup155 (Sachdev et al., 
2011). After Nup93 tethering, Nup188 and Nup205 are recruited. The final steps of 
nuclear pore assembly are recruitment of the central channel components, forming 
the FG repeats containing diffusion barrier in the central channel as well as 
peripheral nucleoporins forming the nucleoplasmic and cytoplasmic extensions. 
 
1.2.2 NPC assembly in interphase 
 
Nuclear pores are also assembled de novo in an intact nuclear envelope during 
interphase. It is generally assumed, that assembly has to start at the intact nuclear 
envelope and both, inner and outer nuclear membranes have to come in close 
proximity to assemble a new functional pore spanning the nuclear envelope 
(D'Angelo et al., 2006). So far, the spatial and temporal requirements for recruiting 
nuclear pore components to assembly sites as well as the order of assembly during 
interphase are unknown.  
At least one of the three transmembrane nucleoporins, Pom121, although not 
conserved, is assumed to be important in interphasic pore formation. Pom121 is 
needed for early Nup107/Nup160 complex recruitment (Doucet et al., 2010; Dultz & 
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Ellenberg, 2010). Nup133, member of the Nup107/Nup160 complex forms an 
amphipathic helix and might assist recruitment of the whole complex to the 
membrane by sensing curvature, known to be required for interphasic NPC assembly 
(Doucet et al., 2010).  
  
1.2.3 Nup153 is involved in a variety of processes 
 
The 153 kDa nucleoporin Nup153 is a protein located at the nucleoplasmic side of 
the NPC. Together with TPR, it forms the nuclear basket, a 60–80 nm structure 
protruding in the nucleoplasm. 
Orthologues of Nup153 are found in many organisms but not in yeast, although 
several nucleoporins share specific functions of Nup153. 
The N-terminus of the protein contains the nuclear envelope targeting cassette 
(NETC), containing apotential amphipathic helix, targeting Nup153 to the inner 
nuclear membrane. 
Furthermore, the N-terminus harbors the nuclear pore associating region (NPAR), 
sufficient for incorporation in nuclear pore complexes and a RNA binding motif. The 
central part of Nup153 contains a zinc-finger-region for interaction with DNA. The C-
terminus contains FG rich motifs, assumed to be unfolded (Denning 2003) and 
interacting with transport receptors to facilitate transport of proteins (Kerr & Schirmer, 
2011). 
The overall domain architecture of Nup153 illustrates a multitude of interactions with 
factors, therefore involved in many processes (Ball & Ullman, 2005). 
To characterize the role Nup153 in NPC assembly two prominent interactions with 
the small GTPase ran and the Nup107-Nup160-complex (Y-complex) are examined 
in more detail. Ran plays a major role in the bidirectional transport of cargo through 
nuclear pore complexes and is implied in liberating building blocks of the nuclear 
pore in the nucleoplasm from transport receptors (Walther et al., 2003; Hetzer et al., 
2000). 
The Nup107-Nup160-complex is a major component of the NPC. It forms mainly the 
cytoplasmic ring, anchoring the cytoplasmic filaments and the nucleoplasmic ring, 
anchoring the nuclear basket to the nuclear pore complex (Grossman et al., 2012). 
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1.3 Aims of this study 
 
Herpesviruses are pathogens evolving over 200 million years (McGeoch et al., 1988).  
They are perfectly adapted to infect a wide range of vertebrates including humans. 
Several special features in herpesviral replication mediate a fast dissemination. 
Herpesviral capsids assemble in the nucleus and mature by passing the inner and 
outer nuclear membrane, termed nuclear egress. The nuclear egress involves the 
envelopment of new viral capsids at the inner nuclear membrane and the subsequent 
de-envelopment at the outer nuclear membrane, thus, releasing the capsids in the 
cytoplasm. Two conserved herpesvirus protein families, pUL31 and pUL34, are 
essential for the passage through the nuclear envelope and form the nuclear egress 
complex (NEC). The NEC formation is conserved among all herpesvirus subfamilies 
and mediates the envelopment of herpesviral capsids at the inner nuclear membrane 
by a yet unknown mechanism. The aim of this study was the biochemical 
characterization of pUL31, the interaction with pUL34 and the requirements of the 
viral capsid envelopment mechanism. Therefore, an artificial minimal giant 
unilamellar vesicles (GUV) membrane model system was employed and further 
developed. GUVs are spherical membranes consisting of a single lipid bilayer. By 
reconstitution of the integral membrane protein pUL34 into GUVs the interaction and 
vesicle formation after pUL31 recruitment, in the absence of other viral and cellular 
factors, was studied. Furthermore, artificial tethering of the individual NEC 
components to GUVs was used to dissect the contribution of pUL31 and pUL34 to 
vesicle formation in the GUV system. Additionally, single point mutations in a 
conserved stretch of pUL31 were generated in order to separate the binding ability of 
pUL31 to pUL34 and the ability to mediate membrane deformation in GUVs. 
Moreover, results obtained in the GUV system were verified in transfection 
experiments. 
Understanding the key process of primary envelopment at the inner nuclear 
membrane, and as a consequence preventing herpesviral nuclear egress, can 
contribute to develope antiherpesviral therapies. 
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2 Results 
 
2.1 Nuclear Membrane budding is induced by complex formation of 
two herpes viral proteins  
 
2.1.1 Optimized generation of Giant unilamellar vesicles (GUVs)  
 
Giant unilamellar vesicles (GUVs) provide, due to their low complexity, an optimal 
test system to investigate protein-protein, protein-lipid, or lipid-lipid interactions. 
Compared to cellular systems this minimal setup ensures highly reproducible 
conditions. The size of GUVs of up to 150 µm allows microscopic observations of 
membrane-bound protein-protein interactions that were addressed in this study. In 
the following the interaction of the recombinantly expressed viral proteins pUL31 and 
pUL34 were investigated in detail.  
GUVs are commonly generated by rehydration of lipid films, a passive and time-
consuming method (Meure et al., 2008). To actively assist and improve the formation 
of unilamellar vesicles, electroformation of lipid films, where an alternating current 
field is applied, was developed (Angelova & Dimitrov, 1986). 
The electroformation method using ITO - (indium-tin-oxide) - coverslips or platinum 
wire electrodes in non-conductive buffers is commonly performed. The ITO-coverslip-
system produces GUVs in large amounts, but these vesicles stay closely attached to 
the fragile coverslips not usable for single vesicle analysis.  
Electroformation on platinum wire electrodes results in high yields of detached 
vesicles. The surface area where lipid films can be applied is very limited (~8 mm² 
per electrode) and therefore not suited to dry greater amounts of aqueous proteo-
liposomes being the starting point to generate GUVs. Within this study the problem 
was overcome by increasing the surface area of the platinum wire electrodes by 
using platinum gauze electrodes (BASinc.) combined with a disposable cuvette 
system (Fig. 2.1). Thereby, the area to apply lipid films was increased to ~ 35 mm² 
per electrode. 
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Figure 2.1: Electroformation on platinum gauze electrodes 
Electroformation of lipid films was performed on platinum gauze electrodes (left). 
Applying an alternating current to platinum electrodes with applied lipid film in a non- 
conductive sucrose solution results in GUV formation and subsequent vesicle detachment 
(right). 
 
2.1.2 pUL34 can be reconstituted in GUVs 
 
The viral proteins pUL31 and pUL34 (as well as homologous proteins) are the main 
factors necessary for nuclear egress of herpes virus capsids from the nucleus 
(Reynolds et al., 2001). The integral type-II transmembrane protein pUL34 resides in 
the nuclear envelope, presumably the inner nuclear membrane where it can interact 
with the nucleoplasmic and actively imported protein pUL31. To investigate and 
understand their function in more detail, pseudorabies virus (PRV, suHV-1) 
homologues of both proteins were expressed as full-length proteins in E. coli 
including the C-terminal transmembrane region of UL34. To assist overexpression of 
this membrane protein, a MISTIC (membrane-integrating sequence for translation of 
integral membrane protein constructs) protein tag was fused to the N-terminus of 
pUL34. MISTIC is a membrane protein derived from Bacillus subtilis and was found 
to efficiently increase expression of integral membrane proteins (Deniaud et al., 
2011; Roosild et al., 2005; Petrovskaya et al., 2010) by integrating them into the 
inner membrane of E. coli, presumably bypassing the translocon complex (Dvir et al., 
2009). 
pUL34 was efficiently purified from E. coli membranes by detergent mediated 
solubilisation and subsequent nickel-affinity purification followed by labelling with the 
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fluorescent dye Alexa-Fluor-546 (see methods, (4.2.18)). The viral protein was 
efficiently reconstituted into liposomes (proteo-liposomes) with a lipid composition 
mimicking the nuclear envelope composition (Vollmer et al., 2012; see methods, 
(4.2.24.1). GUVs were generated by electroformation of dried proteo-liposome layers 
employing the previously described GUV preparation method. pUL34 was 
successfully integrated in GUVs and could be visualized by detection of the 
fluorescent Alexa-Fluor-546 label (Fig. 2.2). 
 
 
 
Figure 2.2: Fluorescently labelled pUL34 can be efficiently reconstituted in GUVs 
pUL34 was labelled with Alexa-Fluor-546 and reconstituted by gelfiltration in proteo-
liposomes. Dried proteo-liposome layers were electroformed and resulting GUVs were 
imaged by confocal microscopy. Vesicle membrane was visualized using DiD-C18. bar: 10µm 
 
2.1.3 pUL31 and pUL34 are sufficient for membrane budding and scission in 
giant unilamellar vesicles 
 
pUL31, the interactor of pUL34, was also recombinantly expressed and purified by 
affinity purification from E.coli lysates. The protein was expressed with an N-
terminally fused EGFP tag which proved to enhance its solubility. Because of stability 
issues pUL31 was always purified directly before use. 
Employing the GUV system, not only the binding properties of pUL31 to pUL34, but 
also the functionality of both proteins could be verified. 
Therefore, pUL34 GUVs were incubated with a final concentration of 500 nM of 
EGFP-pUL31 (Fig. 2.3A). This concentration was previously determined by 
evaluating different concentrations of pUL31 and found to be optimal for fluorescent 
imaging of GUVs. Thereby 500 nM of pUL31 was used in all experiments unless 
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differently noted. In this experimental setup pUL31 was recruited to the rim of giant 
vesicles containing pUL34 within the first five minutes after addition. Most 
importantly, after recruitment of pUL31 to the GUV membrane, small vesicles started 
to pinch of from the membrane into the lumen of the vesicles, containing pUL31 and 
pUL34 . To verify the specific interaction of pUL31 and pUL34 another integral inner 
nuclear membrane protein, SCL1, used as a control and sharing the same topology 
as UL34 with a C-terminal transmembrane domain, was reconstituted into GUVs. No 
recruitment and no invaginations formed in GUV membranes when pUL31 was 
added to SCL1-GUVs (Fig. 2.3C). Vice versa, also no interaction was observed in 
pUL34- or SCL1-GUV when EGFP alone was added (Fig. 2.3B). Quantification of 
three independent experiments under three individual conditions was performed (Fig. 
2.4) showing a nearly constant background of GUVs with invaginations of about 20 % 
(Fig. 2.4A). Only addition of pUL31 to pUL34 GUVs resulted in an increase of intra 
lumenal vesicles (ILVs) while all other conditions tested resulted in background levels 
of ILVs (Fig. 2.4B). To verify the size of the UL31/34 induced vesicles, stack images 
of at least 20 different GUVs containing ILVs were taken in three independent 
experiments and sizes of individual ILVs were measured (Fig. 2.4C). Data analysis 
revealed that the majority of the ILVs had a diameter of 1-1.5 µm (39 %) followed by 
vesicles with greater diameter (23 % Ø 1.5-2 µm) and vesicles with smaller diameter 
(18 % Ø 0.5-1 µm). Similar amounts were found for vesicles ranging from 1.5-2 µm. 
Taking this together this demonstrates that both recombinant expressed viral proteins 
are functional and form a functional complex resulting in vesicle constrictions from 
GUV membranes into the lumen of the vesicles. 
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Figure 2.3: pUL34 and pUL31 interact and complex formation is sufficient to induce 
vesicle formation. 
pUL34 or SCL1 was labeled with Alexa-Fluor-546 and reconstituted in proteo-liposomes. 
Dried proteo-liposome layers were electroformed. Resulting GUVs were imaged using 
confocal microscopy. Upon addition of EGFP tagged pUL31, pUL31 was efficiently recruited 
to the GUV membrane and induced vesicle formation into the lumen (A). When EGFP was 
added no recruitment and vesicle formation was observed (B) or when pUL34 was replaced 
by another inner nuclear membrane protein SCL1 (C), indicating that the interaction and 
induction of lumenal vesicles was specific to pUL34/pUL31 complex formation. bars: 5µm 
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Figure 2.4: Quantification of intralumenal vesicles in pUL34 GUVs 
The number of GUVs with intralumenal vesicles (ILVs) was quantified (A). For each condition 
and experiment at least 70 GUVs were analyzed in three independent experiments. The 
number of GUVs with detectable ILVs was counted before and after the addition of EGFP-
pUL31 to pUL34- or SCL1-GUVs. For each condition and experiment stack images of at 
least 20 GUVs with detectable ILVs were recorded and the amount (B) as well as the 
approximately size (C) of the ILVs was measured. As shown in (A) and (B) a significant 
increase of ILVs could be detected only when EGFP-pUL31 was added to pUL34 GUVs but 
not when added to SCL1-GUVs. Also no increase was observed when EGFP as control 
protein was added to pUL34- or SCL1-GUVs. The size distribution of ILVs (C) shows that the 
most of the ILVs (~ 39 %) was about 1 – 1.5 µm in diameter. Also smaller vesicles < 1 µm 
(~18 %) and vesicles up to 2 µm (~ 23 %) as well as vesicles larger than 2 µm (~20 %) were 
detected. Error bars represents the mean (-/+ SEM) of three independent experiments. 
 
2.1.4 pUL31 induces membrane invaginations in pUL34 GUVs  
 
To show that ILVs in GUVs are formed because of membrane constrictions after 
addition of pUL31 to pUL34 containing GUVs a fluorescent fluid phase marker 
(Cascade Blue NeutrAvidin, life technologies) was added and should be included as 
new vesicles invaginate towards the lumen of the GUVs. This uptake is supposed to 
be visualized by detection of the fluorescence signal in ILVs. Upon adding pUL31 to 
GUVs ILV formation was induced and the added fluid phase marker was incorporated 
(Fig. 2.5A). No incorporation was observed when pUL31 was added to SCL1-GUVs 
(Fig. 2.5B). Also no uptake was visible when the fluid phase marker was added 15 
minutes after addition of pUL31 to pUL34 GUVs (Fig. 2.5C) indicating that the 
vesicles pinched of from the limiting GUV membrane. No effect was observed when 
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the fluid phase marker was added to GUVs in the absence of additional proteins (Fig 
2.6). 
This indicates that ILV formation after pUL31 addition to pUL34 GUVs is only induced 
by complex formation of both proteins. Additionally, vesicles pinched of from the GUV 
membrane and the bulk formation of ILVs in GUVs is completed within 15 minutes 
after applying the protein. 
 
 
Figure 2.5: Addition of EGFP-pUL31 to pUL34-GUVs initiates vesicle budding 
Intralumenal vesicles observed in GUVs are newly formed as a result of the addition of 
EGFP-pUL31 to pUL34-GUVs and were not present before in the GUVs, as a fluorescently 
labeled fluid phase marker (Cascade Blue® NeutrAvidin®, life technologies) was added 
together with EGFP-pUL31. Vesicles budding at the GUV membrane will incorporate 
detectable amounts of the fluid phase marker (A) but not when added 15 min after EGFP-
pUL31 addition to GUVs with reconstituted Alexa-Fluor-546 labeled pUL34 (C) or SCL1 (B). 
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Figure 2.6: Addition of the fluid phase marker to pUL34-GUVs has no effect 
To show that the addition of the fluorescently labeled fluid phase marker (Cascade Blue® 
NeutrAvidin®, life technologies) has no effect, it was added to Alexa-Fluor-546 labeled 
pUL34 GUVs, indicating that the fluid phase marker has no additional effect on GUVs. bar: 5 
µm 
 
2.1.5 pUL31 and pUL34 accumulate in forming buds 
 
Interestingly, when pUL31 is added to pUL34, overlapping fluorescent signals of both 
proteins appear. The distinct enrichment of both proteins in local spots could 
represent an early step in vesicle formation. An example of an emerging bud is 
analyzed (Fig. 2.7A). Fluorescence signals of EGFP-pUL31 and Alexa-Fluor-546 
labeled pUL34 were detected by confocal microscopy and analyzed using the 
straighten function of the image software Fiji. The normalized fluorescence intensity 
was plotted revealing an increase of pUL31 by 2.5-fold and for pUL34 by 2-fold 
compared to the basal fluorescence of both proteins in the GUV membranes. 
Sequential budding events in GUV membranes were imaged (Fig. 2.8) where local 
enrichment of pUL31 and pUL34 was be observed, subsequently followed by 
detachment of small vesicles into the lumen of the giant vesicles containing both 
proteins. A three dimensional reconstitution of a section of a pUL31 treated pUL34 
GUV was generated with IMARIS (v7.7.1) (Fig. 2.7B) showing numerous vesicles 
detached and mobile in the lumen of the GUV with both proteins present. 
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Figure 2.7: pUL31 and pUL34 accumulate in nascent buds and formed vesicles are 
disconnected from the GUV membrane 
pUL31 and pUL34 accumulate at sites were nascent buds in the GUV membrane arise (A). 
Fluorescent signals of EGFP-pUL31 and pUL34 Alexa-Fluor-546 from a GUV membrane 
were quantified using the straighten function of Fiji (ImageJ) and the normalized fluorescent 
intensity for both signal were plotted, indicating an increase of pUL34 in the emerging buds 
of two-fold and nearly 2.5- fold for pUL31. bars: 1 µm 
Three dimensional reconstitution of a pUL34-GUV incubated with pUL31, which shows highly 
mobile vesicles distant and apparently detached from the limiting GUV membrane (B).  
bars: 5 µm 
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Figure 2.8: pUL31 addition to pUL34-GUVs induces vesicles budding and detachment 
from the GUV membrane 
pUL34-GUVs were incubated with EGFP-pUL31. Confocal pictures were taken from different 
representative GUVs showing different time points in budding and detaching of an ILV from 
the GUV membrane. bars: 2 µm 
 
To further characterize the vesicle budding induced by pUL31/pUL34 the influence of 
the used lipid composition was investigated. The lipid composition (referred to as 
complete lipid mix) mimics the nuclear envelope ((Vollmer et al., 2012; see methods, 
(4.2.24.1)) with phosphatidylcholine (PC; 60 mol %) and phosphatidylethanolamine 
(PE; 20 mol %) as major components. The negatively charged lipids 
phosphatidylinositol (PI; 10 mol %) and phosphatidylserine (PS; 2.5 mol %) and as 
well as sphingomyelin (SM; 2.5 mol %) and cholesterol (chol; 5 mol %) were present. 
Individual lipid types except the main components (PC, PE) were removed from the 
mixture (marked by ∆) while therefore the amount of PC was increased (Fig. 2.9) 
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Figure 2.9: Cholesterol and sphingomyelin are required for ILV budding in pUL34-
GUVs  
pUL34 was labeled with Alexa-Fluor-546 and reconstituted in proteo-liposomes utilizing a 
lipid mixture mimicking the nuclear envelope composition (complete lipid mixture) or lacking 
individual lipids (indicated by Δ). Dried proteo-liposome layers were electroformed and GUVs 
were incubated with EGFP-pUL31 inducing vesicle formation. Recruitment of EGFP-pUL31 
was independent of the lipid composition. ILVs were efficiently formed except when GUVs 
were lacking either cholesterol (chol) or sphingomyelin (SM) indicating that both lipids are 
needed (A). Quantification of at least 50 GUVs per experiment and condition. Error bars 
represent mean of three independent experiments (+/- SEM) (B). GUVs were imaged by 
confocal microscopy. bars: 10 µm, PI - Phosphatidylcholine, PS - Phosphatidylserine 
 
pUL34 was reconstituted into GUVs using these different lipid compositions. In all 
conditions the recruitment of pUL31 was independent of the used lipid compositions 
(Fig. 2.9). The complete lipid mix was sufficient to promote vesicle budding from GUV 
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membranes (Fig. 2.2, 2.5, 2.7, 2.8). Additionally, individual removal of the charged 
lipids PI and PS or combined removal resulted in no decrease or block in vesicle 
induction upon pUL31 addition. Interestingly, no invaginations above background 
levels were observed when the lipid mixture was lacking either cholesterol or 
sphingomyelin (Fig. 2.9B) indicating that cholesterol and sphingomyelin are required 
for membrane invagination and scission.  
Both lipids are known to modulate membrane fluidity. As cholesterol and 
sphingomyelin also partition in the liquid ordered phase and are assumed to form 
lipid rafts in membranes the ability to induce phase separation in giant vesicles upon 
binding of pUL31 to pUL34 GUVs was investigated.  
 
2.1.6 Phase separation of lipids in GUV membranes. 
 
Biological membranes are composed of a heterogeneous mix of phospholipids and 
proteins. Some lipids organize themselves because of their physical properties in 
particular regions of the membrane termed phases. One can define two different fluid 
phases: the liquid disordered (Ld, also called Lα) and liquid ordered (Lo). Membranes 
containing high amounts of cholesterol or other sterols are able to form visible Lo 
domains in membranes (Klymchenko & Kreder, 2014; Baumgart et al., 2007). By 
using a mixture composed of equimolar amounts of DOPC: 
cholesterol:sphingomyelin GUVs can be generated having co-existing Lo and Ld 
domains, which are visible by light microscopy. Therefore fluorescent dyes were 
employed partitioning into the corresponding domain. Naphthopyrene was used as 
marker for the liquid ordered domain (LO) and DiD-C18 as marker for the liquid 
disordered (LD) domain. Both dyes showed correct phase behavior (Fig. 2.10B). 
Following the addition of pUL31 ILVs were induced. Visualizing fluorescence signals 
of naphthopyrene and DiD-C18 incorporated in GUV membranes showed no 
formation of a specific dye enriched phases neither in the giant vesicle membrane 
nor in the intra luminal vesicles formed employing the nuclear envelope mimicking 
composition (Fig. 2.10A). This indicates that pUL31/pUL34 interaction does not 
induce phase separation although it cannot be excluded that sub-resolution domains 
are formed which promote vesicle budding or ILV are enriched in specific lipids 
allowing membrane restructuring to vesicles. 
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Figure 2.10: pUL31 and pUL34 induce no visible phase separation in GUVs 
Alexa-Fluor-546 labeled pUL34 was reconstituted in GUVs and pUL31 was added to induce 
ILV formation. The used NE lipid mix was supplemented with naphthopyrene as marker for 
the cholesterol-and sphingomyelin-rich liquid ordered phase (LO) and the lipophilic dye DiI-C18 
as marker for the liquid disordered phase (LD). pUL34 was equally distributed and no phase 
separation was visible before or after the addition of pUL31 (A). To ensure functionality of the 
individual phase markers, GUVs comprising of a lipid mixture of 
DOPC:cholesterol:sphingomyelin (1:1:1), were generated with addition of naphthopyrene and 
DiI-C18 showing functional phase separation and localization of the fluorescent dyes (B). 
bars: 5 µm 
 
2.1.7 pUL31 is also recruited to the liquid ordered phase in ternary GUV system 
 
The ternary system of DOPC:cholesterol:sphingomyelin was used to assess the 
phase behavior of pUL31 when added to pUL34 GUVs. pUL34 was partitioning in the 
liquid disordered phase. Weak signals of pUL34 fluorescence were obtained in the 
liquid ordered phase and naphthopyrene signal were recorded in the liquid 
disordered phase resulting from incomplete phase separation (Fig. 2.11). 
Interestingly, an increased signal in the Lo phase of pUL31 could not be attributed to 
a binding affinity of pUL31 to either cholesterol or sphingomyelin as no binding was 
observed to either Lo or Ld phase in the absence of pUL34 (Fig. 2.12).  
Additionally, no invaginations could be observed when the ternary lipid composition 
was used. As high amounts of cholesterol increase the rigidity of the membrane 
(Rossman et al., 2010; Song & Waugh, 1993) the membrane bending ability of the 
pUL31/pUL34 complex is probably not high enough to overcome the membrane 
tension. 
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Figure 2.11: pUL31 is also recruited to the liquid ordered phase upon binding to pUL34 
GUVs were generated with reconstituted and Alexa-Fluor-546 labeled pUL34 from a lipid 
mixture of DOPC:cholesterol:sphingomyelin (1:1:1) supplemented with the liquid-ordered-
partitioning dye naphthopyrene (gray). EGFP-pUL31 was added to the GUVs leading to 
recruitment to the vesicle membrane containing pUL34, present in the liquid-disordered 
phase of the GUV. pUL31 was also strongly recruited to the liquid-ordered phase, almost 
lacking pUL34 indicating a presumable self-recruiting step. bars: 10 µm 
 
 
 
Figure 2.12: pUL31 does not bind ternary GUVs in the absence of pUL34 
GUVs were generated from a lipid mixture of DOPC:cholesterol:sphingomyelin (1:1:1) 
supplemented with the liquid-disordered-partitioning dye with DiI-C18 (red). EGFP-pUL31 was 
added to the GUVs leading to no recruitment to the liquid-disordered or liquid-ordered phase. 
bar: 10 µm 
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2.1.8 No energy depending step is involved in vesicle budding 
 
To verify that vesicle budding in GUV membranes involves an energy dependent step 
pUL34 giant vesicles were generated in a 130 mM glucose / 130 mM sucrose 
solution. A Hexokinase-glucose-system is commonly used to deplete energy 
(Magalska et al., 2014; Purich & Allison, 2000; Newmeyer et al., 1986). Prior to the 
addition of pUL31, both GUVs and pUL31 were incubated with either 10 mM ATP, 10 
mM GTP or 10 U / ml Hexokinase for at least 15 minutes. Vesicle formation was 
induced by adding pUL31 to the GUVs. Vesicle formation was quantified and no 
difference in efficiency could be observed in either supplying additional energy or 
depletion of energy (Fig. 2.13). 
 
 
Figure 2.13: Vesicle budding is not depending on provided energy  
GUVs were generated with Alexa-Fluor-546 labeled pUL34 in 130 mM glucose / 130 mM 
sucrose. EGFP-pUL31 was added to induce vesicle formation in presence of 10 mM ATP, 10 
mM GTP or an energy depletion system containing 10 U / ml Hexokinase. GUVs with ILVs 
were counted before and after the addition of EGFP-pUL31. No significant difference was 
observed in the three different conditions. 
 
Taken together, this data demonstrates that the two viral proteins pUL31 and pUL34 
are sufficient to induce membrane perturbations in the minimal GUV system resulting 
in generating intra-GUV vesicles. The forming buds were enriched in pUL31 and 
pUL34. Both proteins are therefore also sufficient for scission of budding vesicles. In 
addition binding, budding and scission do not require additional factors or provided 
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energy. Moreover, the GUV system is a valuable tool to investigate different aspects 
of the pUL31-pUL34 interaction mediating vesicle budding and scission. 
 
2.1.9 Determining the importance of the pUL34 transmembrane region 
 
The role of the transmembrane region in vesicle budding was analysed. For this a 
soluble pUL34 construct was generated lacking the C-terminally predicted 
transmembrane region. This pUL34 fragment referred to as pUL34∆TMR consisted of 
the N-terminal aa 1-240. The fragment was purified in sufficient amounts from E. coli 
lysate by nickel affinity purification and labeled with the Alexa-Fluor-546 fluorescent 
dye. Soluble proteins are not only recruited to membranes by protein-integral 
membrane-protein-interactions but also by direct lipid binding. Direct membrane 
binding is mediated by specific protein domains like e.g. formation of a membrane 
inserting amphipathic helices, BAR domains or FYVE zinc finger domains. These 
interactions are mediated by high initial curvature or by electrostatic interactions with 
special lipid types including phosphoinositide (PIPs), phosphatidic acid (PA), diacyl-
glycerol (DAG), Ceramide (van Meer et al., 2008). As no structural predictions 
indicate for lipid binding domain formation in pUL34 or pUL31 as well as no special 
lipids are present in the lipid mixture, a head group functionalized lipid was employed. 
Phosphatidylcholine modified with a chelating Ni-NTA group is capable of efficiently 
binding His6-tagged proteins and was added to 1 mol % to the complete lipid mixture 
and is referred as Ni-DGS. Giant unilamellar vesicles obtained by electroformation of 
dried chloroform solved lipid films usually result in high yields achieved in less time. 
Unfortunately due to the use of chloroform no membrane proteins can be 
reconstituted thereby preventing the use of this technique in the previous assays 
(see methods, (4.2.27)). When the soluble His6-tagged fragment of pUL34∆TMR was 
added to nickel lipid functionalized GUVs, it was efficiently recruited to the vesicle 
membrane (Fig. 2.14). 
The recruitment was not sufficient to induce ILV formation into GUVs consistent with 
the observation that full length pUL34 is not sufficient to induce vesicle budding (Fig. 
2.2). Verifying if pUL31 can still interact with the soluble pUL34 fragment, pUL31 was 
added to GUVs previously incubated with pUL34∆TMR. Additionally, it was verified, if 
in case of binding, the proteins are still functional to remodel GUV membranes to 
vesicles. To avoid a direct interaction with the functionalized GUV membranes the 
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pUL31 added was lacking a His6-tag. Indeed, pUL31 still bound to the GUV-bound 
pUL34 fragment and pUL31 recruitment was also sufficient to induce vesicle 
formation. The vesicle formation was induced independent if pUL31 bound the N-
terminally (Fig. 2.14A) or C-terminally (Fig. 2.14B) His6-tagged pUL34∆TMR fragment 
recruited. This gave rise to address the contribution of pUL34 to membrane 
deformation and vesicle budding in more detail. 
 
 
2 Results 
 
34 
 
 
Figure 2.14: The transmembrane region of pUL34 is not important for vesicles budding  
Chloroform dissolved lipids (NE-mix) supplemented with 1 mol % Ni-DGS were dried and 
electroformed. GUVs were incubated with a Alexa-Fluor-546 labelled pUL34 fragment (aa 1-
240) lacking the C-terminal transmembrane domain. The either (A) N- or C-terminally (B) 
His6-tagged fragment was efficiently recruited to the GUV membrane but was not sufficient to 
induce vesicle formation. Upon addition of EGFP-pUL31 lacking a His6-tag was recruited to 
the limiting membrane indicating that pUL31 was recruited via interaction with pUL34 to the 
vesicles. Most importantly the pUL31-pUL34 (aa 1-240) interaction was also sufficient to 
induce vesicle formation suggesting that the transmembrane region is not essential to drive 
vesicle budding. bars: 5 µm 
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2.1.10 pUL34 is dispensable and pUL31 is sufficient for vesicle budding 
 
As previously demonstrated, pUL34 alone is not sufficient to induce vesicle budding. 
Only addition of pUL31 to pUL34 GUVs either harbouring an authentic 
transmembrane domain (Fig. 2.2) or artificially recruited to membranes (Fig. 2.14) is 
sufficient for budding and scission of ILVs. Therefore the contribution of pUL31 was 
determined. 
Hence, His6-EGFP-pUL31 was artificially recruited to Ni-DGS-GUV membranes. 
Interestingly, the recruitment of pUL31 to the vesicle membranes was already 
sufficient to induce budding and scission of vesicles from the GUV membranes (Fig. 
2.15A). In contrast, no invaginations were observed when His6-tagged EGFP was 
recruited to Ni-DGS-GUVs (Fig. 2.15B).  
 
Figure 2.15: Artificial recruitment of pUL31 is sufficient to induce vesicle budding 
GUVs from chloroform dissolved lipids (NE-mix) containing 1 mol % Ni-DGS were generated 
by electroformation. His6-tagged pUL31 was efficiently recruited to the GUV membrane (A). 
The recruitment induced vesicle formation and detachment from the GUV membrane 
visualized by EGFP fluorescence in forming ILVs while recruitment of His6-tagged EGFP only 
led to no vesicle formation (B). The GUV membrane was visualized by addition of the 
lipophilic dye DiD-C18. bars: 5 µm 
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Figure 2.16: The number of GUVs with intralumenal vesicles (ILVs) was quantified. 
For each condition and experiment at least 80 GUVs were analysed in three independent 
experiments. The number of GUVs with detectable ILVs was counted before and after the 
addition of His6-EGFP-pUL31 to GUVs originated from chloroform dissolved lipids + 1 mol % 
Ni-DGS. For each condition and experiment stack images of at least 20 GUVs with 
detectable ILVs were recorded and the amount (B) as well as the approximately size (C) of 
the ILVs was measured. A significant increase of ILVs could be detected only when His6-
EGFP-pUL31 was added to the GUVs but not when His6-EGFP was added (A-B). The size 
distribution of ILVs (C) shows that the most of the ILVs (~ 67 %) was about 0.5 - 1 µm in 
diameter. Also vesicles of 1 – 1.5 µm (~25 %) and vesicles larger than 1.5 µm (~8 %) were 
detected. Error bars represents the mean (-/+ SEM) of three independent experiments. 
 
Quantification of three independent experiments in three different conditions was 
performed (Fig. 2.16) showing a constant background of GUVs with invaginations of 
about 15 - 20 % (Fig. 2.16A) as observed previously (Fig. 2.4A, Fig. 2.9B). Only 
addition of pUL31 to Ni-DGS-GUVs increased ILV levels while recruitment of EGFP 
did not raise levels above background (Fig. 2.16B). To determine the size of the 
observed ILVs found in pUL31 treated GUVs stack images of at least 20 different 
GUVs containing ILVs were taken in three independent experiments. Data analysis, 
by counting and measuring ILV in each recorded stack, showed that the majority of 
the ILVs had a diameter of 0.5 - 1.0 µm (65 %) followed by vesicles with a greater 
diameter (25 % Ø 1.0-1.5 µm). Vesicles with diameter greater than 1.5 µm 
represented only 10 % (Fig. 2.16C) 
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2.1.11 pUL31 concentrates in emerging buds formed in GUV membranes 
 
Artificial recruitment of pUL31 resulted in enrichment of the protein in GUV 
membranes. Upon recruitment vesicle buds were formed and pinched of from the 
limiting membrane (Fig. 2.15). As pUL31 and pUL34 enrich upon addition of pUL31 in 
pUL34 GUVs, also pUL31 recruitment to Ni-DGS-GUVs resulted in local enrichments 
in formed buds (Fig. 2.17A, upper panel). By using the straighten line tool of the 
image analysis software ImageJ, fluorescent signals in induced buds of EGFP-pUL31 
and the membrane, stained by DiD-C18 were analyzed. Intensities were normalized 
and plotted (Fig. 2.17A, lower panel). EGFP-pUL31 is clearly concentrated in the 
forming buds and as indicated by fluorescence analysis enriched at least two fold 
compared to average EGFP-pUL31 signals. The membrane fluorescent dye DiD-C18 
does not seem to increase above background levels indicating a specific enrichment 
only in EGFP-pUL31. A three dimensional reconstruction of stack images taken was 
done from a Ni-DGS-GUV incubated with His6-EGFP-pUL31 showing multiple ILVs in 
close proximity of inner GUV membrane as well as vesicles detached and floating in 
the lumen of the giant vesicle (Fig. 2.17B).  
Budding steps of vesicles from representative GUV membranes based on the His6-
EGFP-pUL31 signals (Fig. 2.18) indicate that pUL31 is sufficient to induce membrane 
budding as well as vesicle formation and final scission. 
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Figure 2.17: pUL31 accumulates in nascent buds and is sufficient to form vesicles 
which are disconnected from the GUV membrane. 
pUL31 accumulates at sites were nascent buds in the GUV membrane emerge. Fluorescent 
signals of His6-EGFP-pUL31 and of the lipophilic dye DiD-C18 was quantified using the 
straighten function of Fiji (ImageJ) and the normalized fluorescent intensity for both signal 
was plotted indicating an accumulation of pUL31 in the emerging buds (A). bars: 1 µm 
Three dimensional reconstitution of a GUV with 1 mol % Ni-DGS incubated with His6-pUL31 
which shows efficiently bound His6-EGFP-pUL31 and highly mobile vesicles distant and 
apparently detached from the GUV membrane (B). bars: 5 µm 
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Figure 2.18: Recruiting pUL31 to GUVs is sufficient for vesicles budding and 
detachment from the GUV membranes 
GUVs containing 1 mol % Ni-DGS were incubated with His6-EGFP-pUL31. Confocal pictures 
were taken from different representative GUVs showing different time points in budding and 
detaching of ILVs from the GUV membrane. bars: 2 µm 
 
2.1.12 Determining the influence of lipid compositions in His6-EGFP-pUL31 
induced vesicle budding 
  
One benefit of the GUV system is that lipid compositions used can be varied. 
Therefore the roles of lipids and their contribution in vesicle budding upon His6-
EGFP-pUL31 can be investigated. Thus, individual lipids were removed from the lipid 
composition (see methods, (4.2.24.1)) used (indicated by ∆). Removed lipids were 
replaced by the same amount of PC. The negatively charged lipids 
phosphatidylinositol (PI; 10 mol %) and phosphatidylserine (PS; 2.5 mol %) as well 
as sphingomyelin (SM; 2.5 mol %) and cholesterol (chol; 5 mol %) were present in 
minor quantities (as indicated in mol %).  
All used lipid compositions were able to recruit His6-EGFP-pUL31 to GUV 
membranes (Fig. 2.19). Removal of the negatively charged lipids PI or PS as well as 
co-removal of both from the lipid composition had no influence on His6-EGFP-pUL31 
recruitment as well as induction of vesicle budding from the GUV membrane. 
Again, as observed before (Fig. 2.9) exclusion of cholesterol and sphingomyelin, or a 
combination of both, resulted in block of vesicle budding after adding His6-EGFP-
pUL31 (Fig. 2.19). This was also apparent as vesicle amounts in GUVs were not 
higher than background levels of untreated GUVs indicating a requirement for 
cholesterol and sphingomyelin to remodel GUV membranes to promote vesicle 
budding and scission. 
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Figure 2.19: Cholesterol and sphingomyelin are required for pUL31 mediated vesicle 
formation 
GUVs were generated from a chloroform dissolved lipid mixture mimicking the nuclear 
envelope composition (complete lipid mixture) or lacking individual lipids (indicated by Δ) (A). 
All lipid mixtures contained 1 mol % of the head group modified lipid Ni-DGS. GUVs were 
incubated with EGFP-pUL31 inducing vesicle formation. Recruitment of EGFP-pUL31 was 
independent of the lipid composition. ILVs were efficiently formed except when GUVs were 
lacking either cholesterol (chol) or sphingomyelin (SM) indicating that both lipids are needed. 
Shown is the quantification of at least 60 GUVs per experiment and condition analysed 
before and after the addition of EGFP-pUL31 (B). Error bars represent mean of three 
independent experiments (+/- SEM). GUVs were imaged by confocal microscopy. bars: 
10µm, PI - phosphatidylinositol, PS - phosphatidylserine 
 
2.1.13 pUL31 is able to self-interact on GUV membranes  
 
The mechanism of pUL31/pUL34 as well as pUL31-only mediated vesicle budding is 
still enigmatic. As observed before pUL31 is concentrated in invaginations and 
budding spots. Many membrane remodelling proteins, such as clathrin or 
components of the COP I/II or ESCRT machinery can oligomerize on the deforming 
membrane (McDonald & Martin-Serrano, 2009; Ford et al., 2002). The hypothesis 
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that pUL31 could form a coat or coat-like structure driving membrane deformation 
and vesicle budding is tempting. Therefore, giant unilamellar vesicles utilizing the 
complete lipid mix supplemented with 1 mol % of Ni-DGS were used. His6-tagged 
and unlabeled pUL31 was added to GUVs in a 60 nM concentration. This 
concentration was not sufficient to induce vesicle formation (Fig. 2.20A, first row). 
Untagged EGFP-pUL31 was then added to pre-treated GUVs or as a control to 
untreated vesicles (Fig. 2.20A, last row). Indeed, EGFP-pUL31 was recruited to 
pUL31 pre-treated GUVs but not to untreated vesicles. To verify that soluble proteins 
were not unspecifically binding to pre-treated GUVs untagged EGFP was added and 
showed no binding to pre-treated GUVs (Fig. 2.20A, fifth row). Concentrations of 125 
nM of EGFP-pUL31 as well as additional 60 nM His6-UL31 already induced ILV 
formation (Fig. 2.20A, second row). 
This demonstrates that membrane tethered pUL31 can recruit soluble pUL31 by self-
interaction to membranes and is sufficient for vesicle formation in the GUV system. 
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Figure 2.20: pUL31 self-interacts on GUV membranes 
GUVs from chloroform dissolved lipids containing 1 mol % Ni-DGS were incubated with 60 
nM His6-pUL31 not sufficient to induce vesicle formation. EGFP-pUL31 lacking a His6-tag 
was added in different concentrations. EGFP-pUL31 was recruited in a concentration 
dependent manner only to pre-incubated vesicles but not in the absence of with His6-UL31 
nor was EGFP recruited to the pre-incubated vesicles (A). 
Quantification indicating a drastically increase in ILV formation only when EGFP-pUL31 was 
added. Error bars represents the mean (-/+ SEM) of three independent experiments (B). 
 
2.1.14 pUL31 does not oligomerize in solution 
 
As pUL31 can oligomerize on GUV membranes (Fig. 2.20A) it was tested for 
oligomerization in solution. A GST-pull-down assay was employed to test if pUL31 
can recruit pUL31 in solution. GST (control), GST-pUL31 and GST-pUL34ΔTMR 
were bound to GSH sepharose and incubated after blocking with BSA with bacterial 
lysates expressing either His6-pUL31 (Fig. 2.21A) or EGFP-UL31 (Fig. 2.21B). Bound 
proteins were eluted with PreScision protease and subsequently analysed by SDS–
PAGE and western blotting. Detection using His6- and EGFP-antibodies revealed an 
interaction of His6-pUL31 as well as EGFP-pUL31 with GST-pUL34ΔTMR 
demonstration that the interaction between pUL31 and pUL34 is independent of the 
used protein tag. In addition, no interactions were observed between His6-pUL31 or 
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EGFP-pUL31 and GST-pUL31 or with the GST control verifying that pUL31 does not 
self-interact in solution and the pUL31/pUL34 interaction is specific.  
 
 
 
Figure 2.21: pUL31 does not self interact in solution 
GST pull down experiments were performed using GST alone (control), GST-pUL31 or GST-
pUL34ΔTMR (aa 1-240) as baits. Recombinant proteins were expressed in E. Coli, purified 
and bound to GSH-sepharose. Baits were incubated with bacterial lysates containing 
recombinant His6-pUL31 or EGFP-pUL31. Eluates were analysed by western blot analysis 
using antibodies against His6 (A) or EGFP (B). pUL31 was pulled down in both cases (A and 
B) by pUL34, while pUL31 does not pull down pUL31 and also no interaction with pUL31 was 
observed when using GST as bait. 
  
In addition, size exclusion chromatography coupled with multi-angle laser light 
scattering (MALLS) was performed, a technique for determining the absolute molar 
mass and the average size of particles in solution. This revealed that EGFP-pUL31 
exists monomeric in solution with a size of 49.2 kDa (calculated size = 58.7 kDa) and 
does not oligomerize in solution (Fig. 2.22). 
 
2 Results 
 
44 
 
 
 
Figure 2.22: EGFP-pUL31 runs monomeric in solution  
Size exclusion chromatography was performed on a Superdex 75/300 GL column followed 
by multiangle static laser light scattering (MALLS) of EGFP-UL31 and shows that it is 
monomeric in solution (calculated mass 58.7 kDa). The black dots relate to the secondary 
axis and show the measured molecular weight of the eluting particles. 
 
2.1.15 pUL31 induces oligomerization in supported lipid bilayers 
 
To visualize the pUL31 oligomerization on membrane surfaces and accompanied 
membrane restructuring, supported lipid bilayers, comprised of the nuclear envelope 
lipid composition supplemented with Ni-NTA-DGS were employed. His6-EGFP-
pUL31 was recruited to the supported lipid bilayers within seconds where it formed 
patches of 1.0 ± 0.5 µm in diameter (Fig. 2.23A). 
In addition, not only patch formation was induced also recruitment gave rise to the 
appearance of multiple membrane defects indicating disruption of the lipid bilayer 
(Fig. 2.23A). Accumulation of membrane defects resulting most likely by increased 
membrane tension associated with the membrane deforming activity of pUL31. In 
contrast, His6-EGFP was also efficiently recruited to the supported lipid bilayers but 
did not induce patch formation or disruption of the bilayer (Fig. 2.23B).  
Formed patches on bilayers were tracked over time (Fig. 2.23C). Subsequently, 
individual patches fused and were not traceable after 40 seconds. 
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Figure 2.23: pUL31 addition leads to disruption of supported lipid bilayers (SLBs) 
SLBs were generated utilizing NE-mix supplemented with 1 mol % Ni-DGS as well as 0.1 
mol % Rhodamin-PE. The same areas on SLBs were imaged before and after the addition of 
His6-EGFP-pUL31 (A). After only few seconds pUL31 is efficiently recruited to the SLB and 
forms patches of about 1.2 ± 0.2 µm. Further pUL31 recruitment is observed in a time series 
leading to disruption of the lipid layer and lipid accumulation (A, lower panels). Addition of 
His6-EGFP instead results in recruitment but no observable morphological changes of the 
SLB (B). The diameter of formed patches was analysed until about 40 seconds. After that 
time point the majority of patches fuse and can no longer be tracked (C). bars: 50 µm 
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2.1.16 Atomic force microscopy reveals oligomerization into small protein 
patches of pUL31 on supported lipid bilayers 
 
Atomic force microscopy (AFM) was performed on supported lipid bilayers incubated 
with His6-EGFP-pUL31 or His6-EGFP, respectively. AFM allows high resolution 
imaging of lipid surfaces. A cantilever with a small tip is scanning the surface of the 
sample by lateral movement of the probe or sample. By measuring lateral and 
vertical deflection of a laser beam by a photo detector high image resolution, with a 
vertical resolution up to 0.1 nm, is achieved. 
Supported lipid bilayers with a nuclear envelope lipid composition including 1 mol % 
Ni-DGS and 0.1 mol % Rhodamin-PE for fluorescent imaging were generated (Fig. 
2.24A). pUL31 was added to the supported bilayer in a concentration of about 150 
nM (Fig. 2.24B). Higher resolution images of patches formed showed no clear 
structure of recruited pUL31 (Fig. 2.24, right panel). Higher concentration added 
resulted in excessive recruitment to the bilayer and in no general observable 
structures (not shown), as time between addition of the protein and image acquisition 
is about five to ten minutes. 
Recruitment of His6-EGFP to supported lipid bilayers followed by atomic force 
microscopy showed not the patch phenotype but a smooth recruitment to the lipid 
layer. Additionally no increase in surface height could be noticed (Fig. 2.24C and D) 
demonstrating no remodeling activity of EGFP. A surface profile was created which is 
depicted by a yellow line (Fig. 2.24A-D) tracing the height and distance. The diameter 
and height (roughness) of the patches upon His6-EGFP-pUL31 addition were 
analyzed (Fig. 2.24E and F). The majority of patches observed had a diameter of 
about 1 µm ± 0.5 µm (~ 66 %) while patches with greater diameters (~31 %) and 
smaller diameter (~ 3 %) were less frequent. Also the average height (roughness) 
showed a mean patch height of about 2 nm (~75 % of analyzed patches). Atomic 
force microscopy (AFM) and supported lipid layer (SLB) experiments were performed 
in collaboration with Prof. Dr. Ana J. García-Sáez and Joseph Unsay at the 
Interfaculty Institute for Biochemistry (IFIB), University of Tübingen, Germany. 
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Figure 2.24: Atomic force microscopy (AFM) of supported lipid bilayers (SLBs) reveals 
patch formation upon addition of pUL31 
Supported lipid bilayers were generated by applying SUV (NE mix + 1 mol % of Ni-DGS) in 
presence of calcium to mica support discs. AFM was performed on SLB before and after 
addition of His6-EGFP-pUL31 (A and B) or before and after addition of His6-EGFP (C and D) 
revealing patch formation as well as membrane resculpturing upon incubation with pUL31. 
Incubation of EGFP only with the SLB had no topological effect. The right panel in B is a 3x3 
µm magnification of the yellow marked box of the left panel. Graphs below the images are 
corresponding profiles of the yellow lines in each image. Upon addition of His6-EGFP-pUL31 
the diameter (E) and roughness (average height of the patches) (F) distributions of the 
observed patches was analysed and plotted. The graphs indicate a peak at 1.0 ± 0.5 µm in 
diameter (mean ± standard deviation), and 2.0 ± 0.1 nm in roughness (F). bars: (A) 10 µm, 
(B-D) 2 µm 
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2.1.17 Mutational analyses of a conserved sequence in UL31 
 
Sequence alignments of pseudorabies virus UL31 and homologues of human 
pathogenic herpes viruses revealed four constant regions (Loetzerich et al., 2006) 
with high conservation (Fig. 2.25) indicated by gray boxes. The highest grade of 
conservation was found in the region comprising aa 56-101 of suid herpes virus-I 
(PRV, suHV-1) pUL31. The interaction site of homologues of pUL31 with pUL34 in 
MCMV was mapped to the CR1 of the pUL31 homologue (Loetzerich et al., 2006). To 
verify if single conserved residues in the CR1 are involved in binding to pUL34 and 
the remodelling activity of pUL31 a mutational analysis was performed. Using this 
method it was analyzed if both functions membrane remodeling and pUL34 binding 
of pUL31 could be separated or if they are located in the same region. Therefore 
single point mutations of conserved residues were generated. 
 
 
 
Figure 2.25: Sequence alignments indicate four constant regions 
Sequence alignment of PRV pUL31 and homologues of human pathogenic herpes virus 
subspecies including the N-terminal 240 aa of each protein. Areas with high conservation are 
indicated by gray boxes. Multiple sequence alignment was created using ClustalX software 
v.2.1. 
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Most noticeable were three conserved and one only in herpes HHV-1/2 and Kaposi's 
sarcoma-associated herpesvirus (HHV-8/KSHV) conserved cysteine residues in the 
first constant region. Cysteine residues are important for stabilizing protein structures 
e.g. upon stable formation of disulfide bridges or complexing metal ions such as zinc. 
To understand the importance of these residues in pUL31 individual point mutants of 
C73S, C88SC89S and C92S were generated (Fig. 2.26). The cysteine residues may 
be engaged in disulphide bond formation allowing this conserved stretch of the 
protein to form an interface for pUL34 interaction and/or to form higher order homo-
oligomers/hetero-oligomers. 
 
 
 
Figure 2.26: Sequence alignment of the first constant region of UL31  
Homologous pUL31 sequences among the herpes viruses family are shown. The highly 
conserved cysteine residues are shown in purple and red arrows indicate cysteines that were 
substituted by serine residues.  
  
2.1.18 Cysteine mutations block pUL31 interaction with pUL34 
 
Cysteine to serine mutants in pUL31 were expressed in E. coli with an EGFP tag as 
before. When added to UL34 GUVs none of these UL31 mutants were recruited to 
the membrane surface (Fig. 2.27). 
As no interaction with pUL34 was observed it was tested if the ability to induce 
vesicles upon addition to Ni-DGS containing GUVs was affected. 
pUL31 cysteine mutants were added in the same concentration of 500 nM to GUVs. 
The mutants were efficiently recruited to GUV membranes, but were not able to 
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induce vesicle formation (Fig. 2.28B-D). Also higher concentrations were tested (not 
shown) and were not able to restore membrane remodelling ability compared with the 
wild-type protein (Fig. 2.28A). 
 
 
 
Figure 2.27: pUL34 and pUL31 cysteine mutants do not interact in GUV membranes 
pUL34 was labeled with Alexa-Fluor-546 and reconstituted in proteo-liposomes. Dried 
proteo-liposome layers were electroformed. Resulting GUVs were incubated with EGFP 
tagged pUL31 cysteine mutants. None of the pUL31 mutants was recruited to the GUV 
membrane demonstrating a block in pUL34 binding. bars: 10µm 
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Figure 2.28: Cysteine point mutations also abrogate vesicle formation in GUV 
membranes 
GUVs from chloroform dissolved lipids (NE-mix) containing 1 mol % Ni-DGS were generated 
by electroformation. His6-tagged pUL31 was efficiently recruited to the GUV membrane (A). 
The recruitment induced vesicle formation and detachment from the GUV membrane 
visualized by EGFP fluorescence in forming ILVs while recruitment of His6-tagged pUL31 
point mutants resulted in no ILV formation (B-D). The GUV membrane was visualized by 
addition of the lipophilic dye DiD-C18. bars: 5 µm 
 
A GST pull down assay was performed to confirm the observed block in interaction 
with pUL34 GUVs. Therefore GST only (control) and GST-pUL34ΔTMR (aa 1-240) 
were used as baits. The baits expressed in E. coli and immobilized to GSH 
sepharose beads were incubated with bacterial lysates containing recombinant His6-
pUL31 or His6-pUL31 mutants. The eluates were generated by PreScission protease 
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cleavage of the target sequence in the bait proteins. The elutions were analysed by 
western blot analysis using antibodies against EGFP (Fig. 2.29). pUL31 was pulled 
down efficiently by pUL34 but not the pUL31 mutants (Fig. 2.29B) indicating the 
cysteine mutations abrogated interactions between pUL31 and pUL34. 
 
A 
 
 
 
B 
 
 
Figure 2.29: GST pull down assays indicate no interaction of pUL31 mutants with 
pUL34 
GST pull down experiments were performed using GST alone (control) and GST-
pUL34ΔTMR (aa 1-240) as baits. Recombinant proteins were expressed in E. coli purified, 
bound to GSH-sepharose and blocked with BSA. Baits were incubated with equal amounts of 
bacterial lysates containing recombinant His6-pUL31 or His6-pUL31 mutants (A). Eluates 
were analysed by western blot analysis using antibodies against EGFP (B). pUL31 was 
pulled down efficiently by pUL34 but not the pUL31 mutants (B) indicating mutations 
abrogated interaction between both proteins. 
 2 Results 
 
53 
 
2.1.19 Mutation of conserved amino acids in the first constant region of pUL31 
affects pUL34 binding and self-interaction  
 
Mutation of the conserved cysteine residues in the first constant region of pUL31 
resulted in a block of pUL34 interaction and membrane remodeling ability upon 
artificial recruitment to giant vesicle membranes (Fig. 2.27, Fig. 2.28). This indicates 
that these cysteine residues play an important structural role or are involved in 
pUL31-pUL31-interaction. Therefore, both functions could not be separated by 
cysteine mutations.  
To further assess if additional mutations in the first constant region could fulfill this 
requirement further single point mutations were generated (Fig. 2.30). Additionally, 
the double cysteine mutation C88SC89S in pUL31 was further investigated by the 
respective individual point mutations verifying if only one or both cysteines are 
involved in membrane deformation. The membrane remodeling ability of the mutants 
was determined employing Ni-DGS-GUVs. All mutants expressed with an EGFP tag 
were efficiently recruited to GUV membranes (Fig. 2.31, Fig. 2.32). Wild type pUL31, 
the L76A, S77A, G80A and C88S mutations were able to induce vesicle formation 
from GUV membranes while P62A, L74A and C89S mutations in pUL31 were not 
sufficient for vesicle formation (Fig. 2.31, Fig. 2.32, summarized in Tab. 2.1). These 
results further indicate an importance of the first constant region for the membrane 
remodeling property of pUL31 and pUL34 binding. 
 
Figure 2.30: Multiple conserved residues in the first constant region were exchanged 
Sequence alignment of a part of the first constant region of pUL31 and homologues of 
human pathogenic herpes virus subspecies are shown. Conserved residues additional to 
cysteines were mutated and are highlighted. Amino acid exchanges are represented in green 
letters above the alignment. 
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Figure 2.31: Conserved residues in pUL31 are involved in membrane remodelling 
The amino acids proline (position 62) and leucine (position 74) in pUL31 appear to be 
important for membrane remodeling activity of pUL31 in GUV membranes. Amino acid 
exchange of leucine (position 76 substituted by alanine) is still able to form invaginations in 
GUV membranes 
 
 
  
 2 Results 
 
55 
 
 
 
Figure 2.32: Conserved residues in pUL31 are involved in membrane remodeling 
The cysteine residue (in position 89) is important for membrane remodeling activity of pUL31 
in GUV membranes while cysteine mutation (position 88 to serine) appears not to influence 
remodeling activity. Single point mutation of serine (position 77 substituted by alanine) and 
glycine (position 80 substituted by alanine) are still able to induce vesicle budding in GUV 
membranes. 
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protein 
membrane  
remodelling 
 activity 
  protein 
membrane  
remodelling 
activity 
His6-EGFP-pUL31 yes   His6-EGFP-pUL31 S77A yes 
His6-EGFP-pUL31 P62G no   His6-EGFP-pUL31 G80A yes 
His6-EGFP-pUL31 L74A no   His6-EGFP-pUL31 C88S yes 
His6-EGFP-pUL31 L76A yes   His6-EGFP-pUL31 C89S no 
 
Table 2.1: S Summary of mutated conserved residues in pUL31 and their membrane 
remodeling activity  
His6-EGFP-tagged pUL31 mutants were bound to GUV containing 1 mol % Ni-DGS and 
analyzed for their membrane remodeling activity. 
  
2.1.20 Coexpression of pUL31 and pUL34 in eukaryotic cells shows remodeling 
of nuclear membranes 
  
The viral proteins pUL31 and pUL34 are required for primary envelopment at the 
inner nuclear membrane. Coexpression of pUL31 and pUL34 of alpha-herpesvirus 
pseudorabies virus (PRV) in RK13 cells resulted in the formation and accumulation of 
vesicles in the perinuclear space between outer and inner nuclear membrane (Klupp 
et al., 2007). Vesicles present in the perinuclear space are supposed to be similar to 
viral envelopes. These vesicles contain pUL31 and pUL34 and are derived most 
likely from the inner nuclear envelope. Thus, coexpression of only these two 
herpesvirus proteins in the absence of other viral factors is sufficient to remodel 
nuclear membranes. 
To verify results obtained from the giant unilamellar vesicle assay with recombinant 
proteins a eukaryotic cell system was employed. HeLa cells as well as HEK293T 
cells were transiently transfected for 24 hours. Cells were fixed with 4 % PFA and 
subjected to confocal microscopy to verify localization and possible interactions of 
pUL31 and pUL34. 
Upon expression pUL31 localizes in the nucleoplasm while pUL34 is localized in the 
nuclear membranes and endoplasmic reticulum (Fig. 2.33, upper and middle panel). 
Coexpression of pUL31/pUL34 resulted in their relocalization. The predominant part 
of pUL31 was localized to the rim of the nucleus while also pUL34 distribution was 
altered to be increase in nuclear membranes. Additionally and most noticeable was 
the appearance of nuclear spots with co-localizations of both proteins (Fig. 2.33, 
lower panel) consistent with previous observations (Klupp et al., 2007). These spots 
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were mostly localized at the nuclear rim as well as in the nucleoplasm probably 
disconnected from the nuclear periphery. The cotransfection of pUL31 with pUL34 
did not only result in spot formation, but also showed protrusions forming from 
nuclear membranes towards the cytoplasm presumably representing membrane 
proliferation overlapping in pUL31 and pUL34 fluorescent signals (Fig. 2.34). The 
observed membrane proliferations is consistent with previous studies showing 
membrane proliferation upon overexpression of pUL31/pUL34 homologs orf67/orf69 
of HHV-8 and BFRF1/BFLF2 of HHV-4 (Luitweiler et al., 2013; Gonella et al., 2005; 
Lake et al., 2004). 
 
 
 
Figure 2.33: Coexpression of pUL31 and pUL34 results in patch formation 
HeLa cells were transiently transfected with plasmids expressing either EGFP-pUL31 or 
mCherry pUL34 for 24 hours. Expression of pUL31 only shows an exclusively nucleoplasmic 
localisation while expression of pUL34 shows an ER and nuclear membrane localisation. Co-
expression of both proteins leads to the recruitment of pUL31 to the nuclear membrane and 
patch formation showing overlapping signals of both proteins. DNA was stained with DAPI. 
bars: 5 µm 
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Figure 2.34: Coexpression of pUL31 and pUL34 results in membrane alterations 
Transient overexpression of cotransfected pUL31 and pUL34 results in membrane 
protrusions, presumably forming from the inner nuclear membrane. Chromatin structure 
appears to be altered at spots colocalizing with putative membrane lobes.  
 
2.1.21 Expression of artificial membrane tethered pUL31 induces patch 
formation in the nuclear envelope 
 
pUL31 is a soluble protein located in the nucleoplasm due to a nuclear localization 
signal formed by a basic stretch in the first 20 aa of the protein. As pUL31 is only 
recruited via pUL34 to the inner nuclear membrane, analyzing pUL31 membrane 
interaction in the absence of pUL34 requires therefore artificial tethering to nuclear 
membranes. Therefore constructs were generated expressing full length pUL31 C-
terminally fused with the transmembrane domain of pUL34 (aa 241-262) or SCL1 (aa 
77-97), an integral membrane protein of the inner nuclear membrane (Fig. 2.38). In 
addition full length pUL31 fused N-terminally with the N-terminal transmembrane 
domain of pom121 (aa 1-55), a integral membrane protein of the nuclear pore 
complex and upstream of the transmembrane domain the construct harbours a inner 
nuclear membrane signal of rat gp210 also another integral membrane protein of the 
nuclear pore complex (Fig. 2.38).  
Transient transfection of HeLa cells expressing artificial membrane constructs 
resulted in patch formation lining up at the presumably inner nuclear membrane 
confirming membrane remodelling activity of pUL31 also in the absence of pUL34 
(Fig. 2.35). Additional nucleoplasmic EGFP signal was observed which presumably 
results from degradation of membrane bound pUL31. 
To verify that the observed results are independent of the used cell type HEK293T 
cells were also transiently transfected with pUL31 and pUL34. The same pattern was 
observed in HEK293T cells expressing either pUL31 or pUL34 or co-expression of 
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both (Fig. 2.36), demonstrating that membrane remodelling activity of the 
pUL31/pUL34 complex or of artificial tethered pUL31 only (Fig. 2.37) is independent 
of the cell type used. 
 
 
Figure 2.35: Expression of membrane bound pUL31 leads to patch formation. 
HeLa cells were transiently transfected with plasmids expressing transmembrane fusion 
constructs of pUL31 for 24 hours. Expression of constructs with a C-terminally fused 
transmembrane region (TMR) of pUL34 (aa 241-262) or SCL1 (aa 77-97) as well as a N-
terminally fused TMR of Pom121 (aa 1-55) together with an inner nuclear membrane 
localisation signal of rat gp210 resulted in a mostly nuclear membrane localisation and patch 
formation. DNA was stained with DAPI. bars: 5 µm 
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Figure 2.36: Coexpression of pUL31 and pUL34 results in patch formation 
HEK293T cells were transiently transfected with plasmids expressing either EGFP-pUL31 or 
mCherry pUL34 for 24 hours. Expression of pUL31 only shows an exclusively nucleoplasmic 
localisation while expression of pUL34 shows an ER and nuclear membrane localisation. Co-
expression of both proteins recruits pUL31 to the nuclear membrane and patch formation is 
induced resulting in overlapping signals of both proteins. DNA was stained with DAPI. bars: 5 
µm 
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Figure 2.37: Expression of membrane bound pUL31 results in patch formation in 
HEK293T cells 
HEK293T cells were transiently transfected with plasmids expressing transmembrane fusion 
constructs of pUL31 for 24 hours. Expression of constructs with a C-terminally fused 
transmembrane region (TMR) of pUL34 (aa 241-262) or SCL1 (aa 77-97) as well as a N-
terminally fused TMR of POM121 (aa 1-55) together with an inner nuclear membrane 
localisation signal of rat gp210 resulted in a mostly nuclear membrane localisation and patch 
formation. bars: 5 µm 
 
 
 
 
Figure 2.38: Scheme of pUL31 transmembrane constructs 
The transmembrane domains (TMR) of pUL34 (aa 241-262) or SCL1 (aa 77-97), an 
integral membrane protein of the inner nuclear membrane were fused to the C-
terminus of full length pUL31. The transmembrane domain of Pom121 (aa 1-55), an 
integral membrane protein of the nuclear pore complex and the inner nuclear 
membrane targeting signal of rat gp210, another integral membrane protein of the 
nuclear pore complex, were fused upstream of the N-terminus of full length pUL31. 
 
2.1.22 Nuclear patches do not contain nuclear pore complexes 
 
To define the observed nuclear patches in more detail the presence of nuclear pore 
complexes was analysed. If the patches are originating from the nuclear envelope 
nuclear pore complexes could be present in them. Therefore, HeLa cells were 
transiently transfected for 24 hours with plasmids encoding pUL31 and pUL34. Cells 
were fixed with paraformaldehyde and stained with mAB414, an antibody recognizing 
a subset of FG-repeat proteins. Coupling mAB414 to an Alexa-Fluor-647 labeled 
secondary antibody revealed that apparently no nuclear pore complexes are present 
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in nuclear patches (Fig. 2.39). This could indicate a tight packing of proteins thereby 
excluding other factors and large protein assemblies e.g. nuclear pore complexes. 
 
 
Figure 2.39: Nuclear pore complexes are not present in nuclear membrane patches 
when coexpressing pUL31 and pUL34 
Cells were fixed with 4 % PFA and analysed with mab414 antibody (gray). Fluorescent 
signals of pUL31 and pUL34 colocalized in formed patches but no mAb414 signal was 
detected in patches formed, indicating that no NPCs are present. DNA was stained with 
DAPI. bars: 10 µm 
 
To verify that the patches observed upon artificial transmembrane tethering of pUL31 
are also not protein aggregates due to failed import of the proteins at nuclear pore 
complexes colabelling of NPCs was performed. Therefore, HeLa cells were 
transiently transfected for 24 hours with plasmids encoding pUL31 and pUL34. Cells 
were fixed with paraformaldehyde and immunostained again with mAB414. In this 
case coupling mAB414 to an Alexa-Fluor-546 labelled secondary antibody revealed 
that apparently no nuclear pore complexes are present in nuclear patches and more 
importantly most of the nuclear patches do not colocalize with the mAB414 signal 
indicating that no NPCs are present in nuclear spots at the membrane (Fig. 2.40) and 
also presumably patches are not formed upon protein aggregation of the pUL31 
transmembrane constructs. Consistent with the previous results upon co-transfection 
with pUL31 and pUL34 (Fig. 2.39) as well as previous observations (Leuzinger et al., 
2005) indicate a tight packing of proteins at sites where proteins interact. Thereby 
excluding large protein assemblies e.g. nuclear pore complexes from budding sites 
as well as from membrane proliferating sites also in the absence of pUL34 (Fig. 
2.40). 
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Figure 2.40: Nuclear pore complexes are not present in nuclear membrane patches 
when expressing chimeric TMR-pUL31 constructs 
HeLa cells were transiently transfected with plasmids expressing transmembrane fusion 
constructs of pUL31 for 24 hours. Expression of constructs with a C-terminally fused 
transmembrane region (TMR) of pUL34 (aa 241-262) or SCL1 (aa 77-97) (A and B) as well 
as a N-terminally fused TMR of Pom121 (aa 1-50) together with an inner nuclear membrane 
localisation signal of rat gp210 (C) resulted in a mostly nuclear membrane localisation and 
patch formation. Cells were fixed with 4 % PFA and analysed with mab414 antibody (red). 
Fluorescent signals of the TMR-constructs of pUL31 and mAB414 did mostly not colocalize 
at the nuclear periphery and no mAb414 signal was detected in patches formed, indicating 
that no NPCs were present in patches. DNA was stained with DAPI. bars: 10 µm 
 
Nuclear spots observed upon transfection of pUL31/pUL34 or when transmembrane 
pUL31 fusion constructs were transfected no clear structures or the origin of these 
spots was definable. Therefore, ultrastructural analyses using transmission electron 
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microscopy was performed to exclude nuclear spots are protein aggregation. 
Additional, it was verified that these spots contain membrane vesicles located 
between the inner and outer nuclear membrane. HEK293T cells were transiently 
transfected for 24 hours with plasmids expressing pUL31 or pUL34 as well as co-
transfection of both. Also plasmids expressing transmembrane fusion constructs of 
pUL31 were transfected. Cells were fixed and stained with Osmium Tetroxide (OsO4) 
and uranyl acetate (UAc) followed by subsequent embedding in EPON. Thin sections 
of cells were generated and imaged using a Tecnai G20 transmission electron 
microscope.  
Electron microscopy revealed that upon co-expression of pUL31 and pUL34 indeed 
vesicles form in the perinuclear space between the inner and outer nuclear 
membrane accompanied by increased spacing between the nuclear membranes (Fig. 
2.40A), consistent with previous findings (Klupp et al., 2007). In addition, a strong 
nuclear membrane proliferation was observed (Fig. 2.43A). A similar membrane 
proliferation phenotype was shown for homologues of pUL31/pUL34 (Luitweiler et al., 
2013; Gonella et al., 2005; Lake et al., 2004). Expression of pUL31 only in HEK293T 
cells did not result in vesicle formation or increased spacing between the membranes 
nor does expression of pUL34 alone (Fig. 2.41). Furthermore, pUL34 expression 
induced stacked membrane arrays probably in response to overexpression (Fig. 
2.41). 
Interestingly, expression of transmembrane fusion constructs of pUL31 was sufficient 
to form vesicles between the inner and outer nuclear membrane (Fig. 2.42B-D) 
confirming that pUL31 alone is sufficient to remodel and induce vesicle formation in 
nuclear membranes when artificially tethered. 
In addition, expressing pUL31 and pUL34 together as well as pUL31 transmembrane 
constructs induced formation of membrane structures similar to reported organized 
smooth ER (OSER) / karmellae, stacked arrays of proliferated nuclear membrane 
associated membranes (Fig. 2.43) (Snapp et al., 2003). 
These structures were induced due to interactions between transmembrane 
anchored proteins indicating self-interaction of pUL31 or pUL31/pUL34 complexes in 
endoplasmic membranes. 
 
 
 
 2 Results 
 
65 
 
 
 
Figure 2.41: Electron microscopy of single transfected HEK293T cells  
HEK293T cell were transiently transfected with either pUL31 (A) or pUL34 (B) for 24 hours. 
No membrane alterations were observed upon single transfection with pUL34. Transfection 
of pUL34 only in HEK293T induced membrane proliferation upon overexpression of the 
membrane protein. The nucleus (N) and cytoplasm (C) are marked. bars: A (left panel) 2 µm, 
A (right panel) in 200 nm; B (left panel) 0.5 µm, B (right panel) in 250 nm 
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Figure 2.42: Electron microscopy of transfected HEK293T cells showed vesicle 
formation upon co-transfection of pUL31 and pUL34 as well as pUL31 transmembrane 
constructs 
HEK293T cell were transiently transfected for 24 hours with either pUL31 or pUL34 or 
artificial pUL31 transmembrane constructs for 24 hours. Vesicle formation between the inner 
and outer nuclear membrane was observed in all conditions with the size of about 200 nm 
(A-D). Right panels are magnifications of the white boxes in the left panel. The nucleus (N) 
and cytoplasm (C) are marked. bars: A-D (200 nm), D left panel 500 nm 
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Figure 2.43: Electron microscopy of transfected HEK293T cells showed membrane 
proliferation upon co-transfection of pUL31 and pUL34 as well as pUL31 
transmembrane constructs 
HEK293T cell were transiently transfected with either pUL31 or pUL34 or artificial pUL31 
transmembrane constructs for 24 hours. Membrane proliferation and increased spacing 
between the inner and outer nuclear membrane was observed in all conditions (A-D). Right 
panels are magnifications of the white boxes in the left panel. The nucleus (N) and cytoplasm 
(C) are marked. Bars: A, B and D (left panel 200 nm, right panel 100 nm), C (left panel 500 
nm, right panel 250 nm) 
 
2.1.23 Mutational analysis of conserved residues in pUL31 constant region 
affects pUL34 interaction in cells 
 
The results obtained from mutational analysis of the first constant region in pUL31 
using the GUV system (Fig. 2.27, Fig. 2.31, Fig. 2.32) were verified in a cellular 
context. Therefore, pUL31 mutants were transfected individually or co-transfected 
with pUL34 (Fig. 2.45-2.51) and pUL31 recruitment to the nuclear periphery was 
quantified (Fig. 2.52). 
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Figure 2.44: pUL34 and the pUL31 cysteine mutants do not colocalize and do not form 
patches 
Hela cells were transiently transfected with plasmids expressing the EGFP-pUL31 cysteine 
C73S, C88SC89S and C92S mutants cotransfected with mCherry-pUL34. Expression of all 
pUL31 cysteine mutants together with pUL34 resulted in no recruitment of the pUL31 mutant 
to the nuclear membrane and no patch formation was observed. DNA was stained with 
DAPI. bars: 5 µm 
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Figure 2.45: pUL34 and the pUL31 mutant P62G do not colocalize and do not form 
patches 
Hela cells were transiently transfected with plasmids expressing either the EGFP-pUL31 
P62G mutant alone or cotransfected with mCherry-pUL34. Expression of pUL31 P62G only 
shows an exclusively nucleoplasmic localisation while expression of pUL34 gives an ER and 
nuclear membrane localisation as shown before. Coexpression of both proteins leads to no 
recruitment of the pUL31 mutant to the nuclear membrane and no patch formation was 
observed. DNA was stained with DAPI. bars: 10 µm 
 
 
 
 
Figure 2.46: pUL34 and the pUL31 mutant L74A do not colocalize and do not form 
patches 
HeLa cells were transiently transfected with plasmids expressing either the EGFP-pUL31 
L74A mutant alone or cotransfected with mCherry-pUL34. Expression of pUL31 L74A only 
shows an exclusively nucleoplasmic localisation with partial protein aggregation while 
expression of pUL34 gives a ER and nuclear membrane localisation as shown before. Co-
expression of both proteins leads to no recruitment of the pUL31 mutant to the nuclear 
membrane and no patch formation was observed. DNA was stained with DAPI. bars: 10 µm 
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Figure 2.47: pUL34 and the pUL31 mutant L76A do not colocalize and do not form 
patches 
HeLa cells were transiently transfected with plasmids expressing either the EGFP-pUL31 
L76A mutant alone or cotransfected with mCherry-pUL34. Expression of pUL31 L76A only 
shows an exclusively nucleoplasmic localisation with partial protein aggregation while 
expression of pUL34 gives an ER and nuclear membrane localisation as shown before. Co-
expression of both proteins leads to no recruitment of the pUL31 mutant to the nuclear 
membrane and no patch formation was observed. DNA was stained with DAPI. bars: 10 µm 
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Figure 2.48: pUL34 and the pUL31 mutant S77A do colocalize and form patches 
HeLa cells were transiently transfected with plasmids expressing either the EGFP-pUL31 
S77A mutant alone or co-transfected with mCherry-pUL34. Expression of pUL31 S77A only 
shows an exclusively nucleoplasmic localisation while expression of pUL34 gives a ER and 
nuclear membrane localisation as shown before. Coexpression of both proteins results in 
recruitment of the pUL31 mutant to the nuclear membrane and patch formation was 
observed albeit reduced compared to wild-type pUL31. DNA was stained with DAPI. bars: 10 
µm 
 
 
 
 
Figure 2.49: pUL34 and the pUL31 mutant G80A do colocalize and not form patches 
HeLa cells were transiently transfected with plasmids expressing either the EGFP-pUL31 
G80A mutant alone or cotransfected with mCherry-pUL34. Expression of pUL31 G80A only 
shows an exclusively nucleoplasmic localisation while expression of pUL34 gives a ER and 
nuclear membrane localisation as shown before. Coexpression of both proteins leads to 
recruitment of the pUL31 mutant to the nuclear membrane and no patch formation was 
observed compared to wild-type pUL31. DNA was stained with DAPI. bars: 10 µm 
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Figure 2.50: pUL34 and the pUL31 mutant C88S do co-localize and form patches  
HeLa cells were transiently transfected with plasmids expressing either the EGFP-pUL31 
C88S mutant alone or co-transfected with mCherry-pUL34. Expression of pUL31 C88S only 
shows an exclusively nucleoplasmic localisation while expression of pUL34 gives a ER and 
nuclear membrane localisation as shown before. Co-expression of both proteins leads to 
recruitment of the pUL31 mutant to the nuclear membrane and intensive patch formation was 
observed. DNA was stained with DAPI. bars: 10 µm 
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Figure 2.51: pUL34 and the pUL31 mutant C89S do not colocalize and do not form 
patches  
HeLa cells were transiently transfected with plasmids expressing either the EGFP-pUL31 
C89S mutant alone or cotransfected with mCherry-pUL34. Expression of pUL31 C89S only 
shows an exclusively nucleoplasmic localisation while expression of pUL34 gives a ER and 
nuclear membrane localisation as shown before. Coexpression of both proteins results in no 
recruitment of the pUL31 mutant to the nuclear membrane and no patch formation was 
observed. DNA was stained with DAPI. bars: 10 µm 
 
 
 
 
Figure 2.52: Quantification cells expressing pUL34 and pUL31 mutants 
HeLa (A) and HEK293T (B) cells were transiently transfected for 24 hours with plasmids 
expressing mCherry-pUL34 and EGFP-pUL31 single point mutants. Cells expressing both 
proteins were counted and analysed for membrane recruitment of EGFP-pUL31 to the 
nuclear membrane. Error bars represents the mean (-/+ SEM) of three independent 
experiments. For each experiment and condition at least 100 cells were counted. 
 
Mutational analysis of single residues in the first constant region of pUL31 verified the 
relevance of conserved amino acids, most importantly the conserved cysteine 
residues in position 73, 88, 89 and 92 of pUL31 appear to be essential in mediating 
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pUL34 binding (Fig. 2.27, Fig. 2.28, Fig. 2.32) as mutation to serines blocks pUL34 
interaction (Fig. 2.44) and membrane remodeling in GUVs (Fig. 2.32). Interestingly, 
separating the C88SC89S double mutation to individual serine mutations revealed 
that at least the cysteine in position 89 is crucial for membrane remodelling in GUVs 
(Fig. 2.32) and pUL34 binding in HeLa cells (Fig. 2.51) while the cysteine in position 
88 appears not to be essential to promote membrane remodelling in the GUV system 
(Fig. 2.32) and pUL34 binding in a cellular context (Fig. 2.50) as mutation to serine to 
do not result in reduced recruitment to the nuclear envelope (Fig. 2.52). 
The results obtained in the GUV system could be confirmed also in a cellular context 
indicating a functional role of the cysteines in the first constant region for membrane 
remodelling and pUL34 binding of pUL31. Both functions of pUL31, namely pUL34 
binding and membrane remodelling, could not be separated by the cysteine 
mutations of individual residues in this part of pUL31. 
Additional mutations in the first constant region (Table 2.1) were also so far not 
sufficient to separate these functions. An interesting candidate for further analysis 
might be the glycine to alanine mutation in position 80 of pUL34 as cotransfection of 
both proteins results in colocalization but no nuclear membrane spot formation. 
Artificial recruitment of the G80A mutant to Ni-DGS containing GUVs shows 
membrane remodelling activity of this mutant (Fig. 2.32). Thus, pUL31 CR1 single 
point mutants need to be analyzed in further pull down experiments and in the pUL34 
GUV binding assay. 
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2.2. Nup153 recruits the Nup107-160-complex to the inner nuclear 
membrane 
 
Nuclear pore complexes (NPCs) are large, the inner and outer nuclear membrane-
spanning protein complexes. The number of nuclear pores varies depending on the 
size and metabolic activity of the cell between 3000-5000 per nucleus in vertebrates 
and about 190 in yeast. In interphase NPCs are doubled in preparation for a new cell 
division. How these huge protein assemblies are embedded in interphase in an intact 
nuclear envelope remains largely unknown. However, it is assumed that the outer 
and inner nuclear membranes are contacted by local deformation and come in close 
proximity to fuse at these sites. Nucleoporins are inserted in these spots and form 
ultimately a functional nuclear pore. Factors mediating the curvature of the nuclear 
membranes and whether components of the nuclear pore complexes are directly 
involved in this deformation processes are unknown.  
Different scenarios can be assumed resulting in approximation of the inner and outer 
nuclear membrane. This could involve integral membrane proteins inducing 
membrane curvature and fusion. Furthermore, it can be assumed that cytoplasmic or 
nucleoplasmic soluble proteins can induce local membrane curvature. Nevertheless, 
interphasic NPC assembly remains largely enigmatic. 
NPC assembly at the end of mitosis and in interphase requires the Nup107-160-
complex (Y-complex) as an important structural component of the NPC (Doucet et 
al., 2010; D'Angelo et al., 2006; Harel et al., 2003; Walther et al., 2003). In 
postmitotic NPC assembly at the end of mitosis the Y-complex is recruited to the 
chromatin by MEL28/ELYS (Gillespie et al., 2007; Rasala et al., 2006) while 
interphasic NPC assembly does not require MEL28/ELYS (Doucet et al., 2010). Most 
likely NPC assembly in interphase has to begin at the nuclear membranes (Doucet et 
al., 2010; Dultz & Ellenberg, 2010; Rothballer & Kutay, 2013; Vollmer et al., 2012) but 
how this is performed remains largely unknown. Here the GUV system was used to 
analyze the specific role of the nucleoporin Nup153 in interphasic NPC assembly. 
This was done in collaboration with PD Dr. Wolfram Antonin and Benjamin Vollmer. 
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2.2.1 Nup153 interacts via its N-terminus directly with membranes 
 
Sequence analysis within Nup153’s N-terminus (Fig. 2.53A) identified a, within 
vertebrates, conserved region that might form an amphipathic helix depicted in the 
helical wheel presentation (Fig. 2.53B). This amphipathic helix could be responsible 
for Nup153 recruitment to the nuclear envelope. A point mutation was generated 
(valine-50 to glutamate, V50E) which predictably disrupts the hydrophobic surface of 
the helix. So far it is not clear how Nup153 is recruited to the inner nuclear 
membrane. To test if the membrane interaction is direct, the recombinant and purified 
N-terminal region of Xenopus laevis Nup153 (aa 1-149) was incubated with giant 
unilamellar vesicles with a nuclear envelope lipid composition. Upon addition of the 
EGFP-tagged N-terminus of Nup153 to GUVs it was efficiently recruited to the vesicle 
membrane indicating direct membrane interaction (Fig. 2.53C, left row). The V50E 
mutant (Fig. 2.53C, right row) did not bind to GUVs confirming that an amphipathic 
helix is required for membrane binding. Similarly recombinant EGFP as control did 
not bind the limiting GUV membrane. Additionally when transfected in HeLa cells the 
EGFP fused N-terminus of Xenopus laevis (xl) Nup153 localized to the nuclear 
envelope presumably the inner nuclear membrane (Fig. 2.53E). The expression also 
induced nuclear envelope proliferation which is typical for membrane interacting 
proteins (Prufert et al., 2004; Ralle et al., 2004) and has been previously observed 
when overexpressing full-length Nup153 (Bastos et al., 1996). The V50E mutation 
abolished nuclear envelope localization and membrane proliferation also in 
transfected cells (Fig. 2.53E). Instead, the protein localized to the nucleoplasm 
indicating that also in cells the mutation is sufficient to prevent membrane interaction 
of Nup153’s N-terminus. 
Next the direct membrane binding was confirmed for the full-length Nup153. Low 
expression yield of the Xenopus laevis protein resulted in usage of the human 
orthologue.  
When the fluorescently labeled protein was added to nuclear envelope GUVs it was 
also efficiently recruited to membranes (Fig. 2.53D). The corresponding mutant 
(valine-47 to glutamate in the human protein, Nup153hs V47E) abrogated Nup153 
membrane interaction.  
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Figure 2.53: Nup153 contains an N-terminal region, directing it to the nuclear 
membrane  
Sequence alignment of vertebrate Nup153 N-terminus (aa 1-149) shows a conserved region 
presumably forming an amphipathic helix (helical wheel depiction, (A)). A single point 
mutation (valine-50 to glutamate), disrupts the hydrophobic surface (B). GUVs were 
generated with a NE lipid composition. EGFP-Nup153xl was added to GUVs and was 
efficiently recruited to the vesicle membrane indicating direct membrane interaction (C). No 
binding was observed when the V50E mutant or EGFP was added to the GUVs (C). 
The human orthologue of Nup153 was Oregon green 488 labeled and added to GUVs. It was 
also efficiently bound to GUV membranes (D). The corresponding single point mutation 
(valine-47 to glutamate) also disrupted membrane interaction. 
HeLa cells were transiently transfected with constructs expressing EGFP-Nup153 (of 
Xenopus laevis) for 24 hours. Nup153 showed an almost exclusive NE localization, 
presumably the inner nuclear membrane and nuclear membrane proliferation (E). 
Transfection of the V50E mutation results in a blocked NE localization and membrane 
proliferation. Additionally, the mutant protein shows increased nucleoplasmic localization 
indicating blocked membrane interaction. bars: 10 µm in C and D, 5 µm in E 
 
2.2.2 Depletion of Nup153 induces NPC clustering 
 
By employing nuclear assembly using Xenopus laevis egg extract, a NE forms 
around the decondensing chromatin in a process resembling the reassembly of the 
nucleus at the end of mitosis (Gant & Wilson, 1997). Nup153 was depleted from egg 
extract. When Nup153 was depleted, the protein was absent from the nuclear rim 
confirming the depletion efficiency. The assembled nuclei contained a closed NE with 
NPCs that were unevenly distributed. This NPC clustering phenotype upon Nup153 
depletion has been previously observed (Walther et al., 2001) and can be visualized 
by surface rendering of confocal stack images of assembled nuclei (Fig. 2.54, right 
row). Adding back recombinant Nup153 to endogenous levels rescued the NPC 
clustering phenotype demonstrating its specificity (Fig. 2.54, left row). NPC clustering 
was also rescued by the Nup153 membrane-binding mutant (V47E) (Fig. 2.54, left 
row), which indicates that the Nup153 membrane interaction is not required for 
proper NPC spacing in the nuclear envelope. 
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Figure 2.54: Depletion of Nup153 results in NPC clustering. 
Nuclei were assembled under mock conditions and using Nup153 depleted Xenopus egg 
extract. Addback of recombinant Nup153 rescued the NPC clustering phenotype. Also 
addback of the Nup153 membrane-binding mutant (V47E) rescued the NPC clustering 
phenotype indicating that the membrane interaction is not important for proper NPC spacing. 
Quantification was done by counting at least 100 randomly chosen chromatin substrates in 
six independent experiments. The right panel shows surface renderings of confocal stacks of 
mAB414 labeled nuclei. Bars: 10 µm 
 
2.2.3 Nup153 is necessary for interphasic NPC assembly 
 
To test whether interphasic NPC assembly was affected by Nup153 depletion nuclei 
were assembled for 120 min and individual NPCs were counted using mAB414 
staining (D'Angelo et al., 2006; Vollmer et al., 2012). Addition of 2 µM importin-β, 
which is known to block interphasic NPC assembly (D'Angelo et al., 2006), to nuclei 
resulted in a reduction in the number of NPCs per nucleus by about 50 %. Depletion 
of Nup153 caused a reduction in NPC number, which was not further affected by the 
addition importin-β. Re-addition of wild type Nup153 but not the membrane binding 
deficient V47E mutant rescued the reduced number of NPCs formed (Fig. 2.55). This 
suggests that NPC formation during interphase requires Nup153 and the ability to 
bind the NE. 
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Figure 2.55: Nup153 membrane interaction is important for interphasic NPC assembly 
Nuclei assembled were fixed after 120 min and NPC numbers per nucleus counted 
based on mAB414 staining. Where indicated, interphasic NPC assembly was blocked by 
importin  addition after 50 min (average from a total of 30 nuclei in 3 independent 
experiments, normalized to the mock control, error bars are SEM). 
  
2.2.4 Artificial recruitment of the Y-complex to membranes bypasses the 
presence of Nup153 
 
The membrane binding ability of Nup153 is important for interphasic NPC assembly. 
As Nup153 binds the Nup107-160 complex (Y-complex) forming the cytoplasmic and 
nucleoplasmic rings of the NPCs this could point to a recruitment of the Y-complex to 
the nuclear membranes. Also ran is a known interactor of Nup153 and is required for 
interphasic NPC assembly (D'Angelo et al., 2006; Doucet et al., 2010). Ran could be 
important by inducing a release of import receptors from potential targets required for 
NPC assembly. It was investigated if artificial recruitment of the Y-complex via the Y-
complex binding region of Nup153 to membranes can bypass the need of full length 
Nup153 and results in NPC assembly. Similarly it was assessed if recruitment of ran 
via the ran-binding site of Nup153 contributes to interphasic NPC assembly. 
The Y-complex binding region (aa 210-338) or the ran binding region (aa 658-890) of 
human Nup153 were each fused N-terminally to EGFP and at the C-terminus with the 
transmembrane protein SCL1, yielding EGFP-ycBD-SCL1 and EGFP-ranBD-SCL1 
(Fig. 2.56A). SCL1 contains a C-terminal transmembrane region and efficiently 
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targets to the inner nuclear membrane (Theerthagiri et al., 2010). Both constructs 
were expressed in E. coli, purified and reconstituted into small liposomes. To test the 
functionality of the fusion proteins these liposomes were incubated with Y-complex 
purified from Xenopus egg extracts or recombinant ran and floated through a sucrose 
gradient. Liposomes containing the EGFP-ycBD-SCL1 protein efficiently bound the 
Y-complex but not ran and EGFP-ranBD-SCL1 liposomes bound ran but not the Y-
complex (Fig. 2.56B). Similarly, when incorporated into GUVs, EGFP-ycBD-SCL1 
recruited fluorescently labeled Y-complex to the GUV membrane and EGFP-ranBD-
SCL1 recruited ran (Fig. 2.56C). To assess if Y-complex or ran recruitment by these 
artificial binding constructs restores interphasic NPC assembly, nuclei were 
assembled in mock or Nup153 depleted extracts supplemented with empty, EGFP-
ycBD-SCL1 or EGFP-ranBD-SCL1 containing liposomes. Nuclei were fixed and NPC 
numbers were determined by mAB414 staining (Fig. 2.56D). When EGFP-yc-SCL1 
was incorporated into the nuclear membrane this indeed restored interphasic NPC 
assembly upon Y-complex recruitment when Nup153 was depleted from the egg 
extract, while ran binding did not restored interphasic NPC assembly. 
Thus, the presumable function of Nup153 in interphasic NPC assembly is to direct 
the Y-complex to the newly forming NPCs at the NE. 
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Figure 2.56: Recruitment of the Y-complex to membranes bypasses the presence of 
Nup153 
Schematic representation of Nup153 fusion constructs indicating the Y-complex (aa 210-338) 
and the ran (aa 658-890) interacting region (blue), an N-terminal EGFP (green), and C-
terminal inner nuclear membrane protein SCL1 (orange) yielding EGFP-ycBD-SCL1 or 
EGFP-ranBD-SCL1, respectively (A). To show binding of ran and the Y complex to the fusion 
constructs EGFP-ycBD-SCL1 or EGFP-ranBD-SCL1 were reconstituted into small 
unilamellar liposomes (SUVs) with a nuclear envelope lipid composition. Liposomes were 
incubated with purified Xenopus Y-complex or recombinant ran (start material 50% for the 
EGFP-ycBD-SCL1 or EGFP-ranBD-SCL1, 30 % for the Y-complex and ran) and top fractions 
were analyzed by western blotting using EGFP, Nup160, Nup107 and ran antibodies (B). 
EGFP-ycBD-SCL1 or EGFP-ranBD-SCL1 were reconstituted into GUVs and Alexa-Fluor-546 
labeled Y-complex or ran were efficiently recruited to the GUV membrane (C). 
Nuclei were assembled in mock or Nup153 depleted extracts supplemented with empty, 
EGFP-ycBD-SCL1 or EGFP-ranBD-SCL1 containing liposomes. NPC numbers were 
determined using mAB414 staining of an average from 30 nuclei from three independent 
experiments, normalized to the mock control, error bars are SEM (D). 
 
In summary, the data obtained by me and the data generated by PD Dr. Wolfram 
Antonin and Benjamin Vollmer reveals that Nup153 can bind to the inner nuclear 
membrane via its N-terminus and recruits the Y-complex to the newly assembling 
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pores. Thus, it appears that Nup153 is an important factor in interphasic NPC 
assembly. 
 
 
 
.  
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3 Discussion 
 
3.1 Nuclear membrane budding is induced by complex formation of 
two conserved herpesviral proteins  
 
3.1.1 Giant unilamellar vesicles as a valuable tool to reconstitute membrane 
related processes 
 
Cellular membranes are essential key components of living organisms as they are 
involved in many biological functions like endo- and exocytosis, transport and 
signaling. The study of membrane related processes is limited by the availability of 
suitable test systems. Cellular systems are generally employed but the complexity of 
cellular structures and functions as well as redundancy often prevents a detailed 
analysis of fundamental biological mechanisms at membranes. 
Bottom up approaches come more and more into focus as they can overcome these 
limitations. Reconstituting cellular behavior by using a minimal set of components 
enables a new level of controllability in order to dissect their specific functions and 
requirements. In addition, they mostly enable visualization and tracking on a 
microscopically scale. 
Up to now, many model membrane systems were developed to fulfill these 
requirements. These systems are therefore perfectly suited to address biochemical 
and biophysical issues. These artificial membrane systems include spherical vesicles 
of different sizes, lipid functionalized micro-beads, as well as planar lipids in 
supported lipid bilayers, nanodiscs or black-lipid-systems (Bayburt & Sligar, 2010; 
Heimburg, 2010; Borch & Haman, 2009; Castellana & Cremer, 2006; Ries et al., 
2004). The selection of suitable systems depends on the issue and availability of the 
needed components. 
Giant unilamellar vesicles (GUVs) are used here to mimic the nuclear envelope and 
to monitor membrane associated processes. As GUVs are vesicles consisting of one 
lipid bilayer and, due to their enormous size of up to 150 µm, they can be visualized 
by light microscopy. The generation of GUVs is straightforward and allows a large 
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variability in composition. In addition, these vesicles provide the unique opportunity to 
observe global and local membrane bilayer restructuring. 
Many protocols are available to generate giant vesicles but the main drawback of 
most of them is the incapability to include integral membrane proteins. 
Biological membranes are complex structures composed of lipids, proteins and 
carbohydrates. Many biological functions at membranes are attributed to integral 
membrane- or membrane-associated proteins. Thus, it is crucial to include these 
proteins and mimic their environment in order to understand their involvement in 
membrane associated processes.  
Proteo-liposomes obtained by gel filtration are used to generate giant unilamellar 
vesicles by alternating current assisted electroformation (Angelova  & Dimitrov, 1986) 
on conductive electrodes (Fig. 2.1). Electroformation using ITO-(indium-tin-oxide)-
coverslips is commonly performed but the majority of vesicles stays attached to the 
fragile coverslips. This not only impedes single vesicle visualization but also the 
addition of soluble factors. Furthermore, the amount of formed vesicles is mostly 
uncontrollable and large amounts of vesicles can create dense meshwork’s which are 
inaccessible for the bulk solution. Electroformation employing platinum electrodes is 
more robust in vesicle formation and results in mostly detached vesicles. The main 
drawback is the limited surface to apply lipid films. Combining the advantages of both 
electroformation methods resulted in higher reproducibility and yield of vesicles. 
Employing platinum meshes instead of single platinum wires drastically increased the 
surface providing enough space to distribute membrane material. The amount of 
vesicles used in each approach is more adjustable and can be distributed more 
equally in order to set the same start conditions.  
 
3.1.2 Heterologous expression of pUL31 and pUL34 results in functional 
proteins 
 
Membrane proteins in artificial membrane systems can purified from natural sources, 
if possible at all, but are mostly not abundant enough. In addition, isolation of 
endogenous proteins always bears the risk of co-purifying interaction partners which 
may result in false positive results and interferes generally with the idea of bottom up 
approaches. Therefore, to investigate membrane associated processes it is desirable 
to reconstitute pure, individual components thereby, minimizing the possibility of 
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artifacts. Heterologous expression of membrane proteins with subsequent extraction 
is a valuable way to overcome the issues of amount and purity. Still, expression of 
membrane proteins is a challenging task and depends on the expression system as 
well as the properties of the individual protein. Furthermore, successful membrane 
protein expression is not linked to functionality as proteins can become post-
translationally modified in order to function.  
The issue of insufficient expression was overcome by using the MISTIC protein tag 
derived from B.subtilis. This efficiently enhances expression of integral membrane 
proteins (Roosild et al., 2005). Employing MISTIC and its self membrane integrating 
property was therefore well suited to express the herpesviral membrane protein 
pUL34 in E.coli to obtain sufficient amounts of integral membrane proteins.  
Extraction of expressed membrane proteins is a demanding task. Membrane proteins 
are usually extracted by detergent-mediated solubilisation of membranes. 
Determining the detergent of choice as well as the correct concentration is an 
important factor to retain functional membrane proteins (Eisenhardt et al., 2014).  
Generation of lipid layers with incorporated membrane proteins on the other hand is 
straightforward. Detergent solubilised lipids or lipid mixtures are combined with 
solubilized membrane proteins and undergo subsequent detergent removal either 
slow by dialysis or fast by gel filtration. Advantages of fast removal by gel filtration are 
a higher functionality of the reconstituted proteins as well as a higher detergent 
removal rate. This is especially important for the here used detergent CTAB, as this 
has a very low cmc (critical micelle concentration) value of about 1 mM making it 
unfavorable for dialysis assisted removal. In addition, the reconstitution rate of the 
protein is higher using gel filtration. 
   
3.1.3 The viral proteins pUL31 and pUL34 are sufficient for membrane budding 
and scission in the GUV system 
 
Recombinant expression, purification and subsequent fluorescently labeling of pUL34 
(see methods) was efficiently done by detergent solubilisation from E. coli 
membranes. Interaction and recruitment of the other is presumably one function of 
either pUL31 or pUL34 but not meaningful to predict potential membrane remodeling 
activity of the formed complex. In order to test for functionality of pUL34, 
electroformation of proteo-liposome films containing the integrated pUL34 was done. 
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This reconstitution and electroformation resulted in sufficient amounts of individual 
giant vesicles containing the pUL34 protein. Recruitment of EGFP tagged pUL31 to 
pUL34 after the addition indicates that pUL34 comprises an integral membrane 
region as well as the interacting region with pUL31 is functional. This was indicated 
by membrane remodeling upon addition of pUL31 (Fig. 2.3A).  
In case of no interaction and if no membrane deformation can be observed addition 
of a protein rich source could overcome the potential lack of cellular interacting or 
modifying proteins. The source could be either Xenopus laevis egg extract or cell 
lysates e.g. HeLa cell lysates.  
Moreover, as budding at the inner nuclear membrane is a locally confined process 
added cell lysates comprising factors from diverse compartments could initiate 
misleading interactions. But this could hint to potential interactions and regulations of 
both viral proteins beyond their role in primary envelopment, as pUL31 and pUL34 
were shown to be phosphorylated by the viral kinase pUS3 (Mou & Baines, 2009; 
Yamauchi et al., 2001; Chang & Roizman, 1993; Purves et al., 1992). Regulation 
might also involve direct phosphorylation of pUL31 or pUL34 by cellular kinases, as 
well as indirect by other cellular factors, targeting the individual proteins or the formed 
complex. Thus, this might reveal that cellular factors are involved in the budding 
mechanism of the viral capsid at the inner nuclear membrane.  
Addition of pUL31 to GUVs showed recruitment of pUL31 to the GUV membrane only 
in the presence of pUL34. Small vesicles were formed towards the lumen of the giant 
vesicle with pUL31 and pUL34 integrated, indicating that both proteins are functional 
and sufficient in the GUV system to remodel membranes in the absence of other viral 
or cellular proteins (Fig. 2.3A). Furthermore, it appears that both proteins mediate not 
only membrane deformation but also scission of vesicles from the originating 
membrane as vesicles were found detached floating in the GUV lumen and detached 
in close proximity to the GUV membrane (Fig. 2.3A). Budding and scission of 
vesicles were shown to be independent of provided energy (Fig. 2.13). The bending 
force applied to the lipid bilayer by the pUL31/pUL34 complex appears to be 
sufficient for inward directed budding. The needed bending force might result from 
conformational changes upon binding of pUL31 to pUL34 or pUL31 oligomerization 
after recruitment and, thus, a rigid coat induces curvature to the GUV membrane. 
However, membrane deformation is strictly dependent on the presence of pUL31 
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while pUL34 alone is not sufficient to induce membrane remodeling indicative for a 
recruiting function of pUL34 (Fig. 2.2). 
 
3.1.4 Defining the requirements for vesicle budding 
 
By assessing the requirements for budding at GUV membranes the transmembrane 
region of pUL34 was demonstrated to be dispensable for budding and scission of 
formed vesicles (Fig. 2.14). The reconstitution of the full length pUL34 in GUVs but 
also the artificial recruitment of a soluble fragment of pUL34 lacking the predicted C-
terminal transmembrane region is not able to induce remodeling in GUV membranes 
(Fig. 2.2, Fig. 2.14). Furthermore, only the addition of pUL31 restored membrane 
deformation leading to vesicle budding. Interestingly, vesicle formation and 
subsequent scission was induced independently of the orientation of pUL34 bound to 
GUVs, prior to addition of pUL31. This indicates even more that the transmembrane 
region of pUL34 is not important for vesicles budding and scission (Fig. 2.14). This is 
consistent with the observation that the C-terminal transmembrane region can be 
replaced by integral membrane regions of cellular inner nuclear membrane proteins, 
suggesting that the essential role of pUL34 depends on its soluble domain (Schuster 
et al., 2012). Moreover, these results gave rise to the question of the general function 
and contribution of pUL34 in vesicle budding. 
Therefore, the effect of direct tethering of pUL31 to membranes was determined. 
Interestingly, artificial tethering of pUL31 was sufficient for vesicle budding in GUV 
membranes. Vesicles pinched of from the GUV membrane into the lumen of the giant 
vesicles while recruitment of other soluble proteins did not. This observation indicates 
that pUL31 combines both functions: budding and scission in the absence of other 
viral and cellular proteins (Fig. 2.15). These minimal requirements could be a result of 
the used artificial membrane system. Nevertheless, transfection experiments followed 
by electron microscopy demonstrated that employing an artificial pUL31 
transmembrane construct to recruit pUL31 to the nuclear membrane in HeLa and 
HEK293T cells was also sufficient to induce vesicle formation at the inner nuclear 
membrane, even though these events are not very abundant (Fig. 2.42B-D). This 
could be explained by structural constraints posed by the nuclear lamina. 
Interestingly ribonucleoprotein (RNP) granules were shown to exit the nucleus in a 
process, similar to herpesviral mediated nuclear egress (Rose & Schlieker, 2012; 
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Speese et al., 2012). These specific RNP granules in Drosophila larval 
neuromuscular junctions are predicted to have approximately the same size as viral 
capsids und thus exceed the pore size limit of the NPC. It was found that nuclear 
localized granules are transported in a similar way from the nucleoplasm into the 
cytoplasm as subpopulations are found on the outside of the outer nuclear 
membrane. Also in this process an atypical protein kinase C (PKC) isoform, as well 
as LamC, a Drosophila lamin, are required for this formation. However, the precise 
mechanism and involvement of factors needs to be elucidated. Interestingly, in both 
processes the cellular kinase PKC is needed and both include membrane vesicles 
residing in the PNS followed by subsequent fusion with the outer nuclear membrane. 
Thus, herpesviruses may highjack a jet unknown cellular pathway to transport viral 
capsids through the nuclear membrane. 
  
3.1.5 The functions of pUL34 in passing the nuclear envelope 
 
Artificial pUL31 recruitment to GUV membranes is sufficient for vesicle budding 
induction and scission in the absence of pUL34. These experiments indicate that 
pUL34 is only functioning as a stalk to recruit pUL31 to membranes. 
Nevertheless, it is likely that pUL34 is involved in regulation or definition of the 
induced membrane curvature as vesicles are smaller upon artificial pUL31 tethering 
compared to vesicles formed in the presence of pUL34 (Fig. 2.4, Fig. 2.16). It should 
be mentioned, that the presence of sub-resolution vesicles in both cases cannot be 
excluded. It appears unlikely that pUL34 only fulfills a recruiting and potential 
regulatory role in primary envelopment. In the absence of pUL34 viral capsids 
accumulate at the inner nuclear membrane as a result of impaired primary 
envelopment. Thus, the involvement of the pUL31/pUL34 egress complex in de-
envelopment at the outer nuclear membrane cannot be tested. Expression of artificial 
transmembrane tethered pUL31 might be a possible way to elucidate the role of the 
pUL31/pUL34 complex for the de-envelopment process. Both proteins are located 
inside in perinuclear vesicles and the transmembrane region of pUL34 is predicted to 
extend only three amino acids into the PNS. Therefore, it is unlikely that these 
proteins are involved directly in the fusion of vesicles with the outer nuclear 
membrane. It is more likely, however, that interplay of the pUL31/pUL34 coat 
disassembly and cellular/viral factors could drive fusion of both membranes.  
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Phosphorylation of the pUL31/pUL34 by cellular or viral kinases might weaken 
interactions between both proteins and could give rise to fusogenic potentials of NEC 
or vesicle-interacting factors. The viral US3 kinase directly phosphorylates the viral 
proteins UL34 and pUL31 (Kato et al., 2005; Purves et al., 1992) but however, 
phosphorylation of pUL34 appears not involved in vesicle fusion with the outer 
nuclear membrane as a not phosphorylatable mutant of pUL34 results in normal viral 
growth behavior. This indicates that pUL31, but not pUL34 phosphorylation might 
affect perinuclear vesicle fusion. In addition, pUS3 is phosporylated by the viral 
pUL13 kinase which might provide an extra level of modulating phosphorylation 
patterns. Deletion of the pUS3 kinase or its catalytical activity results in accumulation 
of enveloped perinuclear virions and, thus, pUS3 kinase activity effects virion fusion 
with the outer nuclear membrane (Schumacher et al., 2005; Ryckman & Roller, 2004; 
Wagenaar et al., 1995). 
Interestingly, a pUL34 and pUS3 kinase relationship is also implied to regulate lamina 
disruption as expression of either pUL34 or pUS3 proteins alone disrupted lamin A/C 
and lamin B localization while expression of pUL34 and pUS3 together had only little 
effect on lamin A/C localization (Bjerke et al., 2006). 
However, a function of pUL34 involves the previously mentioned dissolution of the 
nuclear lamina (Bjerke et al., 2006; Reynolds et al., 2004; Simpson-Holley et al., 
2004). The presence of pUL34 only or in complex with pUL31 appears to be crucial 
for that. Bending rigidity of the inner nuclear membrane might be too high to induce 
membrane deformation in presence of the nuclear lamina. Artificial tethering of 
pUL31 results in vesicle formation into the PNS as well as membrane proliferation 
(Fig. 2.43B-D) in transfected cells. The necessity of pUL34 was therefore overcome 
to recruit pUL31 to the membrane. The lack of pUL34 may result in reduced or no 
recruitment of the cellular kinases to pUL31 necessary to inducing local lamina 
softening. As a consequence, this would result in a need of higher bending strength 
to deform the inner nuclear membrane and, thus, explain the observed low 
abundance of perinuclear vesicles (Fig. 2.42B-D).  
In contrast, in the GUV system no lamina is present and, therefore, artificial tethered 
pUL31 has to overcome a less prominent membrane rigidity to induce vesicle 
formation. 
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3.1.6 Contribution of perinuclear factors to herpesviral nuclear egress 
 
The perinuclear space is continuous with the lumen of the endoplasmic reticulum, 
and known to be a calcium reservoir (Xu et al., 2005). Measurements of resting 
calcium concentrations of the endoplasmic reticulum revealed concentrations of 250 
to 600 μM (Demaurex & Frieden, 2003) complexed with ER chaperones, acting as 
Ca2+ buffers (Coe & Michalak, 2009; Papp et al., 2003; Lievremont et al., 1997). 
Divalent cations like calcium or magnesium play a role in fusion processes. They bind 
to negatively charged lipids (Papahadjopoulos et al., 1990) shielding the overall 
negative charge of the bilayer. This reduces the electrostatic repulsion of vesicle 
membranes and target membranes and, thus, contributes to vesicle fusion. Thereby, 
the endoplasmic calcium in combination with viral glycoproteins could contribute to 
perinuclear vesicle fusion with the outer nuclear membrane in a process which could 
be envisioned similar to the SNARE mediated vesicle fusion (Jena, 2011).  
It is still unclear, and it was not yet examined, if the perinuclear calcium also 
contributes to vesicle formation at the inner nuclear membrane. Furthermore, fusion 
between perinuclear vesicles might be envisioned but the presence and relevance of 
such effects is questionable. 
Interestingly, calcium is known to be a key factor involved in herpesviral entry and 
cell to cell spreading (Bandyopadhyay et al., 2014; Cheshenko et al., 2013). 
However, as calcium is essential for countless of cellular processes dissecting a 
potential contribution of calcium in cellular systems without affecting other processes 
is difficult. 
Furthermore, the contribution of torsinA, a cellular AAA+ ATPase residing in the 
lumen of the endoplasmic reticulum and implied to be involved in nuclear envelope 
maintenance and HSV-1 egress (Maric et al., 2011; Ozelius et al., 1997) as well as 
perinuclear proteins in general is not clear and might provides a new and interesting 
field of research. 
 
3.1.7 The role of pUL31 and lipids in vesicle coat formation  
 
pUL31 is crucial for vesicle budding and scission at GUV membranes. It mediates 
membrane remodeling when bound to membranes via pUL34 (Fig. 2.3) or upon 
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artificial recruitment (Fig. 2.15, Fig. 2.20, Fig. 3.1). While pUL31 does not self interact 
in solution (Fig. 2.21, Fig. 2.22) it was self recruiting when bound to membranes and 
resulted in vesicle formation into the GUV lumen (Fig. 2.20), presumably by 
oligomerization and rigid coat formation on the GUV surface. Interestingly, electron 
microscopy revealed dense proteinaceous structures at budding sites and vesicles 
upon pUL31/pUL34 cotransfection (Klupp et al., 2007), presumably representing 
tightly packed pUL31/pUL34 complexes at the inner nuclear membrane. Tight 
packing of pUL31/pUL34-complexes or artificial tethered pUL31 would result in a 
gapless, rigid coat assembly engulfing incoming capsids. Furthermore, exclusion of 
inner nuclear membrane proteins as well as large protein structures like NPCs would 
be a plausible explanation for the lack of NPCs in nuclear spots in transfected cells 
(Fig. 2.39, Fig. 2.40).  
How pUL31 mediates its own recruitment in presence of membranes (Fig. 2.20) is a 
puzzling question as no direct preference for specific lipids was observed when only 
pUL31 was incubated with GUVs (Fig. 2.19). Additionally, no block in pUL31 
recruitment as well as vesicle budding and scission was observed when specific 
lipids were removed from the used lipid mixture. Also in the absence of the negative 
charged lipids phosphatidylserine and phosphatidylinositol pUL31 was sufficient to 
induce vesicle budding and scission in GUV membranes (Fig. 2.9, Fig. 2.19). This 
indicates, that no electrostatic interactions between lipids and pUL31 and pUL34 
mediate membrane remodeling. 
Conditions either lacking cholesterol or sphingomyelin resulted in blocked vesicle 
formation. Both lipids are known to alter membrane fluidity and thus, pUL31 
oligomerization, in presence or absence of pUL34, seems not sufficient to overcome 
the membrane rigidity (Fig. 2.9, Fig. 2.19). 
The same also applies to unnaturally increased amounts of both lipids (Fig. 2.11) as 
high concentrations counteract vesicle formation in presence of pUL34 due to the 
increased rigidity of membranes (Fig. 2.11) (Rossman et al., 2010). 
Lipids can also induce membrane curvature as a result of shape and insertion in the 
lipid bilayer mostly by conical or cone shaped lipids e.g. DHPC (1,2-Dihexanoyl-sn-
glycero-3-phosphocholine) or DPPC (1,2-dipentadecanoyl-sn-glycero-3-phospho-
choline). None of these special lipids were used in this work. 
However, membrane deformations induced by protein crowding, demonstrate an 
opposite topology: away from the vesicle membrane and not into the lumen 
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(Stachowiak et al., 2012) and thus, cannot be an explanation for vesicle budding 
observed upon direct tethering of pUL31 (Fig. 2.15). 
Also asymmetries in the bilayer can promote membrane deformation by affecting lipid 
packing. Such restructuring involves lipid transporters (flippases) (Devaux et al., 
2008) resulting in redistribution of lipids in bilayers. Neither pUL31 nor pUL34 are 
predicted to have a lipid transport activity. Additional, budding and scission of pUL31 
and pUL34 do not depend on provided energy (Fig. 2.13). Lipid transport activity 
across a lipid bilayer is also not inevitably energy dependent. Thus, it cannot be 
excluded that a local redistribution of lipids by the viral proteins induces membrane 
curvature or at least contributes to it. Furthermore, the headgroup modified lipid Ni-
DGS (Avanti polar lipids) is commonly used for artificial tethering of factors to 
membranes (Kubalek et al., 1994; Krogsgaard et al., 2005) and was shown not to 
effect membrane rigidity (Settles et al., 2010).  
pUL31 is sufficient to promote membrane curvature towards the lumen of giant 
vesicles (Fig. 2.15). It enriches at membranes upon seeding of untagged pUL31 (Fig. 
2.20) and is enriched in formed buds in GUV membranes pointing to the center of the 
vesicle (Fig. 2.17A). pUL31 and pUL31/pUL34 mediated budding have a reverse 
topology compared to most other cellular budding processes e.g. COP-I/-II vesicle 
transport or clathrin mediated endocytosis. In contrast, the endosomal sorting 
complexes (ESCRT) mediate budding away from the cytoplasm as the pUL31/pUL34 
mediated primary envelopment bud away from the nucleoplasm but involves 
numerous proteins compared to two, here described, viral proteins. Thus, both 
budding processes share the same topology. Interestingly, many viruses, including 
herpesviruses (Pawliczek & Crump, 2009; Tandon et al., 2009) recruit the hosts 
ESCRT machinery in order to facilitate their escape from the cell. So far, there is no 
evidence that the ESCRT machinery participates in primary envelopment and de-
envelopment at the nuclear membranes. 
Artificial recruitment of pUL31 to supported lipid layers results in rupturing of the lipid 
layer (Fig. 2.23A) accompanied by an increase in surface height by pUL31 (Fig. 
2.24B). This is topologically contradicting but the surface attached lipid layer is 
incapable to promote inwarded budding but additional points to the membrane 
remodeling and coat forming ability of pUL31. 
Curvature in membranes can be induced by proteins in several ways (Farsad & De 
Camilli, 2003). Structural predictions of pUL31 or pUL34 do not indicate special 
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properties of the proteins like membrane inserting amphipathic helices (Drin & 
Antonny, 2010) or other lipid interacting domains e.g. FYVE domains or Bar domains. 
This is consistent with observations that pUL31 cannot interact with membranes in 
the absence of pUL34 or artificial tethers (Fig. 2.3C, Fig. 2.5B, Fig. 2.12). Although 
an amphipathic helix formation upon pUL31 and pUL34 interaction cannot be 
excluded. 
 
 
Figure 3.1: Model of budding steps in GUV membranes 
(A) Membrane-bound pUL34 (red) recruits pUL31 (green) to the membrane. 
Subsequent recruitment of pUL31 by pUL34 and pUL31 itself leads to accumulation 
of both proteins in certain spots at the membrane. (1) Because of presumably 
structural changes in pUL31 and/or pUL34 accumulation of proteins results in 
membrane deformation (2) accompanied by more recruitment of pUL31 and pUL34 
(3). This results in increased membrane deformation and finally scission of vesicles 
from the originating membrane. (B) The same sequence of events (1-4) is assumed 
for vesicles containing the Ni-chelating lipids (Ni-DGS, black dots), which fulfills 
artificially the initial and subsequent role of pUL34. 
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3.1.8 The influence of membrane domain organization in reconstituting 
membrane budding by pUL31 and pUL34 
 
Lipids are organizing themselves according to their physical properties in particular 
regions of the membrane termed phases. These membrane phases have specific 
properties and thereby specify the orientation and mobility of membrane lipids and 
proteins. Beside the solid ordered phase (SO, gel phase, Lβ), where lipids are highly 
ordered, two different fluid phases are defined: the liquid disordered phase (LD, Lα) 
and liquid ordered phase (Lo), the latter one enriched in the sphingolipid 
sphingomyelin and the sterol cholesterol. 
The thickness of the individual lipid phase depends on the chain length of the lipids. 
Thus, the liquid ordered phase tends to be thicker as saturated hydrocarbon chains 
of sphingolipids are more extended (van Meer, 2008; Brown, 2006). 
Using GUVs comprised of a minimal set of components lipid separation and thus 
separation of phases can be visualized (Baumgart et al., 2007). GUVs composed of 
only two or three lipid components can be used to mimic lipid raft formation in vitro 
(Garg et al., 2007). Cholesterol and sphingomyelin rich phases can act as local 
functional domains by concentrating proteins (Lingwood & Simons, 2010). 
Additionally, these phases can be stabilized by proteins e.g. calveolin interacts with 
cholesterol and oligomerizes forming caveolae (Pelkmans et al., 2004). Thus, a 
potential mechanism how the pUL31/pUL34 complex mediates membrane curvature 
and budding can be envisioned by inducing lipid separation and subsequent coat 
formation. Experiments testing this hypothesis by using adequate lipid phase markers 
(Sezgin et al., 2012; Baumgart et al., 2007) in GUVs, employing the nuclear envelope 
mimicking lipid mixture revealed no indication for a phase separation (Fig. 2.10A). 
Interestingly, employing the ternary lipid GUV system resulted in a recruitment of 
pUL31 to pUL34, which is localized in the liquid disordered phase (Fig. 2.11). 
Moreover, also a strong pUL31 signal was detected in the liquid ordered phase. This 
result might imply an interaction of pUL31 with cholesterol but pUL31 does not 
interact with the liquid ordered phase in the absence of pUL34 (Fig. 2.12). 
An explanation could be that the cholesterol affinity changes upon interaction of 
pUL31 and pUL34 which might be a reason for the observed interaction of pUL31 
with cholesterol. In addition, insufficient separation of lipids and, thus, separation of 
pUL34 in GUV membranes might be a more reasonable explanation for the observed 
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pUL31 interaction. The presence of small amounts of pUL34 in the formed liquid 
ordered phase might function as a recruiting platform for pUL31 and, in agreement 
with the self interaction ability of pUL31, results in oligomerization on the GUV 
membrane. Interestingly, a dependency of cholesterol and sphingomyelin was 
reported for the formation of nano-rafts, enriched in cholesterol and sphingomyelin, in 
the outer leaflet of bud-necks of budding vesicles (Ryu et al., 2014). This might 
contribute to the budding process by stabilizing the local membrane curvature and 
thereby lowering the energy required for budding (McMahon & Gallop, 2005). As 
cholesterol and sphingomyelin enrichment occurs in the outer leaflet of the bud-necks 
it is not accessible by the cholera-toxin-GM1, which was used there as a marker for 
the ordered phase, as a result of the inward budding in the GUV system. 
However, no phase separation was detectable employing adequate membrane 
markers (Fig. 2.10) but so far one cannot exclude the formation of sub-resolution 
nano-domains induced by pUL31 and pUL34.  
 
3.1.9 The vesicle size discrepancy in the GUV system 
 
The intralumenal vesicles (ILVs) formed upon pUL31/pUL34 interaction as well as 
when pUL31 was artificially recruited to GUV membranes are at least ten times 
bigger compared to the perinuclear vesicles in infected cells of about 150 nm (Klupp 
et al., 2007). Upon addition of pUL31 to pUL34 GUVs, the majority of intralumenal 
vesicles (ILVs) showed an average size of 1 -1.5 µm (Fig. 2.4C). In comparison the 
ILVs in the artificial pUL31 tethered GUV system were found to have an average size 
of 0.5 – 1 µm (Fig. 2.16C). This might indicate a role of pUL34 in regulating vesicle 
size. Consistent with that, a recent publication (Bigalke et al., 2014) demonstrates a 
hexagonal meshwork of pUL31/pUL34 complexes on vesicles. In the absence of 
pUL34, pUL31 recruitment is still able to remodel vesicle and cellular membranes but 
the regularity of the coat or the spacing might be affected, resulting in the observed 
smaller vesicles. An indication might be that no detectable regular structure formation 
was observed upon artificial pUL31 recruitment to supported bilayers and subsequent 
atomic force microscope analysis (Fig. 2.24B). In order to resolve potential structures 
on membranes, high resolution analysis e.g. electron microscopy needs to be 
performed in further experiments. 
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The overall increase of vesicles formed in the GUV system can only be in part 
attributed to the presence of the bulky EGFP tag fused to the N-terminus of pUL31. 
Due to the topology of the budding reaction the coat assembly by pUL31/pUL34 or 
pUL31 alone is formed at the inside of the vesicle. In contrast, an increase in vesicle 
size upon coat assemblies on the outside of vesicles e.g. by clathrin or COP-I/-II 
components are not reported and might be due to sufficient space for bulky proteins 
tags. The presence of a spacious protein tag may result in sterical hindrances for 
coat assembly thereby inducing an increase in vesicle size. Although, fluorescently 
tagging of ESCRT components or the retroviral gag protein (Serrano & Neil, 2011; 
Pincetic & Leis, 2009), both sharing the same budding direction as herpesviruses, 
resulted in no increased vesicle size in cell transfection experiments. Correct sized 
herpesviral vesicles were also found in cell transfection experiments, cotransfecting 
pUL31 and pUL34 (Klupp et al., 2007) (Fig. 2.42A) as well as artificial pUL31 
transmembrane constructs (Fig. 2.42B-D). 
However, increases in vesicle size might be of intrinsic nature when employing the 
GUV system (Bigalke et al., 2014; Im et al., 2009; Wollert et al., 2009; Solon et al., 
2005). This indicates that overcoming the high surface tension of the GUV membrane 
might be an additional plausible cause or at least contributes to increased vesicle 
sizes. 
Furthermore, it cannot be excluded that sub-resolution ILVs, formed by either pUL31 
or pUL31/pUL34, are present as they are smaller than the resolution limit of confocal 
microscopy or are exposed to fast photo bleaching upon analysis.  
An indication for this, are the reported correct sized vesicles in GUVs revealed by 
electron microscopy (100 nm - 150 nm) (Bigalke et al., 2014). 
 
3.1.10 Uncoupling the pUL34 binding and membrane remodeling activity of 
pUL31 
 
pUL31 and pUL34 mediate budding and scission of vesicles in the absence of other 
viral and cellular proteins in the GUV system (Fig. 2.3A). pUL31 was sufficient to fulfill 
both tasks when artificially recruited to membranes (Fig. 2.15A). It was investigated 
whether the binding ability of pUL31 to pUL34 and the membrane remodeling activity 
of pUL31 were part of the same region within pUL31. 
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Sequence analyses of pUL31 indicated several regions with greater conservation 
and were classified as constant regions 1-4 (CR1-4) (Fig. 2.25) (Schnee et al., 2006). 
The first constant region is assumed to contain the pUL34 binding region (Schnee et 
al., 2006). Secondary structure predictions indicated that CR1 is mostly unstructured 
(http://toolkit.tuebingen.mpg.de/). Thus, CR1 may provide an interface for pUL34 
interaction and folds upon pUL34 binding. Therefore, the first constant region of 
pUL31 was investigated in more detail in terms of pUL34 binding and membrane 
remodeling activity. Several amino acids within CR1 were conserved throughout all 
analyzed pUL31 homologues (Fig. 2.26, Fig. 2.30). These include three cysteine 
residues in position 73, 89 and 92 as well as one proline residue in position 62 and 
one serine residue in position 77 of pUL31. Several residues highly conserved within 
the alphaherpesviridae and in part within the betaherpesviridae or 
gammaherpesviridae were also included in the analysis (leucine in position 74, 
leucine in position 76, glycine in position 80, cysteine in position 88).  
Mutation of the highly conserved cysteines (C73S, C89S, C92S) in pUL31 to serines, 
containing a hydroxyl group in the position of the thiol group of cysteine, abolished 
not only interaction with pUL34 (Fig. 2.27) but also the pUL31 membrane deformation 
ability upon artificial membrane recruitment in the GUV system (Fig. 2.28). Employing 
the cysteine mutants upon cotransfection with pUL34 in HeLa cells also revealed a 
block in nuclear membrane recruiting presumably by blocked pUL34 interaction and 
thus, nuclear membrane deformation was impaired (Fig. 2.44). Also in the HeLa cells 
system separation of the C88SC89S double mutation indicated that only the highly 
conserved cysteine residue in position 89 is involved in pUL34 interaction, while the 
less conserved cysteine residue in position 88 appears not to be involved in 
mediating pUL34 interaction (Fig. 2.50, Fig. 2.51). 
This might indicate that the conserved cysteines are involved in potential disulfide 
bond formation thereby stabilizing the secondary structure of pUL31. Thus, mutation 
of these cysteine residues could affect folding and therefore results in non functional 
proteins.  
However, it is unlikely that disulfide bonds form in the reducing cellular environment. 
Additional, protein disulfide-isomerases can catalyze formation and breakage of 
disulfide bonds but are residing in the oxidative environment of the endoplasmic 
reticulum, thus, not accessible for pUL31. 
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Cysteines can also play a structural key role, as they can coordinate heavy metal 
ions e.g. iron or zinc. The three conserved cysteines in pUL31 as well as histidines 
could form a cluster coordinating heavy metal ions in order to stabilize the folding 
thereby maintaining protein functionality (Giles et al., 2003). 
Furthermore, they also could be involved in the formation of putative zinc finger 
motifs binding to DNA, RNA and mediating protein-protein interaction. So far no 
nucleic acid binding of pUL31 or homologues is reported. Nevertheless, pUL31 could 
be actively involved in displacing not only the nuclear lamina but also chromatin or 
chromatin interacting factors from potential budding sites and, thus, contribute to 
access the inner nuclear membrane. However this potential novel function remains to 
be determined. Also the function and precise involvement of cysteine and histidine 
residues in pUL31 in the proposed metals chelating needs to be addressed in future 
experiments. In addition, mutations of residues different than cysteine in the CR1 of 
pUL31 revealed that substitution of the proline residue in position 62 by glycine 
(P62G), leucine in position 74 to alanine (L74A) and leucine in position 76 to alanine 
(L76A) (Fig. 2.45, Fig. 2.46, Fig. 2.47) resulted in loss of pUL34 interaction in HeLa 
cells. However, the L76A and the G80A mutation within pUL31 were still sufficient to 
induce vesicle formation upon artificial recruitment to Ni-DGS-GUVs (Fig. 2.31, Fig. 
2.32). Interestingly, the G80A mutation in pUL31 was not able to induce nuclear 
patch formation in the nuclear envelope in Hela cells although it was recruited to the 
nuclear envelope upon cotransfection (Fig. 2.49). These residues in pUL31 might be 
involved in forming a binding platform for pUL34. Thus, mutation of these could result 
in structural changes of the binding region of pUL31 unable to bind pUL34 and/or to 
self interact. A general unfolding upon mutation of single residues cannot be 
completely excluded but still present membrane remodeling activity of several 
mutants in the GUV system (Fig. 2.31, Fig. 2.32) and in transfected HeLa cells, there 
in part with pUL34 binding (Fig. 2.48-50), speaks against this hypothesis. 
Taking together, these results indicate that both functions of pUL31, binding to 
pUL34 and membrane remodeling, are most likely located in the first constant region. 
A consistent loss of functions after mutations of individual cysteines in pUL31 
indicates a particular importance of these residues in pUL31. So far, mutations of the 
cysteine residues in the CR1 do not allow the separation of both functions. This might 
also be an indication that both functions are structurally linked within pUL31. Also the 
binding ability of pUL31 mutants other than cysteines to pUL34 containing GUVs was 
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yet not examined and remains to be elucidated. The pUL31 G80A mutant appears to 
be an interesting candidate for further dissection of pUL34 binding and membrane 
remodeling activity. To further dissect the influence of mutations in the first constant 
region for both functions of pUL31 as well as for the pUL31/pUL34-complex future 
biochemical and biophysical experiments must be employed. 
After fusion of periplasmic vesicles with the outer nuclear membrane the fate of 
pUL31 and pUL34 is unknown. Presumably, pUL31 is rapidly degraded, if not 
interacting with pUL34 (Ye & Roizman, 2000), consistent with the instability of the 
protein when purified without pUL34 pUL34 and pUL31 might be reimported into the 
nucleus to perform another round of vesicle budding. 
Whether, and, if yes, how the NEC is disassembled upon or before vesicle fusion 
with the outer nuclear membrane is unknown.  
Herpesviruses evolved a two component system, mediating budding, scission and 
potential fusion of vesicles with membranes. This might represent the driving force for 
the vesicle transport of capsids through the nuclear envelope and, thus, impose the 
directionality of the process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 Discussion 
102 
 
3.2 Nup153 recruits the Nup107-160-complex to the inner nuclear 
membrane 
 
3.2.1 Nup153 is targeted to membranes by its N-terminus 
 
NPC assembly at the end of mitosis is a well coordinated and regulated assembly 
process. By employing cell free assays like the Xenopus leavis egg extract system 
the stepwise fashion of this self assembly was intensively studied. The chromatin 
binding nucleoporin MEL28/ELYS is known to be crucial for post-mitotic NPC 
assembly and initiates NPC assembly on the decondensing chromatin (Franz et al., 
2007; Rasala et al., 2006). 
The requirements for interphasic NPC assembly into the intact nuclear envelope are 
yet poorly defined. Most likely, NPC assembly in interphase is directly performed at 
the nuclear envelope as MEL28/ELYS is dispensable (Doucet et al., 2010). 
In order to target structural components to the nuclear envelope a factor similar to 
MEL28/ELYS must perform initial recruitment steps of nuclear pore components. 
Experiments shown here suggest that Nup153 provides a building platform thereby 
allowing recruitment of nuclear pore building blocks in interphase. Sequence analysis 
of vertebrate Nup153 (Fig. 2.53A) revealed a predicted amphipathic helix (Segrest et 
al., 1990) in the N-terminus of Nup153 (Fig. 2.53B) (http://heliquest.ipmc.cnrs.fr/). 
Additionally, a single point mutation of the valine residue in position 50 to glutamate 
(V50E) was predicted to disrupt this potential amphipathic helix. The N-terminus of 
Xenopus laevis Nup153 (aa 1-149) was recombinantly expressed with an EGFP tag, 
fused to the N-terminus. Employing GUVs composed of the nuclear envelope 
mimicking lipid mixture demonstrated that indeed the N-terminus of Nup153 is able to 
interact with membranes confirming that the N-terminus of Nup153 mediates 
membrane binding (Fig. 2.53C). The binding of the N-terminal fragment was also 
confirmed by transfection experiments in HeLa cells. Overexpression of this fragment 
induced nucleoplasmic membrane proliferation (Fig. 2.53E) known for membrane 
interacting proteins like lamin B (Ralle et al., 2004). Furthermore, the predicted 
amphipathic helix disrupting mutation V50E impaired interaction with GUV 
membranes (Fig. 2.53C). The human orthologue of Nup153 was fluorescently labeled 
and employed in the GUV system. Consistent with the previous result, human 
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Nup153 was also efficiently recruited to GUVs while the corresponding V47E 
mutation was unable to interact with GUV membranes (Fig. 2.53D).  
These results indicate that indeed Nup153 contains an at least in vertebrates 
conserved amphipathic helix in the N-terminus and, thus, can directly interact with 
membranes. 
In order to define the exact role of Nup153 in nuclear pore assembly, Nup153 was 
depleted from Xenopus laevis egg extract, which was employed in nuclear assembly 
reactions. Interestingly, the NPCs were unevenly distributed in the assembled nuclei 
(Fig. 2.54, right panel). This NPC clustering phenotype upon Nup153 depletion has 
been previously observed (Walther et al., 2001). The NPC clustering phenotype was 
rescued when recombinant Nup153 was added back to the assembly reaction and, 
thus, confirmed the functionality of recombinant Nup153 and the specificity of the 
depletion (Fig. 2.54). NPC clustering was also rescued by the Nup153 membrane-
binding mutant (V47E), although the nuclei formed appeared smaller in size 
compared to the wildtype addback. 
This indicates that the Nup153 membrane interaction is not required for proper NPC 
spacing in the nuclear envelope. 
 
3.2.2 Nup153 membrane binding is necessary for interphasic NPC assembly 
 
The role of Nup153 in interphasic NPC assembly was assessed by individual NPC 
counting in assembled nuclei under Nup153 depletion conditions. Addition of 2 µM 
importin-β is known to block interphasic NPC assembly (D'Angelo et al., 2006). When 
added to forming nuclei this resulted in a reduction in the number of NPCs per 
nucleus by about 50 % demonstrating that half of the final number of NPCs are 
formed by interphasic NPC assembly (Fig. 2.55). The depletion of Nup153 from egg 
extract caused a reduction in NPC number, which was not further affected by the 
addition importin-β, suggesting that Nup153 is necessary for interphasic NPC 
assembly. While the re-addition of wild type Nup153 resulted in similar NPC numbers 
compared to the mock-depleted sample addback of the membrane binding deficient 
V47E mutant did not restore NPC levels (Fig. 2.55). This again indicates that 
interphase NPC assembly requires Nup153 but, furthermore, that the crucial function 
of Nup153 is that of a membrane binding factor necessary to target NPC components 
to the nuclear envelope. 
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Thus, unlike to its dispensable role in NPC assembly after mitosis, the here 
presented results indicate that Nup153 functions as a crucial building platform for 
NPC assembly during interphase. 
Nup153 binds the Nup107-160 complex (Y-complex) forming the cytoplasmic and 
nucleoplasmic rings of the NPCs (Enarson et al., 1998). As membrane binding of 
Nup153 is required for interphasic NPC assembly this could point to a recruitment 
role for the Y-complex to the nuclear membranes by Nup153. 
In addition, the small GTPase ran is also known to interact with Nup153 and is 
required for interphasic NPC assembly (Doucet et al., 2010; D'Angelo et al., 2006; 
Walther et al., 2003). To test if the essential function of Nup153 is to recruit one of 
these two interaction partners to the membrane artificially membrane tethered, EGFP 
tagged constructs containing the Y-complex binding site or the ran binding site of 
Nup153 were generated. The synthetic Y-complex binding construct was able to bind 
purified and labeled Xenopus laevis Y-complex, as demonstrated by liposome 
floatation assays (Fig. 2.56B) and when reconstituted in GUVs (Fig. 2.56C). In 
contrast, the Y-complex was not able to bind the ran-binding construct (Fig. 2.56B-C). 
The opposite pattern was seen for the ran binding construct as ran was efficiently 
recruited but not by the Y-complex (Fig. 2.56B-C). 
This demonstrates that the generated constructs, containing the individual binding 
regions, were sufficient to recruit the Y-complex or ran to membranes, respectively. 
Recruitment of the Y-complex but not ran by the corresponding binding region of 
Nup153 to membranes was sufficient for subsequent interphasic NPC assembly 
when employed in NPC assembly reactions after depletion of endogenous Nup153 
(Fig. 2.56D). Thus, the Y-complex as a crucial structural component of the NPC must 
be recruited by Nup153 to membranes in order to mediate NPC assembly in 
interphase (Fig. 3.2). This to Nup153 previously not assigned function still poses 
several unanswered questions. Nup153 is located at the inner nuclear membrane. 
Nevertheless, formation of new NPCs in interphase is initiated from the nuclear as 
well as the cytoplasmic side (D’angelo et al., 2006). This could indicate that Nup153 
is only necessary for the membrane attachment of the Nup107-160 inside the 
nucleus, acting as an enhancer of membrane binding. Consistent with this view is the 
fact that the inner nuclear membrane is coated by the lattice of the nuclear lamina 
and therefore less accessible than the ONM (Gruenbaum et al., 2005). The Nup107-
160 complex contains several proteins with an intrinsic membrane binding capability 
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like Nup133 (Drin et al., 2007). Nevertheless, this membrane interaction seems not to 
be sufficient for membrane attachment during interphasic NPC assembly. Consistent 
with this, Nup107-160 complex purified from Xenopus laevis did not show an 
interaction with GUVs and LUVs on its own (Fig. 2.56B-C. Therefore, Nup153 would 
provide an interaction platform on the membrane in order to recruit the Nup107-160 
complex for the formation of new NPCs. This function seems to be taken over by 
ELYS/MEL28 during the process of NPC assembly after mitosis. As this mode of 
assembly is most likely initiated on the chromatin, a recruitment factor for the 
Nup107-160 complex needs to interact with DNA. ELYS/MEL28 contains an AT-hook 
that allows an interaction with DNA (Gillespie et al., 2007) providing the interaction 
platform for the Nup107-160 complex, thereby making Nup153 in this respect 
obsolete. Vice versa in NPC assembly during interphase Nup153 takes over this role, 
making ELYS/MEL28 dispensable. 
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Figure 3.2: Model of post-mitotic and function of Nup153 in interphasic NPC 
assembly 
NPC assembly at the end of mitosis is dependent on y-complex recruitment of 
MEL28/ELYS, interacting with chromatin. For interphasic NPC assembly, transportin 
is binding and preventing thereby membrane interaction of Nup153, facilitating import 
into the nucleus. The high concentration of ranGTP in the nucleus results in release 
of the Nup153 cargo and can thereby interact and recruit the Y-complex to the inner 
nuclear membrane for interphasic NPC assembly. 
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4 Material and Methods 
4.1 Materials 
 
4.1.1 Devices 
  
 
 
CP2201 balance Satorius AG, Göttingen, Germany 
Dri-Block DB-2A – heating block Bibby Scientific Limited, Staffordshire, UK   
EmulsiFlex-C3 Avestin Inc., Ottawa, Canada 
BioPhotometer Eppendorf, Hamburg, Germany 
FluoView FV1000 
Olympus Europa Holding GmbH, Hamburg, 
Germany 
GelAir Drying System Biorad Laboratories, Hercules, USA 
Gel-Logic-1500 Imaging Systems  Carestream Health, Inc., Rochester, USA 
HT Multitron Infors-HAT Inc. Bottmingen, Switzerland 
Haake DC10-P5/U Thermo Fisher Scientific, Waltham, USA 
Heraeus Fresco-17 Thermo Fisher Scientific, Waltham, USA 
Heraeus Pico-17 Thermo Fisher Scientific, Waltham, USA 
MR 3000 
Heidolph Instruments GmbH & Co. KG, 
Schwabach, Germany 
Mettler AE240 Mettler Toledo, Gießen, Germany 
Mini-PROTEAN-3 Electrophoresis Cell Biorad Laboratories, Hercules, USA 
Mini-PROTEAN Tetra System Biorad Laboratories, Hercules, USA 
Multifuge Thermo Fisher Scientific, Waltham, USA 
MultiImage Light Cabinet Alpha Innotech, Santa Clara, USA 
Nanodrop ND-1000 Thermo Fisher Scientific, Waltham, USA 
NeoBlock - Heizer Duo 2-2504 NeoLab,Heidelberg, Germany 
Optima L-60 Beckmann-Coulter, Krefeld, Germany 
Optima TLX Beckmann-Coulter, Krefeld, Germany 
Peltier Thermal Cycler PTC-200 Biorad Laboratories, Hercules, USA 
Polymax 2040 
Heidolph Instruments GmbH & Co. KG, 
Schwabach, Germany 
PowerPac Basic Biorad Laboratories, Hercules, USA 
Seven Easy Mettler Toledo, Gießen, Germany 
Sorvall Evolution RC Thermo Fisher Scientific, Waltham, USA 
Stuart SB2 Keison Products, Essex, UK 
TG315 Function Generator AIM-TTI Instruments, Huntingdon, UK 
Thermomixer comfort 5355 Eppendorf, Hamburg, Germany 
Thermomixer compact 5250 Eppendorf, Hamburg, Germany 
Vortex Genie 2 Scientific Industries Inc., New York, USA 
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4.1.2 Reagents and consumables 
  
α-lactose Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
1,4-dithiothreitol Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
agarose                          Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
ammonium peroxydisulfate  Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
ammonium sulfate  Merck KGaA, Darmstadt, Germany 
boric acid                              Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
bromophenol blue  
(3',3",5',5"-
tetrabromophenolsulfonphthalein) 
Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
bovine serum albumin  Calbiochem, Merck KGaA, Darmstadt, Germany 
calcium chloride               AnalaR Normapur, VWR International, Radnor, USA 
chloroform               Thermo Fisher Scientific, Waltham, USA Scientific 
coomassie R-250                          Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
cetyltrimethylammonium bromide Calbiochem, Merck KGaA, Darmstadt, Germany 
dimethyl sulfoxide  
SERVA Electrophoresis GmbH, Heidelberg, 
Germany 
disodium hydrogen phosphate Merck KGaA, Darmstadt, Germany 
Dulbecco´s modified Eagle 
medium  
Life Technologies,Carlsbad, USA 
Disodium-ethylenediamine-
tetraacetic acid  
Merck KGaA, Darmstadt, Germany 
acetic acid                 Sigma-Aldrich,  St. Louis, USA 
ethanol                   Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
fetal calf serum Life Technologies,Carlsbad, USA 
formaldehyde Sigma-Aldrich,  St. Louis, USA 
ethidium bromide              Sigma-Aldrich,  St. Louis, USA 
glucose Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
glycerine                  Sigma-Aldrich 
glycine                                Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
yeast extract  Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
4-(2-hydroxyethyl)-1-piperazine-
ethanesulfonic acid (HEPES)                               
Carl Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
Roth GmbH + Co. KG - Karlsruhe, Germany 
hydroxylamine                 Alfa Aesar, Ward Hill,USA 
imidazole                             Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
isopropyl-β-D-thiogalacto- 
pyranoside  
Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
potassium dihydrogen phosphate Merck KGaA, Darmstadt, Germany 
kanamycin sulfate Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
magnesium chloride             Fluka, Sigma-Aldrich,  St. Louis, USA 
magnesium sulfate               Novagen, Merck KGaA, Darmstadt, Germany 
nonfat dried milk powder AppliChem GmbH, Darmstadt, Germany 
methanol                 Thermo Fisher Scientific, Waltham, USA 
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sodium azide Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
sodium chloride Merck KGaA, Darmstadt, Germany 
sodium carbonate Merck KGaA, Darmstadt, Germany 
sodium hydrogen carbonate Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
sodium dihydrogen phosphate Merck KGaA, Darmstadt, Germany 
sodium dodecyl sulfate Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
sodium thiosulfate Merck KGaA, Darmstadt, Germany 
octyl glucoside Calbiochem, Merck KGaA, Darmstadt, Germany 
phenylmethylsulfonyl fluoride Biochemica, AppliChem GmbH, Darmstadt, Germany 
Ponceau-S                Fluka, Sigma-Aldrich,  St. Louis, USA 
Rotiphorese® Gel 30 (37.5:1) 
solution 
Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
sucrose Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
hydrochloric acid Sigma-Aldrich,  St. Louis, USA 
silver nitrate Merck KGaA, Darmstadt, Germany 
tetramethylethylenediamine Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
tricine                               Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
Tris-HCl                   Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
Tween®-20                          Carl Roth GmbH + Co. KG - Karlsruhe, Germany 
 
  
4.1.3 Kits used 
 
QIAquick Gel Extraction Kit  Qiagen N.V., Venlo, Netherlands 
QIAquick PCR Purification Kit  Qiagen N.V., Venlo, Netherlands 
QIAquick Plasmid Mini Kit  Qiagen N.V., Venlo, Netherlands 
QIAquick Plasmid Midi Kit  Qiagen N.V., Venlo, Netherlands 
Western Lightning Plus ECL 
Kit 
PerkinElmer, Waltham, USA 
 
 
  
4.1.4 Enzymes used 
 
 
 DNase I, RNase-free, recombinant 
10 U/μl (bovine pancreas) 
Roche 
 
 
KOD DNA polymerase 1 U/μl 
(Thermococcus kodakaraensis)  
Novagen 
 
 
 
Nde I, 20 U/µl, recombinant (Neisseria 
denitrificans) 
 
 
NewEngland Biolabs 
 
 
T4 DNA Ligase, 400 U/µl, recombinant 
(T4 bacteriophage, Myoviridae) NewEngland Biolabs 
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Taq DNA Polymerase, recombinant                                                                   
(Thermus aquaticus YT-1) 
  
Xho I, 20 U/µl, recombinant 
(Xanthomonas holcicola) NewEngland Biolabs 
 
4.1.5 Bacterial strains used 
 
 
XL1 blue (Stratagene) recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1  
lac [F’ proAB lacIqZDeltaM15 Tn10 (Tetr)] 
Bl21 (DE3)  F– ompT hsdSB(rB–, mB–) gal dcm lambda(DE3) 
Bl21 gold (DE3) F– omp T hsdS(rB mB) dcm+ Tetr gal lambda(DE3) endA Hte 
Bl21 star (DE3) F– ompT hsdSB(rB–, mB–) gal dcm rne131 lambda(DE3) 
 
 
  
  
4.1.6 Cell lines used 
 
 
HeLa S3 human negroid cervix carcinoma cell line ATCC nr. CCL-2.2 
293T human primary embryonal kidney cell line 293 ATCC nr. CRL-3216 
U-2 OS human osteosarcoma cell line ATCC nr. HTB-96 
RK13 rabbit kidney cell line ATCC nr. CCL-37 
 
 
4.1.7 Primary antibodies used 
 
 
α-His6 mouse Roche 1:500 dilution 
mAb414 mouse covance 1:2000 dilution 
α-EGFP mouse Roche 1:2000 dilution 
 
  
   
 
 
4.1.8 Secondary antibodies used 
 
 
Cy3 goat α-mouse IgG 
life 
technologies 1:2000 dilution 
Alexa-Fluor-488 goat α-mouse IgG    
life 
technologies 1:2000 dilution 
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Alexa-Fluor-546 goat α-mouse IgG    
life 
technologies 1:2000 dilution 
Alexa-Fluor-647 goat α-mouse IgG    
life 
technologies 1:2000 dilution 
goat α-mouse IgG linked horseradish 
peroxidase Calbiochem 1:5000 dilution 
 
 
4.1.9 Oligonucleotides used 
 
Oligonucleotides used in this study were purchased from Sigma-Aldrich and are listed in 
5’ - 3’ orientation. 
 
UL31COXhoINS GGCGGCTCGAGCGGACGCGGAGGACGAAAATC 
UL31CONdeI GGCGGCATATGTTTGAACGTCGTCGTC 
UL31COBamHI CCGCCGGATCCGATGTTTGAACGTCGTCGTCTGC 
UL31COXhoI GGCGGCTCGAGTTATTACGGACGCGG 
UL31COC92Sfw 
GGGTCTGGGTGGTTGTTGTCCGACCAGCGCAGCA 
GCAGAACCGCGTC 
UL31COC92Srev 
GACGCGGTTCTGCTGCTGCGCTGGTCGGACAACA 
ACCACCCAGACCC  
UL31COC73Sfw 
GGTCAGGCAGTTGCAGATAATAGCCTGAGCCTGAG 
CGGTATGG    
UL31COC73Srev 
CCATACCGCTCAGGCTCAGGCTATTATCTGCAAC 
TGCCTGACC    
UL31COC88SC89Sfw 
TATTATCTGGGTCTGGGTGGTAGCAGCCCGACCT 
GTGCAGCAGCA  
UL31COC88SC89Srev 
TGCTGCTGCACAGGTCGGGCTGCTACCACCCAG 
ACCCAGATAATA 
UL31COBamHIpGEX6P GGCGCGGATCCATGTTTGAACGTCGTCGTCTG 
EGFPBamHIpGEX6P GGCGCGGATCCATGGTGAGCAAGGGCGAGG 
UL31COP62Gfw  
AACCGCACCGGTTACCCTGGGTTTTGATCTGGGT 
CAGGCAGTT 
UL31COP62Grv    
AACTGCCTGACCCAGATCAAAACCCAGGGTAAC 
CGGTGCGGTT 
UL31COL74Afw  
TCAGGCAGTTGCAGATAATTGTGCAAGCCTGACG 
GTATGGGTTA 
UL31COL74Arv   
TAACCCATACCGCTCAGGCTTGCACAATTATCTG 
CAACTGCCTGA 
UL31COL76Afw  
AGTTGCAGATAATTGTCTGAGCGCAAGCGGTATG 
GGTTATTATCTGG 
UL31COL76Arv  
CCAGATAATAACCCATACCGCTTGCGCTCAGAC 
AATTATCTGCAACT 
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UL31COS77Afw 
GCAGATAATTGTCTGAGCCTGGCAGGTATGGGTT 
ATTATCTGGGTC 
UL31COS77Arv 
GACCCAGATAATAACCCATACCTGCCAGGCTCA 
GACAATTATCTGC 
UL31COG80Afw 
CTGAGCCTGAGCGGTATGGCATATTATCTGGGTC 
TGGGTGGT 
UL31COG80Arv 
ACCACCCAGACCCAGATAATATGCCATACCGCT 
CAGGCTCAG 
UL31COC88Sfw   
TATTATCTGGGTCTGGGTGGTAGCTGTCCGACCTG 
TGCAGCAG 
UL31COC88Srv    
CTGCTGCACAGGTCGGACAGCTACCACCCAGAC 
CCAGATAATA 
UL31COC89Sfw   
ATCTGGGTCTGGGTGGTTGTAGCCCGACCTGTGC 
AGCAGCAG 
UL31COC89Srv    
CTGCTGCTGCACAGGTCGGGCTACAACCACCCA 
GACCCAGAT      
UL31COH188Afw 
GTGTTTCCGGAAAAAAGCGTGGCAGTTCATCATC 
GTGTTCTGGATC 
UL31COH188Arv 
GATCCAGAACACGATGATGAACTGCCACGCTTTT 
TTCCGGAAACAC 
UL31CONheI CCGCCGCTAGCATGTTTGAACGTCGTCGTCTG 
UL34CONdeI GGCGGCATATGAGCGGCACCCTGG 
UL34COXhoI 
GGCGGCTCGAGCTATTAACGACGCAGACCCAGC 
AGG 
UL34CO240XhoINS GGCGGCTCGAGACGACGCAGACCCAGCAGG 
UL34COstopXhoI 
GGCGGCTCGAGTCATCAGCGCATATTCAGAATAA 
TCACAAT 
UL34COTMRSalIfw GGCGGGTCGACCTGCGTCGTCTGGCAGGTT 
UL34COnsXhoI 
GGCGGCTCGAGGCGCATATTCAGAATAATCAC 
AAT 
Nup153xlNdeI GGCGGCATATGGCAGCAGCCGGTG 
Nup153xl149AseI GGCGGATTAATCAGGCTTGCACGATGCAGG 
Nup153xlSalI GGCGGGTCGACATGGCAGCAGCCGGTG 
Nup153xl149XhoI 
GGCGGCTCGAGTTATTACAGGCTTGCACGATGC 
AGG 
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4.1.10 Used buffers and solutions 
 
 
0.2 M PMSF 3.5 g PMSF were dissolved in 100 ml ethanol  
0.259 M Sucrose 8.9 g sucrose were dissolved in 100 ml double-distilled water 
filtered aliquoted and stored at -20 °C 
1 M CaCl2      55.5 g CaCl2 were dissolved in 1 l double-distilled water 
filtered   
and autoclaved 
1 M DTT      15.45 g DTT were dissolved in 1 l double-distilled water 
aliquoted and  stored at -20 °C 
1 M HEPES-KOH     238.1 g HEPES were dissolved in 800 ml double-distilled 
water adjusted with KOH to pH 8, filtered autoclaved and 
filled up to 1 l 
1M Imidazol 68.08 g were dissolved in 800 ml in double-distilled water 
adjusted with NaOH to pH=7.5 autoclaved and filled up to 1 l 
1 M IPTG 2.38 g were dissolved in 10 ml double-distilled water and 
stored at-20 °C  
1 M MgCl2 47.6 g MgCl2 were dissolved  in 1 l double-distilled water 
filtered and autoclaved 
1 M MgSO4 246.5 g MgSO4 were dissolved  in 1 l double-distilled water 
and autoclaved 
1 M Tris  121.1 g were dissolved in 800 ml double-distilled water and 
adjusted with hydrochloric acid to the desired pH value and 
filled up to 1 l with double-distilled water, filtered and 
autoclaved  
1.5 M Tris pH 8.8 181.7g were dissolved in 800 ml double-distilled water 
ajusted with hydrochloric acid to pH=8.8 , filled op to 1 l with 
double-distilled water, filtered an autoclaved 
2 M KCl 149.1g KCL were dissolved in 1 l double-distilled water 
filtered and autoclaved 
5 % BSA 5 g BSA were dissolved in 100 ml 1x PBS and stored at 4 °C 
1x PBS-Tween (0.1%) 2 ml Tween-20 were dissolved in 2 l 1x PBS  
3x gel buffer 36.3g Tris-HCl and 0.3 g SDS were dissolved in 100 ml 
double-distilled water  
6x DNA-loading buffer  5 ml Glycerin 1 ml 10x TBE 1 ml 10 % Orange G were 
dissolved in double-distilled water and filled up to 10 ml and 
aliquoted 
6x SDS-sample buffer 18.75 ml 1 M Tris pH 6.8 30 g sucrose 9 g SDS 1 ml 10 % 
bromophenol blue were dissolved in double-distilled water 
and filled up to 90 ml. Before use DTT was added to a final 
concentration of 100 mM 
10x Anode-buffer 242.2 g Tris-HCl were dissolved in 800 ml double-distilled 
water adjusted with hydrochloricacid to pH 8.9 and filled up to 
1 l . 
10x Cathode-buffer 121.1g Tris-HCl 179.2 g Tricine and 10 g SDS were 
dissolved in 1 l double-distilled water 
10x Laemmli-buffer 50 g SDS 721 g glycine and 150 g Tris-HCl were dissolved in  
5 l double-distilled water 
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10x PBS 10 g KCL 400 g NaCl 89 g Na2HPO4  12 g KH2PO4 were 
dissolved in 4 l double-distilled water adjusted to pH 7.4 with 
hydrochloric acid filled up to 5 l double-distilled water and 
autoclaved  
10x TBE 540 g Tris-HCl 275 g boric acid and 46.5 g of disodium 
ethylenediaminetetraacetic acid were dissolved in 5 l double-
distilled water 
10x Tris-glycin-buffer 151.5 g Tris-HCl and 720.5 g glycine were dissolved in 5 l 
 double-distilled water  
20x NPS 
66 g (NH4)2SO4 136 g KH2PO4 178 g Na2HPO4 were 
dissolved in 1 l double-distilled water and autoclaved 
50x 5052 250g glycerole (87%w/v) 25g glucose and 100g α-lactose 
were dissolved in  1l double-distilled water and autoclaved  
Blocking buffer 50 g nonfat dried milk powder and 1 ml Tween-20 were 
dissolved in 1 l 1x PBS and stored at 4 °C 
Coomassie stain 2.5 l methanol 0.5 l acetic acid and 10 g Coomassie R-250 
were dissolved in 5 l double-distilled water and filtered 
through Whatman filter paper 
Coomassie destain I 2.5 l methanol and 0.5 l acetic acid were filled up to 5 l   
with double-distilled water 
Coomassie destain II 0.5 l ethanol 0.25 l acetic acid were filled up to 5 l with  
double-distilled water 
Developer solution 12 g Na2CO3 100 µl formaldehyd (37 wt. % in H2O ) and 4 ml 
of postfix solution were filled up to 200 ml with double-
distilled water  
Fixing solution 100 ml methanol 24 ml acetic acid and 100 µl formaldehyd 
(37 wt. % in H2O ) were filled up to 200 ml with double-
distilled water  
Kanamycin (25 mg/ml) 2.5 g kanamycin was dissolved in 100 ml double-distilled 
water, aliquoted and stored at -20 °C  
Lysogeny Broth 
(modified Lennox) 
10 g thryptone, 5 g yeast extract and 5 g NaCl were 
dissolved in 1 l  double-distilled water, adjusted to pH 7 with 
NaOH and autoclaved 
Nickel wash buffer 58.44 g NaCl 40 ml 1 M Tris-HCl pH 7.5 and 60 ml 1 M 
Imidazol pH 7.5 were filled up to 2 l with double-distilled 
water 
Nickel wash buffer  
+ 1 % CTAB 
58.44 g NaCl 40 ml 1 M Tris-HCl pH 7.5 60 ml 1 M Imidazole 
pH 7.5 and 20 g CTAB were filled up to 2 l with double-
distilled water and stored up to 6 month at room temperature 
Nickel elutions buffer 
+ 1 % CTAB 
14.6 g NaCl 10 ml 1 M Tris-HCl pH 7.5 200 ml 1 M imidazole, 
5 g CTAB and 57 ml glycerol (87 % w/w) were dissolved in 
500 ml double-distilled water and stored at room temperature 
Nickel elution buffer 14.6 g NaCl 10 ml 1 M Tris-HCl pH 7.5 200 ml 1 M imidazole 
and 57 ml glycerol (87 % w/w) were dissolved in 500 ml 
double-distilled water and stored at 4 °C 
Ponceau staining 
 solution 
1 g Ponceau S, 10 ml acetic acid (99 %) were dissolved and 
filled up to 1 l in double-distilled water 
Postfix solution 0.1 g Na2S2O3 was dissolved in 500 ml double-distilled water 
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S0-Puffer 
50 mM KCl 2.5 mM MgCl2 and 10 mM HEPES pH 7.5 were 
dissolved in 1 l double-distilled water  
S2100 solution  71.88 g sucrose was dissolved in 100 ml S0 buffer 
Silverstain solution 0.2 g AgNO3 was dissolved in 100 ml double-distilled water 
Lysogeny Broth  
(modified Luria) 
20 g thryptone 5 g yeast extract and 0.5 g NaCl were 
dissolved in 1 l double-distilled water and autoclaved 
STOPP II  solution 18.6 g Na2-EDTA  was dissolved in 1 l double-distilled water  
Blocking buffer (IF) 3 g BSA were dissolved in 99.5 ml 1x PBS, 500 µl of 20 % 
Triton X-100 solution (w/v) was added 
4 % Paraformaldehyde  20 g paraformaldehyde was dissolved in 450 ml 1x PBS and  
adjusted with NaOH to pH 7.5, aliquoted and stored at -20 °C 
Sodium cacodylate 4.28 g sodium cacodylate was disolved in 90 ml double-
distilled water, adjusted to pH 7,4 and filled up to 100 ml 
Fixation buffer 50 ml of 0.2 M sodium cacodylate and 5 ml glutaraldehyde 
(50 % wt. % in in H2O) was filled up to 100 ml double-distilled 
water and stored at 4 °C 
SLB buffer 10 mM HEPES, pH 7.4, 150 mM NaCl 
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4.2 Methodes 
 
4.2.1 Polymerase chain reaction (PCR) 
 
All PCR reactions were performed in the DNA Engine - Peltier Thermal Cycler PTC-
200 (Biorad). Each reaction was composed of  5 μl 10x KOD Buffer (Novagen),  2.5 
μl 25 mM MgSO4 (Novagen), 5 μl dNTP mix (2 mM) (Stratagene),1 ng of the DNA 
template and 10 µl of 0.5 µM forward and reverse primer. 
The mixture was brought if necessary to a volume of 49 μl double-distilled water and 
1 µl of KOD polymerase (1 U/ul, Novagen) was added to a final volume of 50 µl. The 
KOD polymerase has a high elongation rate of 106-138 bases per second (Taq 
polymerase 61 bases per second) and has in contrast to the Taq polymerase a 3' to 
5' exonuclease activity (Takagi et al., 1997). 
For difficult reactions a mixture of 0.8 µl KOD polymerase and 0.2 µl Taq polymerase 
(5 U/µl, Novagen) was used. The commonly used PCR program consisted of usual 
30 cycles starting with an initial denaturing step for 30 seconds at 95 °C. 
This step was followed by 5 cycles each with 30 seconds denaturing at 95 °C and the 
annealing temperature was set to 58 °C. Elongation temperature was set to 75 °C for 
50 seconds. The following 25 cycles were carried out as before but the annealing 
temperature was increased to 62 °C. The final step is an elongation step for five 
minutes at 75 °C. 
After completion of the PCR program the 5 µl of the PCR mixture was mixed with 5 µl 
of 6x DNA loading buffer an analysed according to the size of the PCR product on 
0.8 % - 2 % agarose gel. 
The remaining PCR product was purified using the QIAquick PCR Purification Kit 
(Qiagen) following manufacturer's instruction. The amplified PCR product was eluted 
subsequently in 100 µl EB buffer (Qiagen). 
 
4.2.2 Agarose gel electrophoresis for separation of DNA fragments 
 
The separation of DNA fragments was carried out on 0.8 % - 2 % agarose gels. 
Therefore 8 g/l – 20 g/l agarose (Invitrogen) were boiled with one liter of 1x TBE 
buffer and poured hot in a flat chamber custom made chamber with inserted comb 
and spacers. Additionally 2 μl of ethidium bromide (10 mg/ml) was mixed with the 
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solution. After solidification of the agarose, the spacer and excess agarose was 
removed. Subsequently, the chamber was filled with 1x TBE buffer and the comb 
could be drawn. Prior to the application of the samples they were mixed with 6x DNA 
loading buffer and applied into the respective pockets. Electrophoresis was 
performed by applying a voltage of 90 Vconstant until the sample buffer band reached 
the end of the agarose gel. As DNA standard a DNA size standard marker 
(GeneRuler® DNA Ladder Mix, Fermentas) was applied to determine the size of the 
separated DNA fragments. The analysis was performed on the visualization of the 
intercalated ethidium bromide between the basespairs of the DNA. Ethidium bromide 
has absorption maxima at 210 nm and 285 nm and emits light at 605 nm after 
excitation. Excitation was recordet using a MultiImage Light Cabinet (AlphaImager 
HP System 1.4 Megapixel camera, motorized 8-48 mm, F1.2 zoom lens with +2 
diopter close-up lens, white light table, EPI white lights, Orange filter and UV 
transilluminator (Alpha Innotech)) and analysed using the included AlphaView Image 
Analysis Software v.6.0.  
 
4.2.3 Restriction digestion of DNA 
 
4.2.3.1 Restriction digestion of PCR products 
 
Restriction enzymes recognize specific DNA sequences and can cut out specific 
parts of the DNA. Restriction enzymes are categorizes in five different subclasses 
according to the site they recognize and the site they can cleave as well as the 
dependency cofactors. For double digestion approaches the corresponding buffer 
was chosen in which both enzymes have their highest activity. 
Therefore 100 µl of the elution from the purification using the PCR purification Kit 
(Qiagen)  were mixed with  13 μl of 10x buffer 4 (NewEngland Biolabs) and mixed 
with 1 µl Nde I (NewEngland Biolabs) and 1 μl Xho I (NewEngland Biolabs). The 
reaction mix was was filled up to 130 µl with double-distilled water and incubated for 
2 h at 37 °C. Thereafter 0.5 µl of each enzyme was added and incubated for an 
additional hour. 
The restriction digest was purified using the QIAquick PCR Purification Kit (Qiagen) 
following the manufacturer's instructions and the digested DNA fragment was eluted 
with 30 µl of EB buffer. 
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4.2.3.2 Restriction digest of vector fragments 
 
The vector with the desired DNA fragment was incubated with the desired restriction 
enzymes. The fragment thereby is flanked by the corresponding cleavage sites. The 
appropriate 10x buffer was chosen in which the used enzymes have the highest 
activity. By default, a reaction volume of 30 µl was used. For this purpose 1 μg of 
being cut vector and 3 μl of the appropriate 10x buffer (NewEngland Biolabs) as well 
as 1 µl of each enzyme was mixed. 
The mixture was brought to a final volume of 30 µl with double-distilled water and 
incubated for two hours at 37 °C. After 1 h each of the enzymes used was added 
freshly and incubated for an additional hour at 37 °C. The complete digest was then 
analyzed on an appropriate agarose gel at 90 Vconstant containing 2 µl ethidium 
bromide (10 mg/ml). After the separation the expected DNA fragment (Vetter GmbH 
Contact Lamp Type Chroma 42) was determined using a DNA size standard 
GeneRuler DNA Ladder Mix (Fermentas). Ethidium bromide was excited at 210 nm 
and 285 nm and emission was collected at 605 nm using a Vetter GmbH Contact 
Lamp Type Chroma 42. The correct band was excised from the gel using a scalpel 
and transferred to an Eppendorf 1.5 ml tube. The fragment was purified by QIAquick 
Gel Extraction Kit (Qiagen) according to manufacturer's instructions from the isolated 
gel slice. The elution of the fragment was carried out in 30 µl Buffer EB (Qiagen). 
 
4.2.4 Ligation von DNA fragments 
 
The vectors used for ligations were already cutted using appropriate restriction 
enzymes and dephosphorylated. Always following approach was used for the ligation 
of DNA fragments. 
5 μl of the cutted and purified DNA fragment was mixed with 0.5 μl of the desired 
vector. 1 μl of 10x T4-ligase buffer (NewEngland Biolabs) and 1 μl of T4 ligase (400 
U/µl, NewEngland Biolabs) was added to the mixture and filled up with 2.5 µl to a 
final volume of 10 µl. The mixture was mixed well and the ligation was carried out for 
at least 6 h in a DNA Engine - Peltier Thermal Cycler PTC-200 (Biorad). A DNA 
fragment excised from a DNA vector and should be ligated to another DNA vector, all 
volumes of the ligation mixture were reduced by half. 
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4.2.5 Heat shock transformation of Vector DNA in competent E. coli XL-1 
 
For multiplication of the ligated DNA fragments the vector plasmids were heat-shock 
transformed into competent E. coli XL-1 bacteria (Stratagene) were added. Therefor 
an aliquot (200 ml) was thawed on ice and 3.4 μl β-mercaptoethanol (1.42 M, 
Stratagene) was added. The mixture was gently shaken every two minutes for ten 
minutes. For each transformation mixture 50 µl of competent bacteria were mixed 
with 10 µl of the ligation reaction of a PCR product and incubated for 30 min on ice. 
The heat shock was performed by incubation of the mixture for 45 seconds at 42 °C 
in a water bath (Haake DC10-P5 / U) and subsequent incubation on ice for additional 
two minutes. To each transformation 500 µl of preheated 42 °C SOC medium was 
added followed by one hour incubation at 37 °C and gently shaking at 600 rpm. LB 
(modified Luria) medium was previously complemented with 20 µl of a sterile-filtered 
20 % glucose solution (w/v) and 10 µl of 1M MgCl2 solution. Each transformation 
mixture was plated onto prewarmed agar plates containing the appropriate antibiotic 
and incubated overnight at 37 °C. 
  
4.2.6 Analysis of cloned PCR fragments 
 
After plating the transformed XL-1 bacteria (Stratagene) on antibiotic-containing agar 
plates and overnight overnight at least three grown colonies were picked and 
inoculated in each 5 ml of LB medium supplemented with the appropriated antibiotic 
using sealable test tubes. Further incubation was carried out overnight at 37 ° C and 
and gently shaking at 300 rpm in an incubator (HT Multitron Infor, Infor AG). 2 ml 
each overnight culture were placed in a 2 ml Eppendorf tube and centrifuged at 
13,000 rpm 1 min and the supernatant was discarded. Remaining overnight cultures 
were stored temporarily at 4 °C. The resulting pellets were resuspended in 250 μl per 
P1 buffer (Qiagen). Then 250 μl buffer P2 (Qiagen) were added, mixed by repeated 
inversion and 350 μl N3 buffer (Qiagen) was added. The mixtures were centrifuged 
several times for ten minutes at 13,000 rpm and 4 °C (Heraeus Fresco 17, Thermo 
Fisher Scientific). In parallel spin columns (Qiagen 50) were washed with 800 μl of 
distilled water by centrifugation. The supernatant prepared by alkaline lysis of 
bacteria was added to the centrifugation column and purified by centrifugation for one 
minute at 13,000 rpm. The centrifuged supernatant was discarded and the columns 
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were washed by centrifugation with 800 μl PE buffer (Qiagen). PE buffer was 
discarded again and the remaining buffer removed by an additional washing step for 
one minute at 13,000 rpm. Spin columns were set on top of 1.5 ml Eppendorf tubes 
and incubated for one to two minutes with EB buffer (Qiagen). The plasmid DNA was 
eluted from the spin column matrix by centrifugation with 30 µl EB buffer. 10 µl of 
each elution was mixed with 5 μl of a previously prepared mastermix in a 96-well 
microtiter plate (Nalge Nunc International Corp.) and sealed with Parafilm (Alcan 
Packaging) followed by a 2 h incubation at 37 °C. The enzyme mastermixed for one 
reaction was composed of 0.3 µl each of the appropriate enzymes (NewEngland 
Biolabs), 1.5 µl of the corresponding 10x NEB buffer and was brought to 5 µl with 
double-distilled water. Subsequently each reaction was mixed well with 5 μl of 6x 
DNA sample buffer directly in the microtiter plate and 10 µl each were separated on 
an appropriate agarose gel at 90 Vconstant .The result was verified by comparison with 
the applied DNA standard (GeneRuler DNA Ladder Mix, Fermentas), whether a DNA 
fragment of the correct size was. Documentation was performed using the Multi 
Image Light Cabinet (Alpha Innotech). In case of a positive match 15 ml LB medium 
with the appropriate antibiotic was inoculated using the temporarily stored overnight 
culture followed by further incubation overnight at 37 °C and 300 rpm in a shaking 
incubator (HT Multitron Infors, Infors AG). The overnight culture was further 
processed by pelleting the bacteria in 15 ml centrifugation tubes (BD Falcon) and 
subsequent centrifugtion for 5 minutes at 4,000 rpm 4 °C. 
The plasmid isolation as then performed using the Plasmid Mini Kit (Qiagen) 
according to manufacturer's instructions. Deviating from the manufacturer's protocol 
were the increased volumes of the used P1, P2 and P3 buffers from 300 μl to 600 μl. 
Furthermore, a second centrifugation step to remove genomic DNA was added 
directly after the first centrifugation to remove any residual genomic DNA. Additionally 
to precipitate the eluted plasmid DNA each reaction was mixed with isopropanol but 
the incubation was performed at -20 °C room temperature and not as indicated at 
room temperatur. Finally plasmid DNA was air-dried resuspended in 50 µl TE buffer 
for two hours at 37 °C and shaking at 1400 rpm in a thermo mixer compact 5250 
(Eppendorf). The DNA concentration was determined by measuring the absorbence 
at 260 nm using a NanoDrop 1000 spectrophotometer (peqlab GmbH). The plasmid 
DNA was then sequenced in the in house sequencing facility and stored at -20 °C. 
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The analysis of cloned vector fragements was analogous to the analysis of cloned 
PCR fragements with the difference that only 5 μl of the elution was analyzed and 
filled up with double distilled water to 10 µl. 
 
4.2.7 Generation of chemically competent E. coli BL21 (DE3) 
 
Bacterial stocks stored at -80 °C were used to plate the E. coli strain BL21 (DE3) 
containing the λ DE3 lysogen carrying the gene for T7 RNA polymerase under the 
control of the lac UV5 promoter. 
 
4.2.8 Heat shock transformation of competent E. coli BL21 (DE3) 
 
The heat shock method was used to introduction the desired vector DNA in 
competent E. coli BL21 (DE3). Therefor an aliquot of about 200 µl competent E. coli 
BL21 (DE3) was thawed on ice. For one batch 50 µl competent bacteria were mixed 
with 50 ng – 100 ng the corresponding vector DNA in prechilled Eppendorf tubes and 
incubated for 20 minutes on ice. Each transformation was heat shocked for 30 
seconds at 42 °C using a water bath (Haake DC10-P5 / U) followed by incubation for 
2 minutes on ice. 350 μl of preheated LB medium was added without antibiotic and 
incubated for additional 30 minutes at 37 °C and 600 rpm (Thermo Mixer compact 
5250, Eppendorf). The plating was carried out using agar plates containing the 
appropriate antibiotics and subsequent incubating at 37 °C overnight. 
  
4.2.9 Affinity purification of His-tagged fusion proteins 
 
Affinity purification of His-tagged fusion proteins is the most commonly used 
technique to purify recombinant proteins expressed in E. coli. Therefor proteins were 
designed to be expressed with a polyhistidine, usually six subsequent Histidines 
fused to the N- or C-terminus of the desired protein. This His tag binds specifically to 
bivalent metal ions, mostly nickel ions. The Ni2+ ions are bound by nitrilotriacetic acid 
(Ni-NTA), a chelating agent conjugated to a supportive material, mostly agarose. The 
Ni2+ ions can interact with two histidine residues of the protein and ensures that only 
the fusion protein binds to the used resin. To remove unspecifically bound proteins 
from the resin low Imidazole containg buffers are commonly used. The Imidazol 
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competes for the binding to Ni2+ ions and is thereby displacing the His-tagged 
proteins from the used resin in high concentrations (200 – 500 mM). Because of the 
higher binding affinity of the poly histidine, buffers with low concentrations of Imidazol 
(5 - 50 mM) can be used to remove proteins binding with their endogenous Histidines 
to the resin. 
  
4.2.10 Test expression by affinity purification of His-tagged fusion proteins 
 
To determine the optimal expression conditions of the used recombinant proteins test 
expressions were performed. Therefor 4x 50 ml LB medium containing each 1 mM 
MgSO4 , 1 ml of 50x 5052 and 2.5 ml 20x NPS as well as the appropriate antibiotics  
were placed in 200ml flasks. Each batch was inoculated with 1:100 of the respective 
overnight culture and incubated at 37 °C and 300 rpm in a shaking incubator (HT 
Multitron Infor, Infor AG). After the cultures had reached an OD600 of 1.5 each 
approach was separately incubated overnight at 18 °C, 25 °C, 30 °C and 37 °C. 
The following day, the cultures should have reached OD600 of at least 5. 
Subsequently, the bacteria were harvested. 
 
4.2.11 Purification of test expressions by affinity purification of His-tagged 
fusion proteins 
 
Each of the bacterial cultures grown overnight was transferred in 50 ml centrifugation 
tubes (BD Falcon) and centrifugation for at least 5 minutes at 4,000 rpm and 4 °C 
using a Multifuge 1L-R, (Thermo Fisher Scientific). The LB medium was discarded 
and the bacterial pellet was resuspended in 15 ml cold nickel wash buffer with the 
addition of 200 µl of 0.2 M PMSF .The bacterial suspension was then homogenized 
using a high pressure homogenizer EmulsiFlex-C3 (Avestin). Each crude cell lysate 
was then supplemented  were 1 M MgCl2 to a final concentration of 1 mM MgCl2, 10 
µl DNAse I (Roche, 10 mg/ml in PBS) and 0.1 ml of 0.2 M PMSF, subsequently 
incubated for 10 minutes on ice. Bacterial cell debris was the removed by 
centrifugation in 50 ml containers (Sorvall) for 15 minutes at 15,000 rpm and 4 °C in 
a F21-8x50y rotor (Sorvall) centrifuged (Sorvall Evolution RC, Thermo Fisher 
Scientific). The supernatants after centrifugation were filtered through a piece of 
cheesecloth (Holthaus Medical) and 200 µl a 50 % slurry Ni-NTA-agarose resin 
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(Qiagen) was added followed by 2 h incubation at 4 °C rotating. The Ni-NTA-agarose 
was collected by centrifugation for 2 min at 1000 rpm using a Multifuge 1L-R (Thermo 
Fisher Scientific). The remaining supernatant was discarded. The centrifugation 
concentrated Ni-NTA-agarose was mixed with 2 ml of nickel wash buffer and 
transferred to 5 ml column (Pierce Centrifuge Columns, Thermo Scientific). The 
column was washed twice with 10 ml cold nickel wash buffer and afterwards sealed 
at the bottom end. 200 µl of nickel elution buffer was added to the resin with 
occasional brief shaking. The eluates were collected in 1.5 ml Eppendorf tubed and 
stored on ice. Small quantities of supernatants, cell debris and eluates as well as 
standard dilutions of BSA were subsequently analyzed by SDS gel electrophoresis to 
determine the optimal expression temperature. 
 
4.2.12 Expression His6-tagged fusion proteins 
 
4.2.12.1 Expression by autoinduction 
 
The expression by autoinduction was the commonly used method to express 
recombinant proteins. As the used LB media is supplemented with glucose and 
lactose, glucose is the preferred carbon source for rapid growing of E. coli. In 
presence of glucose uptake of lactose is prevented by inactivation of the lactose 
permease. The glucose present in the media blocks the enzyme adenylate cyclase 
which synthesizes cyclic adenosine monophosphate (cAMP) from ATP. Due to the 
lack of cAMP, complex formation of cAMP and CAP (catabolite activator protein) is 
prevented. Subsequently the required binding of the complex to the promoter to 
activate the transcription of the lac operon is not possible. This regulation is termed 
catabolite repression. 
When most the glucose is metabolized, lactose is becoming the preferred carbon 
source. Thereby lactose is metabolized to preferentially glucose and galactose by β-
galactosidase but also to allolactose, which binds to the tightly bound lac repressor. 
Binding leads to a conformational change and ultimately to a release of the repressor 
from the DNA. The RNA polymerase can now access the lac promoter leading to 
transcription of the lac genes. The used pET28 vector in this study contains the gene 
of the T7 polymerase under the control of a lac Operon. Upon activation of the lac 
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operon, expression of the T7 polymerase leads to transcription and translation of the 
desired gene construct. 
For the expression of larger amounts of protein the amount of reagents was scaled 
up. One liter of LB media supplemented with 1 mM MgSO4, 20 ml of 50x 5052 and 20 
ml 50 ml NPS as well was the appropriate antibiotics and divided equally among two 
2 l flask. Each 500 ml batch was inoculated with 5 ml of the same overnight culture 
and incubated at 37 °C and 300 rpm in a shaking incubator (HT Multitron Infor, Infor 
AG) incubated. After the cultures had reached an OD600 of 1.5, the flasks were 
incubated overnight the atcertain temperature, determined from the previously 
performed test expression. The following day, the cultures should have reached an 
OD600 ≥5. The bacteria were then harvested and further processed. 
 
4.2.12.2 IPTG-Induction 
 
For the expression of toxic and difficult to express proteins IPTG induction was used. 
IPTG as a synthetic analogue of allolactose can also induce the expression of genes 
under the control of a lac operon but is in comparison of allolactose not hydrolysable. 
To express large quantities of proteins by IPTG induction LB media containing the 
appropriated antibiotics was distributed equally at 500 ml among 2 l flasks. Each 500 
ml batch was inoculated with 5 ml of the same overnight culture, incubated at 37 °C 
and 300 rpm in a shaking incubator (HT Multitron Infor, Infor AG) and grown to an 
OD600 of 0.4. Subsequently, all reactions were further incubated at the defined 
temperature and grown to an OD600 of 0.8. Protein expression was induced by 
addition IPTG to a final concentration of 200 µM and further incubated for three 
hours. 
 
4.2.13 large scale purification of His6-tagged fusion proteins 
 
The IPTG-induced cultures were pooled and equally distributed on 1 l centrifugation 
tubes (Sorvall) and centrifuged at 5,000 rpm and 4 °C in a SLC-4000 rotor (Sorvall) 
(Sorvall Evolution RC, Thermo Fisher Scientific). The medium was discarded and the 
bacterial pellets were resuspended in approximately 200 ml of cold nickel wash buffer 
with the addition of 0.2 mM PMSF. The bacteria were then further processed using a 
high-pressure homogenizer (EmulsiFlex-C3, Avestin). The homogenates were 
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supplemented with 1 mM MgCl2, 400 μl DnaseI (10 U/ml in PBS) and 0.2 mM PMSF 
and incubated for 10 min on ice. Bacterial cell debris was removed by centrifugation 
for 15 min at 15,000 rpm 4 °C in 250 ml centrifugation containers (Sorvall) using a 
SLA-1500 rotor (Sorvall) in a Sorvall Evolution RC (Thermo Fisher Scientific). A small 
sample of the cell debris was resuspended in approximately 400 μl of distilled water 
and stored on ice for analysis while the remaining pellets were discarded. The 
supernatant was filtered through a piece of cheesecloth and 1 ml of Ni-NTA agarose 
(50 % slurry, Qiagen) was added for two hours at 4 °C rotating incubation. The 
nickel-NTA-agarose beads were collected using a 10 ml column (Pierce Inc.). About 
200 µl of the flowthrough was kept for further analysis on ice, while the remaining 
supernatant was discarded. The beads were washed with approximately 300 ml of 
cold nickel wash buffer. The column was sealed at the bottom and 1 ml of nickel 
elution buffer was added and incubated with occasional brief shaking for at least 10 
min. The eluate was collected and stored on ice. The stored samples of each 
purification step were on 12 % SDS-polyacrylamide gels and for their protein content. 
 
4.2.14 Testexpression of MISTIC fusion constructs 
 
Testexpressions of MISTIC fusion constructs were performed as previously 
described in test expression by purification of His6-tagged fusion proteins (4.2.9). 
 
4.2.15 Purification of test expressions of MISTIC fusion constructs 
 
Purification of MISTIC fusion constructs was performed as previously described in 
purification of test expressions by affinity purification of His-tagged fusion proteins 
(4.2.10) with the exception that the pellets were taken up in 10 mL of Nickel Wash 
buffer containing 1 % CTAB (w/v) and 0.2 mM PMSF and brought to a final volume of 
80 ml with additional Nickel Wash Buffer + 1 % CTAB. All subsequent steps had to 
be carried out at room temperature, as CTAB precipitates at temperatures lower than 
15 °C. The suspension was incubated for 30 min rotating at room temperature and 
finally centrifuged utilizing a SLA-1500 rotor for 15 min at 10,000 rpm at 20 °C 
(Sorvall Evolution RC, Thermo Fisher Scientific). A small amount of cell debris was 
resuspended in 400 μl of distilled water and not stored on ice due to the presence of 
CTAB. The centrifugation supernatants were filtered through a piece of cheesecloth 
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and 400 μl of a 50 % slurry nickel-NTA agarose (Qiagen) was added. After two hours 
incubation at room temperature the nickel-NTA-agarose beads were pre-
concentrated by centrifugation in conical 50 ml centrifugation tubes (BD Falcon) 
utilizing  a Multifuge 1L-R (Thermo Fisher Scientific)  A small amount of supernatants 
were kept as a sample at room temperature  while the remaining supernatants was 
aspirated and discarded. The nickel-NTA-agarose beads were transferred to 5 ml 
columns (Pierce Centrifuge columns, Thermo Scientific) and washed once with 25 
mL of nickel wash Buffer + 0.1 % CTAB. The columns were sealed at the bottom end 
and 400 μl nickel elution buffer + 1 % CTAB was added to each column and 
incubated with occasional brief shaking for five minutes. Eluates were collected and 
further processed. Stored samples of the individual steps were subsequently 
analyzed on SDS-polyacrylamide gels for their protein content. 
 
4.2.16 Large scale expression of MISTIC fusion constructs 
 
The expression of larger amounts of MISTIC fusion proteins was carried out 
analogously to large scale expression of His6-tagged fusion constructs by auto-
induction with the exception that expression was performed overnight at 25 °C 
instead of 18 °C. This was necessary since all MISTIC constructs showed better 
protein expression at 25 °C. 
 
4.2.17 Large scale expression of MISTIC fusion constructs 
 
Purification of MISTIC fusion constructs were performed as previously described in 
purification of test expressions of MISTIC fusion constructs (4.2.14). with the 
exception that the pellets were taken up in 20 mL of Nickel Wash buffer containing  1 
% CTAB (w/v) and 0.2 mM PMSF and brought to a final volume of 200 ml with 
additional Nickel Wash Buffer + 1 % CTAB.  
The subsequent removal of CTAB from the elution using an appropriate volume of 
dialysis membranes (Spectra / Pore Membrane Dialysis, MWCO 12 – 14 kDa, 
Spectrum Laboratories) against one liter of 1x PBS was followed for one hour on a 
magnetic stirrer (MR 3000, Heidolph Instruments). The dialysis buffer was exchanged 
after 1 h followed by an additional dialysis for at least 1 h or overnight. 
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4.2.18 Fluorescent labelling of proteins 
 
For labeling of proteins with Alexa Fluor fluorescent amine-reactive dyes the desired 
protein solution was dialyzed against two liters of 0.2 M NaHCO3 in dialysis 
membranes (Spectra / Pore Dialysis Membrane MWCO 12 – 14 kDa, Spectrum 
Laboratories) for one hour. After exchanging the buffer a second dialysis step was 
carried out against 0.2 M NaHCO3 for at least an hour. 1 mg of Alexa Fluor 488-
succinimidyl ester (Invitrogen) was dissolved at 30 °C for five minutes and 600 rpm in 
100 µl DMSO (Roth) and centrifugated at 13,000 rpm for five minutes at room 
temperature (Heraeus Pico 17, Thermo Fisher Scientific). The same procedure was 
carried out for the Alexa Fluor 546-succinimidyl ester (Invitrogen). Subsequently, to 
each 100 µl of dialyzed protein solution 5 μl of the dissolved fluorescent dye was 
added and mixed well. Further incubation of the reaction mixture was carried out for 
two hours at 25 °C and 300 rpm (Thermo Mixer compact 5250, Eppendorf) under 
exclusion of light. A 1.5 M hydroxylamine pH 8.5 was prepared by mixing 100 µl a 50 
% hydroxylamine solution with 900 μl of distilled water and 5 µl 37 % HCl solution. 
The conjugation reaction was stopped by the addition of 10 µl of the 1.5 M 
hydroxylamine per 100 µl reaction mixture and further incubation for one hour at 25 
°C and 300 rpm (Thermo Mixer compact 5250, Eppendorf) again under light 
exclusion. The mixture was then aliquoted and stored at -80 °C for further use. 
 
4.2.19 SDS-polyacrylamide gel electrophoresis 
 
For the separation of proteins, the discontinuous SDS polyacrylamide gel 
electrophoresis according to Laemmli (Laemmli, 1970) was used. 
Glass plates with integrated spacers and a small glass plate were assembled. The 
separating gel was prepared and immediately filled with a pipette into the space 
between the glass plates to about 1 cm below the top glass plate and carefully 
covered with about 1 ml of water. When the separation gel was completely 
polymerized the stacking gel was immediately poured onto the separating gel and a 
comb was placed. The completely completely polymerized gels was used directly or 
packaged for long term storage in damp towels at 4 °C. 
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4.2.19.1 Sample preparation 
 
The samples to be analyzed were mixed with 6x SDS sample buffer in ratio a 1:1, 
thoroughly mixed and boiled in a heating block at 95 °C for five minutes (neoBlock - 
Heater Duo 2-2504, neoLab). Subsequently all samples were spun at 13,000 rpm for 
15 s  (Heraeus Pico 17, Thermo Fisher Scientific) and 10 µl were applied to each 
lane. As a molecular weight standard 5 µl Unstained Protein Molecular Weight 
Markers (range 14.4 - 116 kDa (Fermentas) or 5 μl of Unstained SDS PAGE protein 
marker (range 6.5 - 200 kDa, (Serva) were used per gel. 
 
4.2.19.2 Gel run 
 
The prepared SDS gels were hooked into a electrophoresis tank (Mini-PROTEAN 3 
electrophoresis cell or mini-PROTEAN Tetra system, Bio-Rad) and filled with 1x 
Laemmli running buffer. The comb was removed and the pockets were rinsed with 
electrophoresis buffer. After the samples were loaded on the gel a constant current of 
15 mA per gel was applied. After complete entry of the sample into the stacking gel, 
the applied current was increased to 25 mA per gel. When the running front reached 
the bottom of the gel electrophoresis was stopped.  
 
4.2.20 Tricine-SDS-Polyacrylamid-Gelelektrophoresis 
 
To improve the separation of small proteins discontinuous SDS-polyacrylamide-gel 
electrophoresis was used according to Schägger (Schägger & Jagow, 1987). It is a 
modified form of the SDS-PAGE. It is based on a Tricine-Tris buffer system and is 
able to improve the separation of proteins in the range of ~ 1 - 100 kDa. The gel 
assembly was performed as described in SDS-polyacrylamide gel electrophoresis 
(4.2.19) with the exception that the separation gel was immediately overlaid with the 
stacking gel and the comb was placed after pouring the stacking gel. Fully 
polymerized gels were then used directly or stored in packaged wet wipes for not 
more than 2-3 days at 4 °C. 
 
 
separation gel (for 2 gels): 
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1.66 ml Rotiphorese Gel A 30 % Acrylamid 37.5:1 
(Roth) 
1.675 ml gelbuffer (3 M Tris, 0.3 % SDS, adjusted to 
pH 8.5) 
570 µl H2O 
1.06 ml 50 % glycerol 
3 µl TEMED 
25 µl 10 % APS 
 
 
stacking gel (for 2 gels): 
400 µl Rotiphorese Gel A 30 % Acrylamid 37.5:1 
(Roth) 
750 µl gelbuffer (3 M Tris, 0.3 % SDS, adjusted to 
pH 8.5) 
1.85 ml H2O 
4 µl TEMED 
20 µl 10 % APS 
 
 
4.2.20.1 Sample preparation 
 
Sample preparation was performed as previously described in 4.2.19.1 
 
4.2.20.2 Gel run 
 
Gels were hooked in gel electrophoresis systems (Mini-PROTEAN Electrophoresis 
Cell or Bio-Rad Mini-PROTEAN Tetra system, Biorad). The outer region of the 
electrophoresis chamber was filled with 1x anode buffer while the part between the 
gels was filled with 1x cathode buffer. A constant current of 15 mA per gel was 
applied after applying of the sample and the protein standards. After the sample 
entered the stacking gel, the applied current was increased to 25 mA per gel.  
 
4.2.21 Staining and destaining of gels 
 
After separation both the SDS gels and modified according to Schägger were 
incubated for at least one hour at room temperature in Coomassie stain solution. 
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Subsequently, the staining solution was discarded and briefly washed with water. The 
destaining of gels was performed by incubation with destaining solution I for at least 
30 min followed by incubation with destaining solution II for additional 30 min. Gels 
were stored in water or dried using the Gelair Drying System (Biorad). 
  
4.2.22 Western Blot 
 
Using the western blotting procedure separated proteins from SDS polyacrylamide 
gels were transferred to nitrocellulose membranes (Towbin et al., (1979)) utilizing the 
tank blotting procedure in a Trans-Blot Cell (Biorad). By applying an electric field, 
proteins are transferred and fixed to nitrocellulose membranes by hydrophobic 
interactions. The transfer cassettes were assembled in a sandwich process and 
subsequently mounted in the transfer buffer filled. As a transfer buffer used was a 
Tris-glycine buffer + 20 % ethanol. The transfer was carried out at 4 °C with an 
applied constant current of 100 mA for small or 370 mA for large transfer chambers 
for three hours with constant stirring on a magnetic stirrer (MR 3000, Heidolph 
Instruments). After transfer, the nitrocellulose membrane was stained with Ponceau S 
solution (Fluka), an anionic azo dye reversibly binds to amino groups of proteins to 
verify success of the transfer. Nitrocellulose membranes were blocked with blocking 
solution for at least one hour at room temperature or better overnight at 4 °C to 
saturate nonspecific binding sites. Incubation of membranes with primary antibodies 
was carried out for two hours at room temperature in 10 ml of blocking solution with 
an antibody dilution of usually 1: 1000 on a rocker (See-Saw Rocker SSL4, Stuart). 
After incubation membranes were washed. Subsequently the secondary horseradish 
peroxidase-coupled antibody was added and incubated for one hour in blocking 
solution with an antibody dilution of usually 1: 5000 rocking (See-Saw Rocker SSL4, 
Stuart). Non-specifically bound secondary antibodies were largely removed by a 
series of washing steps (3x 1 min, 5x 5 min, 5x 10 min) with PBS-Tween-20 (0.1 %). 
Bands were visualized by applying the ECL reagent I + II (Western Lightning, 
PerkinElmer). The chemiluminescence was recorded using the Gel Logic 1500 
Imaging System (Kodak). 
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4.2.23 GST pulldown assay 
 
Each 2 mg of GST-fusion protein were coupled with 400 μl of a 50 % GSH-
Sepharose suspension (Glutathione Sepharose 4 Fast flow, GE Healthcare) 
overnight rotating (SB2, Stuart) at 4 °C. After incubation GSH-Sepharose beads were 
centrifuged for five minutes at 5,000 rpm (Heraeus Fresco 17, Thermo Fisher 
Scientific), the supernatant was discarded and further blocked for 5 % BSA for one 
hour rotation. Subsequently, the GSH-Sepharose beads were centrifuged, the 
supernatant was removed and the beads washed with 2 ml cold 1x PBS. The 
procedure was repeated at least five times. The blocked and washed beads were 
resuspended in 200 µl 1x PBS and stored until further use at 4 °C. 
To perform pull down assays with bacterial lysates bead bound GST proteins were 
incubated with 500 μl of E. coli lysates or from untransformed bacteria. After 1 h of 
incubation rotating samples were washed six times with 20 mM Tris and 50 mM 
NaCl, pH 7.4 and eluted by cleavage employing 30 μl of recombinant TEV or 
PreScission protease (0.5 mg/ml) for an additional hour at 25 °C shaking at 600 rpm. 
Samples were eluted by centrifugation and analyzed by SDS–PAGE and Western 
blotting. 
 
4.2.24 Generation of proteoliposomes 
 
4.2.24.1 Preparation  
 
A lipid mixture corresponding to the composition of the inner nuclear membrane was 
prepared as follows. The lipids were purchased from Avanti Polar Lipids (Alabaster, 
Alabama, USA). 
 
 
 
 
 
 
4 Materials and Methods 
132 
 
Quantity in 
mol % 
Lipid (source) 
Molar mass 
g / mol 
60   phosphatidylcholine (egg, chicken), powder 770.1 
20   phosphatidylethanolamine (egg, chicken), powder 744.1 
10   phosphatidylinositole (liver, bovine), powder 909.1 
5   cholesterol (ovine wool >98%), powder 286.7 
2.5   phosphatidylserine( brain, porcine), powder 812 
2.5   sphingomyelin (egg,chicken), powder 703 
The weighed amounts of the individual lipid were dissolved for about two hours in 10 
% Octyl-β-D-glucopyranoside (w/v) in H2O with a total lipid concentration of 30 mg/ml 
at 15 °C and 1000 rpm in Thermo Mixer compact 5250 (Eppendorf). The lipid mixture 
was aliquoted and stored at -80 °C. 
An appropriate amount Sepharose (Sephadex G50 fine, GE Healthcare) was added 
to a sufficient volume of 1x PBS. The sepharose was allowed to swell for 5 min and 
was subsequently degased in a Desiccator. Transparent glas gel filtration columns 
(Econo-Column 0.5 x 20 cm 4 ml, Biorad) were clamped in holder (Roth) and almost 
completely filled with the swollen and degased sepharose. By connecting the lid of 
the gel filtration columns they were connected to a higher located buffer reservoir. 
The sepharose was blocked initally by applying 100 µl BSA (1 mg/ml in 1x PBS. The 
column was washed for additional 30 min. 
 
4.2.24.2 Procedure 
 
Membrane protein solution was mixed completely with 20 µl of the desired lipid 
mixture (30 mg/ml) in 100 µl 1x PBS and was completely applied to the column.  
Additionally lipophilic fluorescent dyes e.g. DiI-C18 (1 mg/ml in DMSO) or DiD-C18 (1 
mg/ml in DMSO) can be added. After the mixture completely entered the column 
material, the Sepharose was carefully overlayed with 1 ml of 1x PBS and the column 
was reconnected to the buffer reservoir. In the subsequent separation of the fastest 
continuous colored band was collected when fluorescently labeled proteins were 
used. 
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4.2.25 Preparation of proteoliposomes lipid film 
 
Platinum gauze electrodes (ALS Co., Ltd, Tokyo Japan) were placed in a custom 
made lid and attached spacer.The electrodes had a distance of 0.5 cm. The 
electrodes were washed twice with chloroform followed by washing with 70 % ethanol 
(v/v) and finally with distilled water.The electrodes were dried on a heating block (Dri-
Block DB-2A, Techne) dried at 42 °C. Proteoliposomes were prepared as described 
before and collected. The mixture was transferred to polycarbonate centrifugation 
tubes (11 x 34 mm PC tube) suitable for a TLA120 rotor (Beckmann). The 
proteoliposomes were centrifugated using a TLA120.2 rotor (Beckman Coulter) at 4 
°C 100,000 rpm for 30 min.The resulting pellet was resuspended in 60 µl HB100 
buffer and 5 µl of the solution was spread evenly on the platinum gauzes. The lipid 
film was dried on a heating block (Dri-Block DB-2A, Techne) at 42 °C for 5 min and 
subsequently dried in a desiccator under vacuum for at least one hour at room 
temperature or at 4 °C overnight. 
 
4.2.26 Electroformation of proteoliposome lipid films 
 
To previously prepared lipid film-covered platinum gauzes were mounted in standard 
cuvette (UVette routine pack 50 – 2,000 µl, Eppendorf, Hamburg, Germany) filled 
with 1 ml of 259 mM succrose. A sinoidale alternating voltage of 2.1 V with a 
frequency of 10 Hz (TG315 function generator, TTi) was applied for 140 min followed 
by 20 min at 2 Hz. Throughout the electroformation the chamber was placed on a 
heating block at 42 °C. An 8 well chamber (LabTek) was blocked with 5 % BSA in 
PBS (w/v) for at least 1 h and washed twice with 1x PBS. After electroformation 
GUVs were pipetted with open tips (Molecular Bio Products) in the prepared chamber 
und visualized using a confocal fluorescence microscope (Fluoview FV1000, 
Olympus). 
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4.2.27 Prepararion of lipid films from chloroform dissolved lipids 
 
Chloroform dissolved lipids (Avanti Polar Lipids) were mixed according to the 
composition of the inner nuclear membrane (described in 4.2.24.1). 
The platinum electrodes were cleaned with chloroform and then thoroughly rinsed 
with distilled water and dried. For each electroformation approach 7.5 μl chloroform 
and 2.5 μl of the appropriate chloroform dissolved lipid mixture (10 mg/ml) were 
mixed and supplemented if needed with 0.25 μl DiD-C18 (0.1 mg/ml) / DiI-C18 (0.1 
mg/ml (Sigma-Aldrich). The mixture was spread quickly equally on both platinum 
electrodes and dried by evaporation of the chloroform followed by drying for at least 
one hour under vacuum in a desiccator at room temperature to remove residual 
chloroform. 
 
4.2.28 Electroformation of lipid films from chloroform dissolved lipids 
 
Electroformation of lipid films from chloroform dissolved lipids was performed as 
previously described in 4.2.28. Electroformation time at 10 Hz was decreased from 
140 min to 80 min.  
 
4.2.29 Confocal laser scanning microscopy 
 
To image giant unilamellar vesicles a confocal laser scanning microscope Olympus 
Fluoview FV1000 (Olympus Optical Co.) was utilized. The microscope was equipped 
with an argon laser emitting light at wavelengths of 458 nm, 488 nm and 515 nm is 
emitted. Furthermore, a combined laser diode laser emitting light with wavelengths of 
405 nm, 440 nm, 473 nm, 559 nm and 635 nm was emitted as a laser combiner FV-
10 MCPSU-405-633 used (Olympus). All observations were made using a 60x water 
immersion objective UPLSAPO 60XW N: performed A 1.20. The confocal pinhole 
size (pinhole) was set to one airy and thus 140 μm (UPLSAPO 60XW N: A 1.20). For 
detection of the fluorescent signals is a primary beam splitter SDM405/488/559/635 
(Olympus) was used and split the signal into three channels. For the detection of the 
fluorescence signal of Alexa Fluor 488-labeled proteins or antibodies, a dichroic 
mirror (beam splitter emission SDM560) was used. For the detection of the 
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fluorescence signal of Alexa Fluor 546-labeled proteins and the Texas Red-labeled 
dextran 40 kDa was however a dichroic mirror (beam splitter emission SDM640 
(Olympus)) used. The DiD-C18 membrane dye was determined using the emission 
filter BA655-755 (Olympus) detected in the beam path. Fluorescence signals were 
detected and analyzed with the help of three integrated AOTF - PMTs (acousto-optic 
tunable filter - photomultiplier tubes), detecting faint light signals, convert them into 
electrical signals and amplifying them.Signals were analysed with the associated 
software FV10-ASW FV1000 vers. 4.1. 
 
4.2.30 Atomic Force microscopy 
 
Supported lipid bilayers were imaged using a JPK NanoWizard II system (JPK 
Instruments, Berlin, Germany) mounted on an Axiovert 200 Inverted Microscope 
(Carl Zeiss, Jena, Germany). Intermittent contact (IC or tapping) mode images were 
taken using V-shaped silicon nitride cantilevers (SNL-10) with a typical spring 
constant of 0.08 N/m and a nominal tip radius of 2 nm. The cantilever oscillation was 
tuned to a frequency between 3 - 10 kHz, and the amplitude was set between 0.3 - 
0.6 V. The amplitude was varied during the experiment to minimize the force of the 
tip on the bilayer. The scan rate was set to 0.7 - 1 Hz. The height, deflection and 
phase-shift signals were collected, simultaneously, in both trace and retrace 
directions. AFM images were acquired before and after adding 150 nM His6-EGFP-
pUL31 or His6-EGFP on the bilayer. AFM images were analysed using JPK Data 
Analysis software. 
 
4.2.31 Preparation of supported lipid bilayers 
 
Supported lipid bilayers were prepared as described (Unsay et al., 2013). The 
nuclear envelope lipid mix with 0.2 mol % Rhodamine-PE was dissolved in SLB 
buffer (10 mM HEPES, pH 7.4, 150 mM NaCl) at a concentration of 5 mg/ml. 20 µL of 
the mixture were diluted with 150 µL with SLB buffer. The suspension was then 
vortexed and bath-sonicated until a clear suspension was obtained, indicating that 
small unilamellar vesicles were formed. The clear solution was put in contact at 37 °C 
with freshly-cleaved mica glued to a glas coverslip. CaCl2 was added to a final 
concentration of 3 mM and incubated at 37 °C for 10 min. The samples were rinsed 
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several times with SLB buffer to remove CaCl2 and unfused vesicles, and then 
allowed to equilibrate at room temperature before analysis. 
 
4.2.32 Cell Culture 
 
All cells were cultured under standard cell culture conditions at 37 °C and 5 % CO2. 
 
4.2.32.1 Cell culture media 
 
  440 ml DMEM for HeLa S3 cells and HEK 293 T cells, high glucose    
     (lifetechnologies, Gibco) 
     50 ml fetal calf serum (lifetechnologies, Gibco) 
     5 ml Pen/Strep (10,000 mg/ml Streptomycin, 10,000 units/ml Penicillin)    
     (lifetechnologies, Gibco) 
     5 ml L-glutamine (200 mM) (lifetechnologies, Gibco) 
 
 440 ml DMEM for RK13 cells, low glucose (lifetechnologies, Gibco) 
     50 ml fetal calf serum (lifetechnologies, Gibco) 
     5 ml Pen/Strep (10,000 mg/ml Streptomycin, 10,000 units/ml Penicillin)  
     (life technologies, Gibco) 
     5 ml L-glutamine (200 mM) (lifetechnologies, Gibco) 
 
4.2.33 Transfection of cells 
 
Cells were seeded to 50 - 80 % confluency prior to transfection in 24 well plates 
(Nunc,Thermo Scientific). At the day of transfection 50 µl of serum and antibiotic free 
media was incubated with 1.5 µl of Fugene 6 transfection reagent and incubated for 5 
min. Subsequently 0.5 µg of DNA was added to the mixture and incubated for 15 min 
at room temperature. To each well 20 µl were pipetted dropwise to the media. The 
cells were further incubated for 24 h or 48 h before fixation. 
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4.2.34 Immunofluorescence 
 
Previously on coverslips seeded cells were fixed for 10 min in 4 % paraformaldehyd 
(w/v) in PBS) incubated for 5 min with 50 mM (NH4)Cl to quench autofluoresence and 
subsequently blocked with blocking buffer.Following the cells were incubated with 
1:500 (rabbit antibodies) or 1:1000 for (mouse antibodies) with primary antibodies in 
blocking buffer for 2 h. The cover slips were washed three times with PBS+ 0.1 % 
Tween and secondary antibodies goat anti-rabbit IgG Alexa 488 / goat anti-mouse 
IgG Alexa 488 or goat anti-rabbit IgG Cy3 / goat anti-mouse IgG Cy3 in a dilution of 
1:2000 in blocking buffer was added for 2 h. Following it cells were stained with DAPI 
(1 µg/ml in PBS) for 10 min and washed once with 1x PBS. Coverslip was sealed 
with nail polish and stored at 4 °C. 
 
4.2.35 Electron microscopy 
 
Cells were washed with 1x PBS and fixed with 2.5 % glutaraldehyd in 100 mM 
sodium cacodylat pH 7.5. Subsequent treatment was processed by the inhouse EM 
facility. Fixed cells were removed from the plates, washed twice with 100 mM sodium 
cacodylat and pelleted for 1 min at 1.500g in 15 ml centrifugation tubes (BD Falcons). 
The cell pellet were embedded in 1.8 % gelatine in 100 mM sodium cacodylat (w/v) 
and incubated for 10 min at 37 °C followed by cooling on ice for 30 min. Post-fixation 
of embedded cells was performed with 1 % OsO4 in 100 mM sodium cacodylat for 2 h 
at 4 °C and subsequent contrasting with 1 % UAc (w/v) o/n at 4 °C. Dehydration of 
cell blocks was done by a series of ethanol washes each time increasing the 
concentration of ethanol up to 100 %. After exchange of ethanol by propylenoxid 
cells were embedded in EPON. 
Epon-embedded cells were thin sectioned and imaged employing a FEI Tecnai G20 
transmission electron microscope. 
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Background: Herpesviruses egress from the nucleus by vesicle trafficking through the nuclear envelope.
Results: Using giant unilamellar vesicles, we reconstitute the function of two viral proteins, pUL31 and pUL34, in nuclear
envelope vesicle formation.
Conclusion: pUL34 recruits pUL31 to the membrane, which, on its own, deforms membranes to produce nuclear envelope
vesicles.
Significance: pUL31 constitutes a minimal machinery mediating inwardly directed membrane budding and scission.
Herpesviruses assemble capsids in the nucleus and egress by
unconventional vesicle-mediated trafficking through the
nuclear envelope. Capsids bud at the inner nuclear membrane
into the nuclear envelope lumen. The resulting intralumenal
vesicles fuse with the outer nuclear membrane, delivering the
capsids to the cytoplasm. Two viral proteins are required for
vesicle formation, the tail-anchoredpUL34 and its soluble inter-
actor, pUL31.Whether cellular proteins are involved is unclear.
Using giant unilamellar vesicles, we show that pUL31 and
pUL34 are sufficient for membrane budding and scission.
pUL34 function can be bypassed by membrane tethering of
pUL31, demonstrating that pUL34 is required for pUL31 mem-
brane recruitment but not for membrane remodeling. pUL31
can inwardly deform membranes by oligomerizing on their
inner surface to form buds that constrict to vesicles. Therefore,
a single viral protein can mediate all events necessary for mem-
brane budding and abscission.
Viruses exploit amazing strategies, overcoming various cel-
lular membranes to realize their complex life cycle, including
cell entry, genome replication, and assembly of virus particles as
well as their egress. For many viruses that replicate in the cell
nucleus, amajor barrier is the nuclear envelope, a doublemem-
brane structure enclosing the chromatin. It consists of the inner
nuclear membrane, which, in animal cells, is underlaid by a
tight laminameshwork that connects and stabilizes the nuclear
envelope, and the outer nuclear membrane, which is continu-
ouswith the endoplasmic reticulum (for a review, see Refs. 1, 2).
The nuclear envelope is perforated by nuclear pore complexes,
huge macromolecular assemblies of up to 125 MDa in verte-
brates that act as selective gateways between the cytoplasm and
the nucleus (3). Nuclear pores are used as entry paths for most
viruses that replicate in the nucleus (for a review, see Refs. 4, 5).
Inmany cases, this involves an at least partial disassembly of the
viral capsid at the cytoplasmic side or core of the nuclear pore
complex because these particles are too large to pass the pore
intact.
Althoughmany viruses assemble in the cytoplasm, herpesvi-
ruses package their newly replicated genomicDNA into capsids
of up to 125 nm within the nucleus. Unlike many other DNA
viruses, herpesviruses do not depend on the breakdown of the
nuclear envelope during mitosis for their release and can also
replicate in non-dividing cells. Therefore, they face the chal-
lenge of passing the nuclear envelope a second time, now in the
opposite direction. Because herpesvirus capsids are too large
for passage through the nuclear pore, they are transported
through the nuclear envelope by vesicle-mediated transport,
also described as an “envelopment-de-envelopment” pathway
(6). Capsids bud at the inner nuclear membrane and, therefore,
acquire a (primary) envelope, resulting in a nascent virus
located in the lumenbetween the inner and outer nuclearmem-
branes (for a review, see Refs. 7, 8). Subsequently, the primary
envelope fuses with the outer nuclear membrane, resulting in
translocation of the capsid to the cytoplasm. Final maturation,
including assembly of the tegument and secondary envelop-
ment, follows in the cytoplasm, andmature virions are released
at the plasma membrane.
Egress from the nucleus is a multifaceted process. In all her-
pesviruses studied, it involves the formation of a heterodimeric
nuclear egress complex consisting of two viral proteins that are
conserved throughout the herpesvirus family. One component
is a type II transmembrane protein, tail-anchored in the nuclear
envelope and termed pUL34 in herpes simplex virus 1 and
pseudorabies virus. It interacts with a soluble component,
pUL31, and recruits it to the nuclear envelope (9–15). In the
absence of this complex, nuclear egress is blocked, and capsids
accumulate in the nucleoplasm. One function of the pUL31-
pUL34 complex is the recruitment of viral and cellular kinases
that phosphorylate locally and disrupt the nuclear lamina (15–
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1ﬂﬃ a prerequisite for the access of capsids to the inner nuclear
membrane. In addition, the pUL31-pUL34 complex might also
contribute to the nuclear membrane restructuring necessary
for herpesvirus nuclear egress. Transient or stable transgenic
expression of pUL31 and pUL34 is sufficient to drive the for-
mation of correctly sized primary envelopes in the perinuclear
space between the outer and inner nuclear membrane in the
absence of capsids (10, 20). Therefore, pUL31 and pUL34 are
the only two viral proteins required for budding and fission of
vesicles at the inner nuclearmembrane.Whether this process is
additionally dependent on the recruitment and function of cel-
lular factors is currently unknown. Recently, it has been sug-
gested that, in vitro, pUL31 and pUL34 are sufficient to drive
membrane budding and scission by forming a coat on the sur-
face (21). However, this assay depended on an unnaturally high
content (up to 40%) of negatively charged lipid headgroups on
the deformed lipid bilayer that is not present on physiological
membranes. Therefore, it remains questionable to what extent
it reflects the natural situation.
Primary envelopment of herpesvirus capsids requires exten-
sive restructuring of the host inner nuclear membrane to allow
envelope formation and vesicle detachment into the lumen of
the nuclear envelope. Similar membrane deformations have
been investigated intensively because they are at the heart of
vesicle-mediated intracellular trafficking in the secretory and
endocytic pathways.Many such processes are directed by com-
plex but conceptually straightforward mechanisms in which
coat proteins impose a curvature on the cytosolic membrane
face, thereby generating buds that ultimately constrict to vesi-
cles. The best known coat proteins are clathrin and the COP I
and COP II complexes, which assemble on the outer side of the
membrane and are crucial for vesicle formation into the cytosol
(22). Membrane deformation in the opposite direction, i.e.
away from the cytosol, such as the invagination of the endo-
somal membrane during formation of multivesicular bodies or
egress of HIV and other enveloped viruses at the plasma mem-
brane, both mediated by the ESCRT machinery, are less fre-
quent (23). pUL31-pUL34-mediated inner nuclear membrane
engulfment, much like the suggested pathway for nuclear
egress of large ribonucleoprotein complexes identified recently
in Drosophila (24), represents one of these exceptional path-
ways. It involves vesicle budding and scission from the nucleo-
plasm into the intermembrane space of the nuclear envelope,
which is connected and topologically identical to the lumen of
the endoplasmic reticulum. The molecular machinery mediat-
ing inner nuclear membrane deformation and scission remains
largely obscure. It is especially unclear whether it requires pro-
teins within the lumen of the nuclear envelope that could
assemble a coat on the outer surface of the nascent vesicles,
similar to COP I, COP II, and clathrin coats in the cytoplasm.
We reconstituted the function of pseudorabies virus pUL31
and pUL34 in a simple membrane system by using giant unila-
mellar vesicles (GUVs)2mimicking the lipid composition of the
nuclear envelope. We show that the two viral proteins are suf-
ficient for budding and fission of membrane vesicles into the
lumen of GUVs, a process that is topologically identical to
inwardly directed vesicle formation at the inner nuclear mem-
brane during herpesvirus nuclear egress. Artificial membrane
recruitment of pUL31 alone results in the same membrane
remodelling and generates intra-GUV vesicles. Therefore,
pUL31 and pUL34 are sufficient for vesicle formation without
the need for additional (cellular) proteins. Moreover, we can
assign distinct functions to pUL31 and pUL34 during herpesvi-
rus nuclear egress. pUL34 recruits pUL31 to themembrane and
provides membrane anchorage, whereas pUL31 mediates
membrane budding and scission.
EXPERIMENTAL PROCEDURES
1,19-dioctadecyl-3,3,39,39-tetramethylindodicarbocya-
nine,4-chlorobenzenesulfonate salt (DiDC18), Alexa Fluor 546
carboxylic acid succinimidyl ester, and cascade blue-labeled
neutravidin were obtained from Invitrogen, naphtopyrene
from Sigma, and detergents from Calbiochem. The nuclear
envelope lipid mix consisted of 5 mol% cholesterol, 2.5 mol%
sphingomyeline, 2.5 mol% sodium phosphatidylserine, 10
mol% sodiumphosphatidylinositol, 20mol%phosphatidyletha-
nolamine, and 60 mol% phosphatidylcholine (all from Avanti
Polar Lipids). In lipid mixtures lacking a specific component,
the respective lipid was replaced by an equimolar amount of
phosphatidylcholine.
Protein Expression and Purification—Constructs for expres-
sion of pseudorabies virus pUL31 and pUL34 were generated
froma syntheticDNAoptimized for codonusage inEscherichia
coli (Geneart). pUL31 was expressed from a modified pET28a
vector with a His6 tag and a TEV site, followed by an EGFP
protein amino-terminal of pUL31. The soluble domain of
pUL34 (amino acids 1–240), untagged pUL31, as well as EGFP
were expressed from a modified pET28a vector with a His6 tag
followed by a TEV site. For C-terminal His6 tagging of the sol-
uble domain of pUL34 (amino acids 1–240), the fragment was
expressed from a modified pET28a vector lacking the amino-
terminal His6 sequence. GST fusions of pUL31 and pUL34
(amino acids 1–240) were expressed from a modified pET28a
vector lacking a His6 tag but with an N-terminal GST tag fol-
lowed by a recognition site for precision protease upstream of
pUL31 and pUL34. All His6-tagged proteins were expressed in
E. coli BL21de3 and purified using Ni-NTA. Where applicable,
the His6 tags were cleaved off. Proteins were purified further by
gel filtration (Superdex 200, GE Healthcare). GST fusions were
purified using GSH-Sepharose (GE Healthcare).
Full-length pUL34 and SCL1were expressed fromamodified
pET28a vector with an N-terminal membrane-integrating
sequence for translation of integral membrane protein con-
structs (MISTIC) fragment (25) followed by a thrombin cleav-
age site and purified as described previously (26). Proteins were
labeled usingAlexa Fluor 546 carboxylic acid succinimidyl ester
in 200 mM NaHCO3 (pH 8.4) or the same buffer containing 1%
(w/v) cetyltrimethylammonium bromide for labeling of trans-
2 The abbreviations used are: GUV, giant unilamellar vesicle; DiDC18, 1,19-di-
octadecyl-3,3,39,39-tetramethylindodicarbocyanine,4-chlorobenzenesul-
fonate salt; EGFP, enhanced GFP; Ni-NTA, nickel-nitrilotriacetic acid; DGS,
1,2-dioleoyl-sn-glycero-3-(N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl; ILV, intralumenal vesicle.
tapraid4/zbc-bc/zbc-bc/zbc01415/zbc1106-15z ZSUBMIT xppws S55 2/2/15 9:30 4/Color Figure(s) F1,2,3,4,5,6 ARTNO: M114.627521
pUL31 Mediates Nuclear Envelope Vesicle Formation
2 JOURNAL OF BIOLOGICAL CHEMISTRY
V !"#$
290 •NUMBER ?? •???? ??, 2015
AQ: B
AQ: C
Fn2
AQ: E
m%m&'()% proteins and purified by gel filtration on a Sephadex
G50 fine column (GE Healthcare).
Generation of GUVs—Detergent-solubilized and labeled
SCL1 and pUL34 were reconstituted in proteoliposomes via gel
filtration (27). For this, 20 ml of the nuclear envelope lipid mix
(30 mg/ml in 10% octylglucopyranoside) was mixed with 20 ml
of 2 mM pUL34 or SCL1 protein and 100 ml of PBS. The sample
was applied to a Sephadex G50 fine filled Econo chromatogra-
phy column (0.5 3 20 cm, Bio-Rad) to remove the detergent.
The formed proteoliposomeswere collected and pelleted for 30
min at 100,000 rpm in a TLA120.2 (Beckman Coulter) rotor at
4 °C. The pellet was resuspended in 120ml of 20mMHEPES (pH
7.4), 100 mM KCl, and 1 mM DTT. 5 ml of resuspended proteo-
liposomes were dried onto two 5 3 5 mm platinum gauzes
(ALS) under vacuum for at least 1 h at room temperature. The
gauzes were placed in parallel (5 mm distance) into a cuvette
(UVette, Eppendorf) and submerged in 259 mM sucrose solu-
tion, and for 140 min an alternating current electric field with
10 Hz, 2.2 V was applied, followed by 20 min at 2 Hz at 42 °C.
Lipid GUVs were generated from chloroform-dissolved lipid
mixtures where indicated, supplemented with 1 mol%
Ni-NTA-DGS (1,2-dioleoyl-sn-glycero-3-(N-(5-amino-1-car-
boxypentyl)iminodiacetic acid)succinyl), Avanti Polar Lipids)
and 0.8 nM DiDC18 as described previously (28).
GUV Vesicle Budding Reaction—An 8-well glass observation
chamber (chambered #1.0 borosilicate coverglass system, Lab-
Tek) was blocked with 5% (w/v) BSA in PBS and washed with
PBS. For each reaction, 50 ml of freshly prepared GUVs were
mixed with 150 ml of PBS and placed into a well. Unless indi-
cated otherwise, all soluble proteins were added to a final con-
centration of 500 nM (cascade blue-labeled neutravidin at 3.8
mM). The proteins and buffers used for GUV preparation
matched the osmotic pressure of the sucrose solution, as meas-
ured using an osmometer. Themixturewas incubated for 5min
and imaged immediately at room temperature on an inverted
Olympus Fluoview 1000 confocal laser-scanning system utiliz-
ing an UPlanSApo 360/1.35 oil objective. The cascade blue-
labeled neutravidin was excited by a 405-nm DPSS laser, and
emission was collected between 425–475 nm. EGFP and Alexa
Fluor 546 were excited by an argon ion laser at 488 and 515 nm,
respectively. Emission for EGFP was collected between 500–
545 nmand between 570–625 nm forAlexa Fluor 546. DiDwas
excited by a 635-nm DPSS laser, and emission was collected
between 655–755 nm.The pinholewas set to 1 airy unit. Three-
dimensional reconstructions were generated using Imaris soft-
ware (version 7.4, Bitplane). Linescan analysis was performed
using FIJI software (Fiji.sc/Fiji). Size quantification was done by
stack analysis of GUVs using a stack size of 0.5 mm.
Preparation of Supported Lipid Bilayers—Supported lipid
bilayers were prepared as described previously (29). The
nuclear envelope lipid mix with 0.2 mol % Rhodamine-PE was
dissolved in SLB buffer (10 mM HEPES (pH 7.4) and 150 mM
NaCl) at a concentration of 5 mg/ml. 20 ml of the mixture was
diluted with 150 ml of SLB buffer. The suspension was then
vortexed and bath-sonicated until a clear suspension was
obtained, indicating that small unilamellar vesicles had formed.
The clear solution was put in contact, at 37 °C, with freshly
cleaved mica glued to a coverslip. CaCl2 was added to a final
concentration of 3 mM and incubated at 37 °C for 10 min. The
samples were rinsed several times with SLB buffer to remove
CaCl2 and unfused vesicles and then allowed to equilibrate at
room temperature before analysis.
ConfocalMicroscopy of Supported LipidBilayers—Supported
lipid bilayers were imaged using a commercial LSM 710 (Carl
Zeiss, Jena, Germany) at 22 °C. The excitation light of a DPSS
laser at 561 nm and of an argon laser at 488 nmwas reflected by
a dichroic mirror (MBS 488/561/633) and focused through a
Zeiss C-Apochromat 340, numerical aperture 1.2 water
immersion objective onto the sample. The fluorescence emis-
sion was collected by the objective and directed by spectral
beam guides to photomultiplier tube detectors. Images were
acquired before and addingHis6-EGFP-pUL31 orHis6-EGFP at
the same areas of the supported lipid bilayers. Images were ana-
lyzed using FIJI (particle analysis). Proteins were added to a
final concentration of 500 nM.
Atomic Force Microscopy—Supported lipid bilayers were
imaged using a JPK NanoWizard II system (JPK Instruments,
Berlin, Germany) mounted on an Axiovert 200 invertedmicro-
scope (Carl Zeiss). Intermittent contact (or tapping) mode
images were taken using V-shaped silicon nitride cantilevers
(SNL-10) with a typical spring constant of 0.08N/m and a nom-
inal tip radius of 2 nm. The cantilever oscillation was tuned to a
frequency between 3–10 kHz, and the amplitude was set
between 0.3–0.6V. The amplitudewas varied during the exper-
iment to minimize the force of the tip on the bilayer. The scan
rate was set to 0.7–1 Hz. The height, deflection, and phase shift
signals were collected simultaneously in both trace and retrace
directions. Atomic force microscopy images were acquired
before and after adding 150 nM His6-EGFP-pUL31 or His6-
EGFP on the bilayer. Atomic force microscopy images were
analyzed using JPK data analysis software.
RESULTS
pUL31 and pUL34 Are Sufficient forMembrane Budding and
Scission—Viral pUL31 and pUL34 are necessary for nuclear
egress of herpesvirus capsids. To investigate their function in
detail, we expressed the transmembrane protein pUL34 in
E. coli as a full-length protein, including its transmembrane
region, and, after purification, labeled it with the fluorescent
dyeAlexa Fluor 546 before reconstitution into liposomeswith a
nuclear envelope-like lipid composition (30, 31) (see “Experi-
mental Procedures” for details). GUVs were generated from
these proteoliposomes. The GUVmembrane contained pUL34
as an integral membrane component, which can be detected by
its fluorescent label (Fig. 1A). The vast majority of these GUVs
were large vesicles with no detectable membrane/vesicle struc-
tures in the interior.
When added to pUL34-GUVs, purified recombinant EGFP-
pUL31 was efficiently recruited to the membranes (Fig. 1B),
consistentwith a direct pUL31-pUL34 interaction (9, 12, 14). In
the presence of pUL31, the GUVmembrane was deformed and
invaginated, leading to small intralumenal vesicles inside the
GUVs that contained both pUL31 and pUL34. In typically sized
GUVswith a diameter of 30–40mm,;15 intralumenal vesicles
were detected, the majority of them 0.5–2 mm in size (Fig. 1,
D–F). Formation of intralumenal vesicles was specific for
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p*+,1 because it was not induced by addition of EGFP alone.
The same result was observed in different buffer systems and
with untagged pUL31, confirming that the EGFP tag did not
cause this effect.3 As a control, we replaced pUL34 with the
inner nuclearmembrane protein SCL1/BC08 (32). Like pUL34,
SCL1 is a type II transmembrane protein with a single mem-
brane-spanning domain at its C terminus. Therefore, theN-ter-
minal region preceding the transmembrane domain of both
pUL34 and SCL1 faces the nucleoplasm. EGFP-pUL31 was not
recruited to SCL1-GUVs, and membrane invaginations were
not observed above background levels, demonstrating that this
process specifically requires pUL31 and pUL34 (Fig. 1B).
Cascade blue-labeled neutravidin was used as a fluid phase
marker to assess permeability between the bulk solution and
the pUL31-induced vesicles. When the fluid phase marker was
added as a soluble probe, together with pUL31, to pUL34-
GUVs, the label was found in intralumenal vesicles (Fig. 1G, top
row). When added 20 min after pUL31 addition, intra-GUV
vesicles without the fluid phase marker were detected (Fig. 1G,
bottom row). Therefore, the lumina of vesicles are disconnected
from the bulk solution surrounding theGUVs, indicatingmem-
brane scission. This is consistent with the three-dimensional
reconstitution of an EGFP-pUL31-treated pUL34-GUV that
shows highly mobile vesicles distant and apparently detached
from the limiting GUV membrane (Fig. 1H). When the fluid
phase marker was added to SCL1-GUVs together with EGFP-
pUL31 or to pUL34-GUVs in the absence of EGFP-pUL31 (Fig.
3M. Lorenz, B. Vollmer, J. D. Unsay, B. G. Klupp, A. J. García Sáez, T. C. Metten-
leiter, and W. Antonin, unpublished observations.
F-./02 1. The pUL31-pUL34 complex is sufficient to induce intralumenal vesicles. A, recombinant Alexa Fluor 546-labeled pUL34 (red) was reconstituted
intoGUVs. TheGUVmembranewas stainedwith the lipophilic dyeDiDC18. B, Alexa Fluor 546-labeled pUL34 or the inner nuclearmembraneprotein SCL1were
reconstituted into GUVs (red). Addition of EGFP-pUL31 (green in overlay) induced formation of intra-GUV vesicles on pUL34 but not SCL1GUVs. C, recombinant
proteins employedwere separatedon12%SDS-PAGEand stainedwithCoomassieBlue.D, quantitationof thenumberofGUVswith intralumenal vesicles (ILVs)
shows the mean 6 S.E. of three independent experiments, each including at least 70 GUVs/condition and experiment. E, the number of ILVs per GUV was
quantified from three independent experiments, each including at least 20 GUVs/condition and experiment. Themean6 S.E. is shown. F, the size distribution
of ILVs formed in pUL34-GUVs after EGFP-pUL31 addition was analyzed from three independent experiments, each including at least 20 GUVs/condition and
experiment. G, cascade blue-labeled neutravidin (fluid phasemarker) was added together with EGFP-pUL31 (top row) or 20min after EGFP-pUL31 addition to
GUVs (bottom row) with reconstituted Alexa Fluor 546-labeled pUL34 or SCL1. H, three-dimensional reconstruction of an EGFP-pUL31-treated (green) pUL34
GUV (red). I, highermagnificationof abudding spot on apUL34GUVafter EGFP-pUL31 addition. EGFP-UL31 andAlexa Fluor 546-pUL34was analyzed along the
limiting GUVmembrane. Scale bars 5 5 mm (1 mm in I and insets).
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1G),3 no intra-GUV fluorescence was detected, consistent with
the notion that the pUL31-pUL34 interaction specifically
induces vesicle budding into the GUV lumen.
These data show that, in a minimal membrane system, the
two viral proteins pUL31 and pUL34 are sufficient to induce
membrane perturbations generating intra-GUV vesicles.
Importantly, in our assay, pUL34 is integrated as a transmem-
brane protein into theGUV lipid bilayer,mimicking the natural
situation at the nuclear envelope membranes. The restructur-
ing of the GUV-limiting membrane is reminiscent of the
inwardly directed primary vesicle formation into the lumen of
the nuclear envelope during herpesvirus nuclear egress. The
emerging buds were enriched in pUL31 and pUL34, indicating
that both proteins accumulate at sites of membrane deforma-
tion (Fig. 1I), consistent with a role in this process. Therefore,
this GUV system is a valuable tool to investigate pUL31-
pUL34-mediated vesicle budding and scission in detail.
pUL31 Mediates Membrane Budding and Scission—Many
membrane-deforming processes, including budding of several
viruses at the plasma membrane, specifically involve integral
membrane proteins (33–37). To assesswhether themembrane-
spanning C terminus of pUL34 is required for the formation of
intralumenal vesicles, we artificially recruited a pUL34 frag-
ment lacking its transmembrane domain to GUVs (Fig. 2A). To
this end, the Alexa Fluor 546-labeled soluble domain (amino
acids 1–240) of pUL34 fused to anN-orC-terminalHis6 tagwas
F-./02
2.Membrane tethering of pUL31 is sufficient to induce intralumenal vesicles. A, an Alexa Fluor 546-labeled N- or C-terminally His6-tagged pUL34
fragment (top and bottom rows, respectively) comprising the soluble domain (amino acids 1–240)was bound to 1%Ni-NTA-DGS-containingGUVs. Addition of
EGFP-pUL31 induced intra-GUV vesicles. B, His6-tagged-EGFP or His6-tagged-EGFP-pUL31 was directly bound to Ni-NTA-DGS-containing GUVs. Membranes
were stained with DiDC18. Cascade blue-labeled neutravidin as a fluid phase marker was added together with His6-tagged EGFP-pUL31 or His6-tagged-EGFP
or 20 min after His6-EGFP-pUL31 addition to GUVs. The purity of the employed recombinant proteins is shown by SDS-PAGE and Coomassie staining.
Quantitation shows themean6 S.E. of three independent experiments, each including at least 80 GUVs/condition and experiment. C, the number of ILVs per
GUV was quantified from three independent experiments, each including at least 20 GUVs/condition and experiment. The mean 6 S.E. is shown. D, the size
distribution of ILVs formed in Ni-NTA-DGS-containing GUVs after His6-EGFP-pUL31 addition was analyzed from three independent experiments, each includ-
ing at least 20 GUVs/condition and experiment. E, higher magnification visualizing budding spots on His6-EGFP-pUL31-tethered Ni-NTA-DGS GUVs. F, three-
dimensional reconstruction of a His6-EGFP-pUL31-treated (green) GUV containing 1% Ni-NTA-DGS. Membranes were stained with DiDC18 (gray). Scale bars5
5 mm (1 mm in E and insets).
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(aa%a to GUVs incorporating the Ni21-chelating lipid
Ni-NTA-DGS. GUVs coated with these tethered pUL34 frag-
ments showed no detectable vesicle structures in their interior.
When EGFP-pUL31 was added, it was efficiently recruited to
the GUV membranes regardless of whether pUL34 was
attached to the membrane via its N or C terminus. This finding
is consistent with the fact that the transmembrane region of
pUL34 is not required for pUL31 interaction (9, 38). More
importantly, pUL34-mediated pUL31 recruitment was suffi-
cient for intralumenal vesicle formation. This indicates that the
presence of an authentic transmembrane region is not essential
for this process (21).
It should be noted that, in contrast to the experiments pre-
sented in Fig. 1, where pUL34, because of its reconstitution as
an integral membrane protein, might be present in both orien-
tations in the GUV membrane, the pUL34 fragment is only
located on the outer leaflet of the GUVs. Although unlikely in
the light of its cellular localization, orienting its non-mem-
brane-spanning region into the nucleoplasm, the experiments
shownhere exclude that a (wrongly oriented) fraction of pUL34
is causative for in vitro vesicle formation.
Next we tested whether pUL34 plays an active role in the
invagination process orwhether it ismerely required for pUL31
recruitment. When His6-tagged EGFP-pUL31 was bound
directly to Ni-NTA-DGS-containing lipid GUVs, intralumenal
vesicles were induced efficiently induced (Fig. 2, B and C).
Addition of cascade blue-labeled neutravidin together or 20
min after protein addition indicated that the formed intralume-
nal vesicles pinched off from the limiting GUVmembrane. The
size distribution of these intralumenal vesicles was shifted to
smaller vesicle diameters (Fig. 2D). Although we cannot
exclude other scenarios, it is possible that this is due to the
absence of pUL34. Three-dimensional reconstitution of a His6-
EGFP-pUL31-treated GUV shows many highly mobile vesicles
distant from the GUV membrane, indicating that they have
been disconnected (Fig. 2F). Therefore, artificial membrane
tethering of pUL31 is sufficient for the induction of membrane
invaginations and membrane scission. This effect was specific
for pUL31 because a His6-tagged EGFP, despite efficient
recruitment to the GUVmembrane, did not induce intra-GUV
vesicle formation (Fig. 2, B and C). Therefore, the function of
pUL34 in this minimal system is to target pUL31 to the
membrane.
pUL31-pUL34-mediated Membrane Resculpting Requires
Cholesterol and Sphingomyelin—The GUVs used so far con-
tained a lipid composition resembling the nuclear envelope.
We next assessed whether any specific lipid or lipid class in this
mixture is required for intralumenal vesicle formation. GUVs
were reconstituted with full-length pUL34 in the absence of
specific lipid components. EGFP-pUL31 was efficiently
recruited to the membrane of pUL34-GUVs regardless of lipid
composition (Fig. 3A). In fact, efficient formation of intralume-
nal vesicles was observed in all instances, except when choles-
terol or sphingomyelin were absent from the GUV membrane.
Also, in the absence of both negatively charged lipid classes,
phosphatidylserine and phosphatidylinositol, intralumenal
vesicles formed efficiently. Identical results were obtained
when His6-tagged EGFP-pUL31 was directly targeted to Ni-
NTA-DGSGUVs (Fig. 3B). These data indicate that cholesterol
and sphingomyelin are required for pUL31-inducedmembrane
invagination and scission. Both lipids interact and are crucial
for lateral segregation of membrane components, leading to
membrane subdomain formation, such as rafts (39). However,
we did not observe a pUL31-pUL34-induced phase separation
of sphingolipid-cholesterol from othermembrane components
inGUVs (Fig. 3C), althoughwe cannot exclude the formation of
raft-like nanodomains of a size below the optical resolution of
lightmicroscopy. It is possible that cholesterol and sphingomy-
elin are required for intra-GUV vesicle formation because they
permit membrane fluidity (40) and, therefore, might be essen-
tial for flexibility of the lipid bilayer, allowing its resculpting to
vesicles.
pUL31 Oligomerizes on the Membrane Surface—Our data
show that pUL31 membrane recruitment induces vesicle for-
mation on GUVs. Many membrane remodelling proteins, such
as clathrin or components of the COP I/II or ESCRT machin-
ery, oligomerize on the deforming membrane (22, 23). His6-
EGFP-pUL31 became enriched at the sites of inwardly directed
membrane deformation (Fig. 2E). To test for membrane-in-
duced oligomerization, we bound limiting amounts of His6-
pUL31 to Ni-NTA-DGS GUVs. Under these conditions, no
intralumenal vesicles were detected (Fig. 4). Addition of
increasing amounts of EGFP-pUL31 devoid of a His6 tag
resulted in recruitment of the protein to the membrane and
induction of intralumenal vesicle formation. EGFP-pUL31
membrane recruitmentwasmediated specifically byGUV teth-
ered His6-pUL31 because EGFP-pUL31 membrane labeling
and vesicle formation was not observed in the absence of His6-
pUL31. Interestingly, pUL31 does not self-interact in solution
when tested by GST pulldown experiments or gel filtration fol-
lowed by multiangle laser light scattering (Fig. 4, B–D).
To directly observe pUL31 oligomerization on the mem-
brane surface and induction ofmembrane remodelling activity,
we incubated the protein with supported lipid bilayers of
nuclear envelope lipid composition supplemented with
Ni-NTA-DGS. His6-EGFP-pUL31 was recruited rapidly to the
supported lipid bilayers, where it formed patches of 1.0 6 0.5
mm in diameter (Figs. 5 and 6) and eventually provoked the
appearance of multiple defects, indicating disruption of the
lipid bilayer (Fig. 6). This latter effect is likely due to the increase
in membrane tension associated with the membrane deforma-
tions at the pUL31 assembly sites. In contrast, His6-EGFP was
also recruited efficiently to the supported lipid bilayers but did
not induce patch formation or disruption of the bilayer.
Together, these data indicate that pUL31 forms clusters
when recruited tomembranes. Therefore, our data suggest that
when monomeric pUL31 is recruited to membranes in the cel-
lular context by pUL34, it self-interacts to induce membrane
deformation, leading to vesicle formation.
DISCUSSION
Nuclear egress is a common mechanism for herpesvirus
nucleocapsid translocation through the nuclear envelope (41).
Although it has long been thought to be unique to herpesvi-
ruses, it has recently been recognized that a similar mechanism
also functions in the nuclear export of large ribonucleoprotein
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in Drosophila (24), indicating the presence of a gen-
eral, so far unknownmechanism of vesicular transport through
the nuclear envelope. Although the cellular factors involved in
this process remain largely enigmatic but may include the
AAA1 ATPase torsin (42), all members of the Herpesviridae
family analyzed in this respect are dependent on the viral
nuclear egress complex, composed of pUL31 and pUL34
homologs, for translocation through the nuclear envelope. In
the absence of either complex partner, herpesvirus-induced
nuclear envelope breakdown can substitute for pUL31-pUL34-
mediated nuclear egress (43). This mode of nuclear escape has,
however, only been observed after forced reversion analysis in
cell culture. Differing roles for pUL31 and pUL34 in nuclear
egress have been demonstrated (7, 8), including recruitment of
viral and cellular kinases that locally disrupt the lamina (15–19)
as well as functions in herpesvirus replication beyond nuclear
egress, including viral DNA binding and packaging (44, 45) or
cell-to-cell spread (46).
Here we reconstituted herpesvirus pUL31-pUL34-depend-
ent membrane invagination and scission using a minimal set of
protein components and a simple model for the eukaryotic
nuclear envelope. The presence of pUL31 at the membrane is
sufficient to induce GUV-internal vesicles, a process topologi-
cally similar to the formation of primary envelopes, indicating
that, in this system, pUL34 is only required to recruit pUL31 to
the membrane. In contrast to a recent report (21), we did not
observe a dependence on the negatively charged phospholipids
phosphatidylserine and phosphatidic acid, which needed to be
present in unphysiologically high amounts (up to 40%). In our
system, budding and scission also occur in the absence of the
comparably low amounts of phosphatidylserine and phosphati-
dylinositol found in the nuclear envelope. This difference is
likely due to the fact that, in the previous report, the negatively
charged lipids are required for membrane recruitment by elec-
trostatic interaction of a C-terminally truncated pUL34 lacking
the transmembrane region. In contrast, we used either full-
length pUL34 containing the C-terminal transmembrane
region or directly tethered pUL31 to the GUV membrane.
Therefore, our system is less prone to artifacts and mimics the
natural situation more faithfully.
The minimal GUV model system provides several funda-
mental new insights into the process of herpesvirus nuclear
egress. First, it shows that pUL31-pUL34-mediated membrane
deformation at the inner nuclear membrane can be uncoupled
and is, therefore, functionally disconnected from lamina disas-
sembly. It is formally possible that pUL31-pUL34 regulated
lamina dynamics are a driving force for restructuring the inner
nuclear membrane, similar to other cytoskeleton assembly and
disassembly processes that are linked to membrane shape
changes of a variety of organelles (47, 48). However, in ourmin-
F-./02 3. Cholesterol and sphingomyelin are required for pUL31-mediated vesicle formation. A, recombinant Alexa Fluor 546-labeled pUL34 was
reconstituted into GUVs containing the nuclear envelope lipid mix (complete lipid mix) or the same lipid mix lacking either cholesterol (chol), sphingomyelin
(SM), the negatively charged phospholipids phosphoinositol (PI) or phosphatidylserine (PS), or both (PI1PS). Formation of intralumenal vesicles was induced
and quantified after EGFP-pUL31 addition (mean 6 S.E. of three independent experiments, each including at least 50 GUVs/experiment and condition). B,
His6-tagged-EGFP-pUL31 was bound directly to Ni-NTA-DGS-containing GUVs with the same lipid compositions as in A, and ILV numbers were quantified
(mean6 S.E. of three independent experiments, each including at least 60 GUVs/experiment and condition). C, pUL31was added to pUL34-GUVs loadedwith
themembrane dyes naphthopyrene andDiDC18, which label the liquid ordered (LO) or liquid disordered phase (LD), respectively. Althoughwe cannot exclude
an enrichment of specific lipids in internal vesicles, there no induction and separation of liquid-ordered and -disordered phases was detectable.D, as a control
for the functionality of themembranedyes, their segregationwas testedonphase-separatingmembraneGUVs (33mol%cholesterol, 33mol%sphingomyelin,
33 mol% phosphatidylcholine). Scale bars 5 5 mm (1 mm in insets).
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system, deformation of the GUV membrane leading to
vesicle formation occurs in the absence of lamin proteins. Sec-
ond, pUL31 and pUL34 have well defined and separate func-
tions in the primary envelopment of herpesvirus capsids.
pUL31 and pUL34 are both crucial for this process, and coex-
pression of both proteins in uninfected cells induces the forma-
tion and scission of vesicles from the inner nuclear envelope
(10, 20). It could be envisioned that cellular proteins participate
in the necessary restructuring of the inner nuclear membrane
because a similar process occurs during the nuclear export of
large ribonucleoprotein particles in Drosophila neurons (24).
However, our work shows that cellular proteins are not essen-
tial to execute the basic membrane restructuring necessary for
nuclear egress, including membrane deformation, budding
away from the nucleoplasm, and scission to generate vesicles
detached from the inner nuclear membrane. In contrast, cellu-
lar proteins may be involved in fusion of the intralumenal ves-
icles with the outer nuclear membrane to complete the trans-
port process. Third, pUL31membrane recruitment is sufficient
for membrane remodelling, resulting in vesicle formation.
Therefore, this viral protein is the driving force both for mem-
brane budding and scission in herpesvirus nuclear egress,
which constitutes a new archetype of these non-conventional,
inwardly directed budding events.
Herpesvirus nuclear egress can be regarded as vesicle-medi-
ated transport through the lumen of the nuclear envelope. In
this respect, the process has an inverted topology compared
with classical vesicular trafficking pathways through the cyto-
sol. The prime factors inducing membrane deformation and
scission in vesicular trafficking localize and act on the outer
surface of the exvaginated membrane and/or the vesicle. Our
results demonstrate that such an outer membrane coat is not
required for vesicle formation during herpesvirus nuclear
egress. Rather, formation of the nuclear egress complex on the
emerging inner vesicle surface is sufficient to drive membrane
bending and scission. Different mechanisms implicated in
membrane remodellingmight be envisioned to promote vesicle
formation (35). First, integral membrane proteins can deform
membranes. Well known examples are reticulons and caveo-
lins, which oligomerize and possess unusual hydrophobic seg-
ments that might form wedge-shaped hairpins in the mem-
brane (33, 34), and both features can contribute to membrane
shaping (35). Similarly, budding of some viruses (e.g. coronavi-
ruses) at the plasma membrane is driven by membrane protein
F-./02
4. pUL31 self-interacts on membranes but not in solution. A, where indicated, 60 nM His6-tagged-pUL31 was bound directly to Ni-NTA-DGS-
containing GUVs. Increasing amounts of EGFP-pUL31 were added to the GUVs showing a pUL31-mediated membrane recruitment of EGFP-pUL31 and
formation of intra-GUV vesicles. Where indicated, cascade blue-labeled neutravidin was added as a fluid phase marker 20 min after protein addition to GUVs
to confirm scission of ILVs from the limitingGUVmembrane. Quantitation shows themean6 S.E. of three independent experiments, each including at least 60
GUVs/condition and experiment. Scale bars are 10 mm (1 mm in insets). B, GST pulldown using GST (control), GST-pUL31, and GST-pUL34DTMR (amino acids
1–240, i.e. lacking the transmembrane region) as bait and EGFP-pUL31 as prey. GST-bound EGFP-pUL31was elutedwith precision protease-containing buffer,
which cleaves the GST fusions C-terminal of the GST tag, as analyzed by Western blotting using anti-EGFP-antibodies. C, GST pulldown as in B, but with
His6-pUL31 asprey, detectedusing anti-His6 antibodies.D, size exclusion chromatographyona Superdex 75/300GL column followedbymultiangle static laser
light scattering of EGFP-UL31 shows that it is monomeric in solution (calculated mass, 58.7 kDa). The red dots relate to the secondary axis and show the
molecular weight of the eluting particle.
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o) (49). However, sequence analysis does not sug-
gest such an unusual topology for the pUL34 transmembrane
region. Our data rather show that pUL34 is dispensable for
membrane restructuring leading to vesicle formation in the
nuclear envelope lumen. Furthermore, membrane invagina-
tions can be detected in the GUV system with pUL31 alone,
indicating that a transmembrane region does not play a com-
pulsory role in the process.
A secondwidely discussedmechanism that can contribute to
membrane deformation and budding is the insertion of
amphipathic helixes into the lipid bilayer (31, 50, 51). However,
neither pUL31 nor pUL34 are predicted to form such helixes.
More importantly, helix insertion has to take place in the outer
lipid leaflet of the nascent vesicle to increase the outer in rela-
tion to the inner surface area. pUL31 is localized in the interior
of the vesicle, discounting such amechanism. Similarly, protein
crowding generating lateral pressure, which can curve mem-
branes (52), can be excluded for pUL31-mediated membrane
budding because this mechanism generates membrane defor-
mation in the opposite direction, i.e. outward from the limiting
membrane.
In addition to protein-driven processes, lipid-induced
changes can restructuremembranes. Phase separation can gen-
erate membrane curvature and induce budding and scission in
simplemembrane systems (53–55). Themembrane envelope of
HIV is highly enriched in the raft-forming lipids sphingomyelin
and cholesterol (56, 57), which suggests that budding at the
plasma membrane occurs from lipid rafts (58). However, the
lipid mixture of the nuclear envelope/endoplasmic reticulum
possesses a relatively low amount of cholesterol and sphingo-
myelin compared with the plasmamembrane (30) and does not
formdetectable lipid rafts (40). Accordingly, we did not observe
phase separation between a cholesterol/sphingomyelin-en-
riched ordered and a disordered phase when pUL31 was added
to pUL34-GUVs (Fig. 3C). Therefore, there is no indication for
a locally induced phase separation, giving rise to the observed
invaginations. In addition, changes in lipid composition, espe-
cially the localized generation of non-cone shaped lipids or
their enrichment, such as the unconventional phospholipid
lysobisphosphatidic acid on internal vesicles of multivesicular
bodies (59), can contribute to membrane curving. However,
F-./02
5. pUL31 forms patches on supported lipid bilayers. A, supported lipid bilayers (SLB) mimicking the nuclear envelope lipid composition (supple-
mentedwithNi-NTA-DGS) showa flat topographybefore protein addition. Graphsbelow the image areprofiles of the yellow line in the image.B, upon addition
ofHis6-EGFP-pUL31, patches formwith aggregated structures. The right figure is a 333mmenlarged imageof the yellowboxwithin the left panel.C, supported
lipid bilayers before addition of His6-EGFP. D, supported lipid bilayers after addition of His6-EGFP with no change in topography detectable. E, diameter and
roughness (average height of the patches) distributions of the patches observed upon addition of His6-EGFP-pUL31. Gaussian fitting of the histograms shows
a peak 1.0 6 0.5 mm in diameter (mean 6 S.D.) and 2.0 6 0.1 nm in roughness. Scale bars 5 10 mm for A and 2 mm for B–D.
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%'% is no evidence that pUL31mediates lipid modifying reac-
tions or has a binding preference for a specific lipid.
Therefore, we prefer a model in which pUL31 acts as a scaf-
folding protein self-assembling at the inner surface of the form-
ing vesicle. pUL31 is monomeric and does not detectably self-
interact in solution (Fig. 4,B–D). Artificialmembrane tethering
of limiting amounts of pUL31 that are not sufficient to promote
membrane invaginations can recruit soluble pUL31 (Fig. 4A),
which, in turn, induces intralumenal vesicle formation. This
effect is caused by membrane-induced pUL31 oligomerization,
as suggested by confocal and atomic force microscopy on sup-
ported lipid bilayers. Consistently, budding sites at the GUV
membranes show local enrichment of pUL34-pUL31 or pUL31,
respectively (Figs. 1I and 2E). Although we cannot exclude the
contribution of other proteins, in cells, budding sites at the
inner nuclear membrane are more electron-dense, an observa-
tion that implies high protein density (8, 10). Interestingly, a
recent study shows that a pUL31-pUL34 complex lacking the
pUL34 transmembrane domain forms ordered assemblies
when recruited to membranes (21). Our study suggests that
pUL31 alone can oligomerize onmembranes and induce vesicle
formation. For the Kaposi sarcoma-associated herpesvirus
pUL31 homologORF69, it has been suggested that it is required
for membrane remodelling into circular virion-size vesicles,
whereas the pUL34 homolog ORF67 results in membrane pro-
liferation (60). A double point mutation in HSV-1 pUL34
(D35A/E37A) causes a blockage in nuclear envelope vesicle for-
mation without preventing pUL31 membrane recruitment
(61). When tethered to GUVs, the corresponding pUL31/
pUL34 fails to induce membrane deformation (21). The defect
of pUL34 (D35A/E37A) during infection could be overcome by
a mutation in pUL31 that restored the ability to induce mem-
brane deformation (61). This indicates that pUL34, in addition
to pUL31 recruitment, plays a supportive and regulatory role in
the induction of vesicles (62). It is possible that pUL34 under-
goes a conformational change upon pUL31 binding that either
brings the protein closer to the membrane or triggers multim-
erization of the complex, features that might be blocked in the
D35A/E37A mutation.
The vesicle budding at the nuclear envelope is reminiscent of
the invagination processes mediated by the ESCRT machinery
during formation of intraendosomal vesicles in multivesicular
body formation. In this reaction pathway, ESCRT-I and
ESCRT-II complexes direct membrane budding away from the
cytosol, and ESCRT-III cleaves the bud necks from their cyto-
solic faces (23, 63, 64). In amechanistically related process dur-
ing HIV egress at the plasma membrane, the viral gag protein
assembles and drives initial bud formation but requires the
ESCRT complex components for membrane scission (65, 66).
Gag protein assembly on the cytoplasmic side of the plasma
membrane is thought to be the driving force for bud formation
in HIV, and similar roles formembrane-associated proteins are
implicated in rhabdovirus, filovirus, arenavirus, and paramyxo-
virus formation (37). In contrast to the gag/ESCRTmachinery,
F-./02 6. pUL31 disrupts supported lipid bilayers. A, supported lipid bilayers (SLB) mimicking the nuclear envelope with rhodamine-PE (red) form contin-
uous fluid phase. Bilayers are disrupted upon addition of His6-EGFP-pUL31 (green). A few seconds after addition, pUL31 forms 1.26 0.2mmpatches that grow
over time until they cover thewhole area (around 90 s). The bilayer is destroyed, and lipid aggregation is seen over this period of time. B, addition of His6-EGFP
did not change the bilayer. C, particle analysis of the patches showing the growth of the particles over time. After 40 s, particles fuse and can no longer be
analyzed. Scale bars 5 50 mm
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mediates HIV release at the plasma membrane (67), the
nuclear egress complex requires no energy input for bothmem-
brane budding and scission,3 although we cannot exclude that,
in the cellular situation, an energy-dependent step is involved.
Interestingly, although, in the case of gag/ESCRT-mediated
vesicle formation, several proteins are required and the steps of
membrane budding and scission are separated functionally, a
single protein, pUL31, can execute this task in herpesvirus
nuclear egress. This suggests that pUL31 has the intrinsic abil-
ity to oligomerize on the membrane and cleave its own bud
neck.How this is achievedmechanistically is an interesting ave-
nue for future research. In contrast to a previous report, we did
not detect a regular structural pattern on themembrane surface
(Fig. 5), most likely because of the absence of pUL34. This sug-
gest that pUL34 is, in addition to pUL31 recruitment, required
for formation of the hexagonal arrangement and drives the oth-
erwise unstructured oligomerization of pUL31 into an ordered
pattern.
Although we cannot exclude the presence of smaller-sized
vesicles inside the GUVs because of the refraction limit of light
microscopy and the rapid vesicle movement, the vesicles
observed in the in vitro system are considerably larger than the
vesicles formed in the nuclear envelope lumen during viral
egress (68) but also in the absence of capsids when overexpress-
ing pUL31 and pUL34 (10, 20). Notably, a similar increase in
vesicle diameters has been observed when studying budding
and/or vesicle formation on GUVs mediated by the ESCRT
machinery or other viral proteins, including pUL31/pUL34 (21,
63, 69–71). A number of factors could, in the case of our study,
account for the size difference. The inner nuclear membrane is
tightly connected to the underlying lamina and the chromatin
by integralmembrane proteins (1, 2). This could restrain lateral
mobility of themembrane and, consequently, impact the size of
the vesicles. Moreover, although pUL31 can, on its own, pro-
mote vesicle budding and scission, it is conceivable that cellular
(and additional viral) factors contribute to the process in vivo,
which could restrict vesicle size. The fact that a similar vesicle-
mediated nuclear export of large ribonucleoprotein particles
bypassing nuclear pore complexes is found (24) makes it likely
that a cellular machinery exists that mediates membrane bud-
ding and scission at the inner nuclear membrane as well as
fusion of these vesicles with the outer nuclear membrane and
that could participate in herpesvirus nuclear egress.
In summary, our work establishes that pUL34-mediated
membrane recruitment of pUL31 drives vesicle budding and
constriction in a biochemically well defined system. It shows
that a single protein, pUL31, is sufficient to induce inwardly
directed membrane deformation and scission. It will be inter-
esting to see whether cellular orthologs of herpesvirus pUL31
exist, especially for the process of RNP egress at the nuclear
envelope, which is topologically comparable with herpesvirus
nuclear egress. Finally, the methods established and employed
here to express and reconstitute pUL34 into GUVs are gener-
ally applicable for other single and multiple transmembrane-
spanning proteins and, therefore, present a valuable tool for
studying these proteins inminimal and well definedmembrane
systems.
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Summary 
In metazoa, nuclear pore complexes (NPCs) are assembled from constituent nucleoporins by two 
distinct mechanisms; In the re-forming nuclear envelope at the end of mitosis and into the intact 
nuclear envelope during interphase. Here, we show that the nucleoporin Nup153 is required for NPC 
assembly during interphase but not during mitotic exit. It functions in interphasic NPC formation by 
binding directly to the inner nuclear membrane via an N-terminal amphipathic helix. This binding 
facilitates the recruitment of the Nup107-160 complex, a crucial structural component of the NPC, to 
assembly sites. The nuclear transport receptor transportin and the small GTPase ran regulate the 
interaction of Nup153 with the membrane and in this way direct pore complex assembly to the 
nuclear envelope during interphase. 
 
 
Bullet points: 
 Nup153 binds membranes via its N-terminus. 
 Transportin binding regulates Nup153 membrane interaction. 
 Nup153 membrane binding is required for interphasic nuclear pore complex assembly. 
 Nup153 recruits the Nup107-160 complex to the inner nuclear membrane. 
 
 
  
Introduction 
Nuclear pore complexes (NPCs) are gatekeepers of the nucleus. They restrict the diffusion of proteins 
and nucleic acids between the cytosol and nuclear interior and enable tightly-controlled transport 
between these compartments (Wente and Rout, 2010). Nuclear import of soluble proteins is 
mediated by transport receptors that bind cargo proteins in the cytosol. This interaction massively 
enhances the passage of otherwise inert cargos through NPCs. In the nucleoplasm, transport 
receptors are detached from cargos by binding to the small GTPase ran in its GTP bound form. The 
ranGTP-transport receptor complexes then traverse the NPC in the opposite direction. RanGTP 
hydrolysis at the cytoplasmic site of the NPC frees transport receptors, which are able to act in 
another round of the cycle. 
Despite their enormous size and substantial flexibility with regard to transport substrates, NPCs are 
composed of only about thirty different proteins, nucleoporins, present in multiple copies (Alber et 
al., 2007; Bui et al., 2013). They can be roughly categorized into structural nucleoporins, which form 
the scaffold of the pore, and those responsible for the transport and exclusion functions of the NPC. 
Nucleoporins of the latter class are characterized by a high number of phenylalanine glycine (FG) 
repeats that form a meshwork within the pore. A stack of three rings forms the NPC scaffold. The 
middle ring is laterally linked to the pore membrane and connected to the central transport channel 
formed mostly by the FG-nucleoporins. The cytoplasmic and nucleoplasmic rings are connected to 
cytoplasmic filaments and the nuclear basket structure, respectively. Although the dimensions and 
mass of NPCs varies between different species, the structural arrangement of the three rings is 
conserved (Grossman et al., 2012). 
Most structural nucleoporins are part of one of two evolutionarily conserved subcomplexes within 
the pore. The Nup93 complex (Nic96 complex in yeast), also known as the inner pore ring module, 
forms a large part of the inner ring and connects the pore membrane to the central transport 
channel (Vollmer and Antonin, 2014). The Nup107-160 complex (Nup84 complex in yeast) forms the 
cytoplasmic and nucleoplasmic rings (Alber et al., 2007; Bui et al., 2013) and is, because of its Y 
shaped structure (Lutzmann et al., 2002), also referred to as Y-complex. This complex is related to 
vesicle coats and presumably stabilizes the curved pore membrane of the NPC (Brohawn et al., 2008; 
Devos et al., 2004; Mans et al., 2004). Connected to the nucleoplasmic ring is the nuclear basket, a 
fish trap-like structure extending to the nuclear interior. In metazoans, three nucleoporins localize to 
the basket, Nup153, Nup50 and TPR (Cordes et al., 1993; Cordes et al., 1997; Guan et al., 2000; 
Sukegawa and Blobel, 1993), the best characterized being Nup153. 
Nup153 possesses a tripartite structure (Ball and Ullman, 2005). The N-terminal region is important 
for NPC targeting (Bastos et al., 1996; Enarson et al., 1998), most likely because it mediates binding 
to the Y-complex (Vasu et al., 2001). A central zinc-finger containing domain interacts with ran 
(Nakielny et al., 1999). The C-terminal FG-repeat containing region provides binding sites for a variety 
of transport receptors (Moroianu et al., 1997; Nakielny et al., 1999; Shah and Forbes, 1998; Shah et 
al., 1998). Because of its localization at the nucleoplasmic exit site of NPCs as well as its interactions 
with transport receptors and ran, Nup153 is thought to assist in the dissociation of import cargo-
transport receptor complexes and thus facilitate the nuclear import cycles. Indeed, Nup153 depletion 
reduces importin / mediated import (Ogawa et al., 2012; Walther et al., 2001). Nup153 is also 
important for mRNA export from the nucleus (Bastos et al., 1996; Ullman et al., 1999). Although 
Nup153 is essential in C. elegans and HeLa cells (Galy et al., 2003; Harborth et al., 2001), no 
homologues have been found in yeast species. Nonetheless, yeast nucleoporins (such as Nup1 and 
Nup60 in S. cerevisiae, Nup124 in S. pombe) might share functional and sequence features with the 
metazoan Nup153 (Cronshaw et al., 2002; Hase and Cordes, 2003; Varadarajan et al., 2005). 
While significant process has been made in understanding how NPCs function in the highly selective 
transport between cytoplasm and nucleoplasm, elucidating the NPC formation pathway remains a 
formidable task. The stepwise co-ordinated assembly of NPCs from more than four hundred 
individual components and their integration into the nuclear envelope (NE) is a fascinating example 
of molecular self-organisation. In metazoa, NPC assembly occurs at two different stages of the cell 
cycle: at the end of mitosis and during interphase. During mitotic exit, NPC assembly is concomitant 
with the formation of a closed NE. The early steps of post-mitotic NPC formation, such as the 
recruitment of a subset of nucleoporins to the chromatin; are particularly well characterised due to 
their faithful reconstitution in Xenopus egg extracts. Assembly is initiated by MEL28/ELYS, a 
chromatin binding nucleoporin, which recruits the Y-complex (Franz et al., 2007; Gillespie et al., 
2007; Harel et al., 2003; Rasala et al., 2006; Rasala et al., 2008; Rotem et al., 2009; Walther et al., 
2003a). The next step is the establishment of the membrane connection to the assembling NPC by 
interactions between the transmembrane nucleoporin POM121 and the Y-complex (Antonin et al., 
2005; Mitchell et al., 2010; Yavuz et al., 2010). A second transmembrane nucleoporin, NDC1, is also 
likely to be involved at this step (Mansfeld et al., 2006; Stavru et al., 2006) but its function is less 
defined. Components of the Nup93 complex subsequently assemble stepwise from the membrane 
building laterally towards the centre of the NPC (Dultz et al., 2008; Sachdev et al., 2012; Vollmer et 
al., 2012), which allows for the recruitment of the central channel components, the FG-nucleoporins. 
The final steps of NPC assembly are the addition of peripheral nucleoporins, which form extensions 
to the cytoplasmic and nucleoplasmic sides of the pore (Bodoor et al., 1999; Dultz et al., 2008; Hase 
and Cordes, 2003). 
Interphasic NPC assembly in metazoan is relatively poorly characterized. It takes place under 
fundamentally different conditions. Whereas large numbers of NPCs form in a short time span during 
mitotic exit, NPC assembly events in interphase are rare and sporadic (D'Angelo et al., 2006; Dultz 
and Ellenberg, 2010). Both assembly pathways require the Y-complex as an essential structural 
component of the NPC (D'Angelo et al., 2006; Doucet et al., 2010; Harel et al., 2003; Walther et al., 
2003a). However, while the Y-complex is recruited to the chromatin by MEL28/ELYS at the end of 
mitosis, a feature essential for post-mitotic NPC assembly (Franz et al., 2007; Gillespie et al., 2007; 
Rasala et al., 2006), MEL28/ELYS is not required for interphasic NPC assembly (Doucet et al., 2010). It 
is possible that NPC assembly during interphase is rather initiated at the nuclear membranes (Doucet 
et al., 2010; Dultz and Ellenberg, 2010; Rothballer and Kutay, 2013; Vollmer et al., 2012) but the 
precise mechanism by which this occurs has not been defined. 
Here we show that the nuclear basket component Nup153 is crucially required for NPC assembly 
during interphase but not at the end of mitosis. Nup153 binds the inner nuclear membrane via its N-
terminus, a feature that is fundamental for its function in interphasic NPC assembly as it recruits the 
Y-complex to the assembling pores. Transportin regulates the interaction of Nup153 with the 
membrane and thus directs interphasic NPC assembly specifically to the NE from inside the nucleus. 
  
Results 
Nup153 interacts via its N-terminus directly with membranes 
Nup153 contains a region within its N-terminus that directs it to the inner nuclear membrane 
(Enarson et al., 1998). It is possible that Nup153 is localized to the NE due to interactions with 
integral inner nuclear membrane proteins or lamins, proteins that underlay and stabilize the NE by 
forming a tight meshwork, but it could also bind directly to the lipid bilayer. To test for a direct 
membrane interaction we incubated the purified recombinant N-terminal region comprising the first 
149 aa of Xenopus laevis Nup153 with small unilamellar liposomes with a NE lipid composition 
(Vollmer et al., 2012). Due to their density, lipid vesicles float up through a sucrose gradient. 
Membrane binding proteins can be identified in the top fraction together with the liposomes. This is 
indeed the case for Nup153 (Figure 1A) as well as for a Nup133 fragment previously identified as 
membrane interacting (Drin et al., 2007). The N-terminal region of Nup153 showed preference for 
small vesicle sizes with high curvature that was independent of lipid composition (Figure 1B). 
Sequence analysis of the N-terminus of Nup153 identified a conserved region among vertebrates 
that might form an amphipathic helix, as depicted in the helical wheel representation (Figure 1C,D). 
We generated a point mutation (a valine to glutamate exchange in position 50, V50E) that 
predictably disrupt the hydrophobic surface of the helix. Indeed, the V50E mutation impaired 
liposome binding in flotation assays (Figure 1A,B). To directly visualize the interaction of Nup153 with 
membranes we generated giant unilamellar vesicles (GUVs) with sizes up to 50 µm using the NE lipid 
composition. When the EGFP-tagged N-terminus of Nup153 was added to the exterior of these GUVs 
it was efficiently recruited to the vesicle membrane indicating a direct membrane interaction (Figure 
1E). As a negative control, we employed purified recombinant EGFP, which did not bind the GUV 
membrane. Importantly, the V50E mutant did not bind to GUVs, confirming that the amphipathic 
helix is responsible for the membrane binding capacity of Nup153. 
The N-terminal fragment of Xenopus Nup153 fused to EGFP, when ectopically expressed in HeLa 
cells, localized to the NE, presumably the inner nuclear membrane (Figure 1F). Overexpression of this 
fragment induced NE proliferation (Movie S1), as is typical for nuclear membrane interacting proteins 
(Ralle et al., 2004). Membrane proliferation has previously been observed for the overexpression of 
full-length Nup153 (Bastos et al., 1996). In our experiments, the V50E mutation abolished NE 
localization and membrane proliferation. Instead, the protein localized to the nucleoplasm, indicating 
that the mutation is sufficient to prevent the interaction of the N-terminus of Nup153 with 
membranes in cells. 
In order to confirm the direct membrane binding of full-length Nup153 we turned to the human 
orthologue, due to the low expression yield of the full length Xenopus Nup153. Human Nup153 
possesses 42% amino acid identity and 55% similarity with the Xenopus protein. The fluorescently 
labeled human Nup153 efficiently bound GUVs (Figure 1G). The corresponding membrane binding 
deficient mutation (V47E in the human protein) abrogated the membrane interaction. 
 
Nup153 membrane binding is not required for NPC targeting 
To understand the functional implication of the direct membrane interaction we tested whether the 
inner nuclear membrane targeting of Nup153 is required for its incorporation into NPCs. HeLa cells 
were transfected with EGFP-tagged full-length human Nup153 as well as the membrane binding 
deficient mutant (V47E). Both proteins localized to the nuclear rim and showed a typical punctate 
pattern (Daigle et al., 2001) on the NE surface (Figure 2A,S1). The pattern overlaps with mCherry-
labeled Nup62 but not lamin B, indicating proper NPC localization. Despite its nuclear rim 
localization, the V47E mutant exhibited increased nucleoplasmic staining consistent with an 
abolished direct membrane interaction. 
Immunoprecipitation from transfected HEK cells demonstrated that the V47E mutation did not 
impair known interactions, namely to the Y-complex (Nup133 and Nup107) or other nucleoporins 
(Nup50 and TPR), to A/C and B-type lamins, or to components of the nuclear import machinery, ran, 
importin  and , and transportin (Figure 2B). Together these results indicate that membrane 
binding is not required for the assembly of Nup153 into NPCs. Furthermore, the V47E mutation does 
not disturb the interaction network of Nup153 but rather specifically affects its direct membrane 
binding. 
 
Nup153 membrane interaction is not required for NPC assembly at the end of mitosis 
We used Xenopus egg extracts to assess whether the membrane binding capacity of Nup153 is 
important for the assembly and function of NPCs. Nup153 can be specifically immuno-depleted from 
these extracts without affecting the levels of other nucleoporins, including TPR and Nup50 as well as 
two components of the Y-complex, Nup133 and Nup107, which interact with Nup153 within intact 
NPCs (Figure 3A). Similarly, the levels of lamin LIII, a B-type lamin found in Xenopus egg extracts, and 
components of the nuclear transport machinery (ran, importin  and , transportin) were 
unchanged. 
When de-membranated sperm heads are incubated with egg extracts, a NE forms around the 
decondensing chromatin in a process resembling the reassembly of the nucleus at the end of mitosis 
(Gant and Wilson, 1997). The NE contains NPCs visualized with the antibody mAB414, which 
recognizes several FG-nucleoporins, as seen in the control (mock) depletion (Figure 3B,C). When 
Nup153 was depleted, the protein was absent from the nuclear rim confirming the depletion 
efficiency. The assembled nuclei contained a closed NE with NPCs that were unevenly distributed. 
This NPC clustering phenotype upon Nup153 depletion has been previously observed (Walther et al., 
2001) and is best visualized by surface rendering of confocal stacks (Figure 3B). Addition of 
recombinant Nup153 to endogenous levels (see Figure 3A) rescued the NPC clustering phenotype 
(Figure 3B-D) demonstrating its specificity. NPC clustering was also rescued by the Nup153 
membrane-binding mutant, which indicates that the Nup153 membrane interaction is not required 
for proper NPC spacing. 
Depletion of Nup153 did not affect the localization and regular distribution of lamin B or integral 
inner nuclear membrane proteins, such as LBR or BC08. Several nucleoporin antibodies including 
those recognizing the integral pore membrane protein POM121, the Y-complex members Nup133 
and Nup107 as well as the Nup93 complex members Nup155 and Nup53 showed a patchy staining 
(Figure 3E,S2). These observations demonstrate that the structural backbones of NPCs can assemble 
in the absence of Nup153. Furthermore, the central transport channel (examined by Nup58, Figure 
S2) is also present at NPCs in the absence of Nup153. Consistent with previous reports, TPR was not 
detectable at Nup153 depleted nuclei, as it depends on this interaction for NPC localization (Hase 
and Cordes, 2003; Walther et al., 2001). Re-addition of recombinant wildtype or membrane binding-
deficient Nup153 not only rescued the NPC clustering phenotype but also TPR recruitment. This is 
consistent with the notion that the V47E mutation does not interfere with TPR binding (Figure 2B). 
Taken together, these results suggest that the membrane binding capability of Nup153 is not crucial 
for NPC assembly at the end of mitosis. The interaction of Nup153 with membranes is not mandatory 
for proper NPC spacing, as the V47E mutant also rescues the NPC clustering phenotype. However, we 
observed that the nuclei assembled in the presence of the V47E mutant were smaller in comparison 
to the wildtype addback (Figure 3B,E,S2). Similarly, nuclei lacking Nup153 were smaller than control 
nuclei. 
 
Nup153 membrane interaction is not required for efficient nuclear import  
The addition of membranes to sperm DNA decondensed in egg extracts results in a fully closed NE 
containing NPCs within 20 min. After this assembly, which reproduces nuclear reformation at the end 
of mitosis, the nuclei grow in size - the extent to which depends on the extract quality and an ATP re-
generating system - for another 180 min. This nuclear growth requires import of nuclear proteins 
through NPCs. During this time new NPCs integrate into the growing NE (D'Angelo et al., 2006) in a 
process reproducing interphasic NPC assembly, which in turn allows for more import and accelerated 
growth. 
Nup153 contributes to the efficiency of nuclear transport cycles (Ogawa et al., 2012; Walther et al., 
2001). We therefore tested whether the Nup153 membrane interaction is necessary for its role in 
nuclear import. We added different nuclear import substrates to in vitro assembled nuclei at a time 
point when a closed NE had formed. Nuclear import rates for soluble cargos can be determined by 
the time dependent protection of different import substrates from a cytoplasmic protease as they 
accumulate in the nucleus (in detail described in (Theerthagiri et al., 2010). The translocation of 
integral membrane proteins from the endoplasmic reticulum (ER) to the inner nuclear membranes 
can be assessed in a similar way when the reporter is reconstituted into liposomes, which are then 
added to the assembly reactions and integrated into the ER. Compared to mock reactions, nuclei 
depleted of Nup153 exhibited reduced import of a soluble import cargo with a classical bipartite 
nuclear localization signal (cNLS cargo), which is imported in an importin / dependent manner 
(Figure 4A). In contrast, import of a transportin-dependent cargo (containing an M9 sequence) was 
not affected by Nup153 depletion. The dependency of the importin / import pathway on Nup153 
has been previously reported (Walther et al., 2001). Import of the cNLS-containing cargo was rescued 
by the re-addition of either wildtype or membrane binding-deficient Nup153. Transport of a 
transmembrane cargo through NPCs was not affected by Nup153 depletion or the addition of either 
wildtype or membrane binding-deficient Nup153. These results demonstrate that the membrane 
interaction of Nup153 is not important for efficient nuclear import. 
 
Nup153 is necessary for interphasic NPC assembly 
We next tested whether interphasic NPC assembly was affected by Nup153 depletion. Nuclei were 
assembled for 120 min and individual NPCs were counted using mAB414 staining (D'Angelo et al., 
2006; Vollmer et al., 2012). Addition of 2 µM importin , which blocks interphasic NPC assembly 
(D'Angelo et al., 2006), to nuclei formed under control conditions resulted in a reduction in the 
number of NPCs per nucleus by approximately 50% (Figure 4B). Depletion of Nup153 caused a severe 
reduction in NPC number, which was not further affected by the addition importin . Re-addition of 
wildtype Nup153 but not the membrane binding deficient V47E mutant rescued the reduced number 
of NPCs formed. These data suggest that NPC formation during interphase requires Nup153, 
specifically in its capacity to bind the NE. 
The antibody mAB414 recognizes several FG-nucleoporins including Nup153 (Sukegawa and Blobel, 
1993). Although we did not employ overall staining intensity as readout for NPC numbers but 
counted individual NPC containing spots on the NE this procedure might be considered as biased due 
to the loss of a major antigen. Furthermore, counting might also be affected by the NPC clustering 
observed in Nup153 deficient nuclei. We therefore employed an assay for interphasic NPC assembly 
that is independent of mAB414 staining. In this setup, interphasic NPC assembly proceeds in the 
presence of extract depleted of the nucleoporins forming the permeability barrier of the pore. Nuclei 
with newly integrated NPCs lack this barrier and can be visualized by an influx of fluorescently 
labeled dextrans (Dawson et al., 2009; Vollmer et al., 2012). It should be noted that each nucleus is 
counted as either competent or deficient for interphasic NPC assembly. The addition of importin 
for example completely inhibited interphasic NPC assembly monitored by dextran influx. Dextran 
influx was blocked in nuclei formed in the absence of Nup153, consistent with a block in interphasic 
NPC assembly (Figure 4C). Wildtype Nup153 but not the V47E mutant rescued interphasic NPC 
assembly based on dextran influx (Figure 4C). 
Having identified an essential role for Nup153 and specifically its membrane interaction in 
interphasic NPC assembly, we wondered how Nup153 could function in this process. Two known 
Nup153 interactors are necessary for interphasic NPC assembly, ran and the Y-complex (D'Angelo et 
al., 2006; Doucet et al., 2010). Ran is most likely required to release import receptors from targets 
that are crucial for NPC assembly. Meanwhile the Y-complex is a structural component of NPCs. We 
speculated that Nup153 might recruit these crucial components to the inner nuclear membrane. 
 
Nup153 recruits the Y-complex to the inner nuclear membrane for interphasic NPC assembly 
To assess whether Nup153-dependent NE recruitment of ran or the Y-complex is important for 
interphasic NPC assembly we artificially directed these factors to the inner nuclear membrane 
thereby bypassing the function of Nup153. The Y-complex binding region (aa 210-338) or the ran 
binding region (aa 658-890) of human Nup153 were each fused N-terminally to EGFP and at the C-
terminus with the transmembrane protein BC08, yielding EGFP-ycBD-BC08 and EGFP-ranBD-BC08 
(Figure 5A). BC08 contains a C-terminal transmembrane region and efficiently targets to the inner 
nuclear membrane (Theerthagiri et al., 2010). Both constructs were expressed in E. coli, purified and 
reconstituted into small liposomes. To test the functionality of the fusion proteins these liposomes 
were incubated with Y-complex purified from Xenopus egg extracts or recombinant ran and floated 
through a sucrose gradient. Liposomes containing the EGFP-ycBD-BC08 protein efficiently bound the 
Y-complex but not ran and EGFP-ranBD-BC08 liposomes bound ran but not the Y-complex (Figure 
5B). Similarly, when incorporated into GUVs, EGFP-ycBD-BC08 recruited fluorescently labeled Y-
complex to the GUV membrane and EGFP-ranBD-BC08 recruited ran (Figure 5C).  
When EGFP-ycBD-BC08 or EGFP-ranBD-BC08-containing liposomes where added to nuclear assembly 
reactions they efficiently targeted to the inner nuclear membrane (Figure 5D) as previously observed 
for the EGFP-BC08 fusion (Theerthagiri et al., 2010). Interestingly, Nup153 depletion resulted in 
larger nuclei when EGFP-ycBD-BC08 was incorporated compared to EGFP-ranBD-BC08 nuclei. Most 
importantly, EGFP-ycBD-BC08   but not EGFP-ranBD-BC08 incorporation into the nuclear membrane 
restored interphasic NPC assembly when Nup153 was depleted (Figure 5E,F). We conclude that 
recruitment of the Y-complex to the inner nuclear membrane is sufficient to bypass the requirement 
for full-length Nup153 in interphasic NPC assembly in vitro. Thus, the crucial function of Nup153 in 
interphasic NPC assembly is to direct the Y-complex to the newly forming NPCs at the NE. 
 
Annulate lamellae formation depends on Nup153 membrane interaction 
NPCs can assemble outside the nucleus in the membranes of the ER forming annulate lamellae (AL). 
AL form in egg extracts in the absence of chromatin and this process is highly induced upon addition 
of the constitutively active ran mutant Q69L, which is blocked in the GTP-bound state (Walther et al., 
2003b). We wondered whether this NPC assembly mode also depends on Nup153 and specifically on 
its membrane targeting capability. Membranes were incubated with control or Nup153 depleted 
cytosol, re-isolated and analyzed by western blotting (Figure 6A,B). As expected, addition of ranQ69L 
strongly induced AL formation in control extracts, evidenced by an increased presence of Nup62, 
Nup53 and Nup107 - nucleoporins of the central channel, Nup93 complex or Y-complex, respectively 
- in the re-isolated membrane fraction. POM121, GP210 and NDC1, transmembrane pore proteins, 
were found in equal quantities, independent of the presence of ran Q69L. Reticulon 4, an ER marker, 
was used to control for equal membrane re-isolation efficiency. Nup153 depletion severely reduced 
the quantity of soluble nucleoporins re-isolated with membranes. Furthermore, the addition of 
ranQ69L did not result in increased re-isolation of the soluble nucleoporins as was seen in mock-
depleted extracts, indicating a block in AL formation. Addition of wildtype Nup153, but not the 
Nup153 mutant defective for direct membrane binding, to depleted extracts rescued AL formation. 
Analysis of the re-isolated membrane fraction by electron microscopy showed AL in mock and 
Nup153 depleted extracts supplemented with the wildtype protein but not in depleted extracts 
supplemented with the V47E mutant (Figure 6C). Thus, together these data indicate that Nup153 
membrane binding is also required for NPC assembly in the ER. 
 
Transportin regulates Nup153 membrane interaction 
Having identified a Nup153 membrane interaction that is crucial for both interphasic NPC assembly 
and AL formation, we wondered why the protein does not localize to cytoplasmic membranes under 
normal growth conditions but is rather specifically found at the inner nuclear membrane (Figure 1E, 
2A). The N-terminal region of Nup153 interacts with transportin and mediates its import to the 
nucleus, a pre-requisite for its incorporation in NPCs (Bastos et al., 1996; Enarson et al., 1998; 
Nakielny et al., 1999; Shah and Forbes, 1998), Figure S3). It could be speculated that the rapid 
transportin-dependent import of Nup153 prevents its membrane association outside of the nucleus. 
We wondered whether transportin interaction could also directly affect Nup153 membrane binding. 
To test this, the N-terminus of Nup153 was employed in liposome flotation assays after pre-
incubation with transportin. The presence of transportin strongly reduced the ability of Nup153 to 
interact with membranes (Figure 7A). Importin , a related import receptor that does not bind to this 
region, had no effect on the membrane binding of Nup153. Addition of ranQ69L, which releases 
import receptors including transportin from their cargos, reversed the inhibitory effect of 
transportin. Together, these data indicate that transportin inhibits Nup153 membrane binding and 
that this block is released by ranGTP. As high ranGTP concentrations are found in the nucleus it is 
conceivable that Nup153 can only function as a membrane interacting protein once it has reached 
the nucleus. 
  
Discussion 
Here we show that Nup153 can directly interact with membranes via an N-terminal amphipathic 
helix. This membrane interaction is important for interphasic NPC assembly as well as AL formation. 
During interphasic NPC assembly, Nup153 recruits the Y-complex, a crucial structural component of 
newly forming pores, to the inner nuclear membrane. Transportin binding to Nup153 inhibits its 
membrane interaction presumably by masking the membrane interaction surface of Nup153. Taken 
together our results imply a model in which transportin binding to Nup153, following its synthesis in 
the cytoplasm, prevents Nup153 from interacting with membranes outside of the nucleus (Figure 
7B). After translocation through NPCs, Nup153 is released from transportin due to high 
nucleoplasmic concentrations of ranGTP. The liberated Nup153 interacts with the inner nuclear 
membrane and recruits the Y-complex to this locality where it functions in interphasic NPC assembly. 
NPC assembly, both at the end of mitosis and in interphase, is regulated by ran and transport 
receptors (D'Angelo et al., 2006; Walther et al., 2003b). At the end of mitosis, the chromatin binding 
nucleoporin MEL28/ELYS has been identified as critical ran regulated target (Franz et al., 2007; 
Rotem et al., 2009). Here we show that Nup153 is during interphasic NPC assembly an important ran 
target. Both MEL28/ELYS and Nup153, once liberated from the inhibitory effect of importin  or 
transportin, recruit the Y-complex to NPC assembly sites. 
The Y-complex is a basic structural component of the NPC forming a large part of the nucleoplasmic 
and cytoplasmic rings. It is crucial for NPC formation both at the end of mitosis and during interphase 
(D'Angelo et al., 2006; Doucet et al., 2010; Harel et al., 2003; Walther et al., 2003a). Nup153 is 
dispensable for NPC assembly at the end of mitosis (Figure 3) as previously observed (Walther et al., 
2001). In this assembly mode the Y-complex is recruited to NPC assembly sites by MEL28/ELYS (Franz 
et al., 2007; Gillespie et al., 2007; Rasala et al., 2006). This points to an interesting mechanistic 
difference between NPC assembly at the end of mitosis and in interphase. Post-mitotic NPC assembly 
is initiated on the decondensing chromatin by MEL28/ELYS as an essential Y-complex targeting factor 
(Figure 7B). However, MEL28/ELYS has been reported to be dispensable for interphasic NPC assembly 
(Doucet et al., 2010), most likely because it is initiated at the NE. During interphase, it is Nup153 that 
acts as the crucial Y-complex recruitment factor at the inner nuclear membrane in a, presumably, 
chromatin-independent manner. Accordingly, AL formation is Nup153 dependent but does not 
require MEL28/ELYS, as it is initiated at the membrane in the absence of chromatin. Loss of 
MEL28/ELYS actually induces AL formation, presumably because it prevents post-mitotic NPC 
assembly from being initiated on the chromatin (Franz et al., 2007). 
Although Nup133, a component of the Y-complex, possess an evolutionary conserved amphipathic 
helix (Doucet et al., 2010; Drin et al., 2007; Kim et al., 2014), it does not seem to be sufficient to 
target the Y-complex to the inner nuclear membrane during interphasic NPC assembly. One possible 
explanation is that the Nup153 and Nup133 membrane interaction motifs need to act together to 
possess sufficient affinity for the inner nuclear membrane. However, it cannot be excluded that the 
Nup133 amphipathic helix is non-functional in the intact Y-complex. There is no consensus about the 
orientation of the Y-complex within NPCs, including whether the Nup133 amphipathic helix could 
physically interact with the pore membrane (Leksa and Schwartz, 2010). Although a fragment 
containing this Nup133 motif does bind liposomes (Figure 1A, (Vollmer et al., 2012), the assembled Y-
complex does not detectably bind liposomes or GUVs (Figure 5B,C). Other interactions, such as those 
occurring between the transmembrane nucleoporin POM121 and the Y-complex (Mitchell et al., 
2010; Yavuz et al., 2010) contribute to NPC assembly. 
Whether the Nup153 mediated membrane recruitment of the Y-complex is the initial step of 
interphasic NPC assembly is an open question. Due to the experimental setup of the interphasic NPC 
formation assay it is difficult to determine the precise assembly order as it was done for the post-
mitotic NPC formation pathway (described in (Schooley et al., 2012). The amphipathic helix of 
Nup133 has been proposed to target the Y-complex to the highly curved pore membrane during 
interphasic NPC assembly (Doucet et al., 2010). The amphipathic helix of Nup153 shows a similar 
preference for high curvature (Figure 1B) but it is naturally difficult to distinguish whether that 
represents a curvature sensing or inducing function. In other words, it is unclear whether Nup153 
itself initiates interphasic pore assembly by inducing membrane curvature or whether it binds 
already curved membranes. If Nup153 only binds highly curved membranes, its recruitment would 
necessarily be preceded by proteins inducing nuclear pore formation, such as Nup53, reticulons and 
POM121 (Dawson et al., 2009; Doucet et al., 2010; Dultz and Ellenberg, 2010; Vollmer et al., 2012). 
In summary, our work identifies a crucial function for Nup153 in interphasic NPC assembly. We 
provide insight on an interesting mechanistic difference between NPC assembly at the end of mitosis 
and during interphase. Whereas post-mitotic assembly is initiated by the MEL28/ELYS-mediated 
recruitment of the Y-complex to chromatin, interphasic NPC formation crucially requires Nup153 to 
interact with the inner nuclear membrane to localize the Y-complex to nascent assembly sites. It is 
currently unclear whether Nup153 recognizes a distinct feature at the site of the newly forming NPC 
and this will be an interesting avenue for future research. 
  
Experimental Procedures 
DiIC18, fluorescently labeled dextrans, and secondary antibodies (Alexa Fluor 488 goat α-rabbit IgG 
and Cy3 goat α-mouse IgG) were obtained from Invitrogen, detergents from EMD, and lipids from 
Avanti Polar Lipids.  
 
Membrane binding experiments 
Liposome flotations were done as in (Vollmer et al., 2012). GUVs were generated from a chloroform 
dissolved NE lipid mix (Angelova and Dimitrov, 1986). For the generation of EGFP-ycBD-BC08 or 
EGFP-ranBD-BC08 containing GUVs, detergent solubilized proteins were reconstituted in proteo-
liposomes (Eisenhardt et al., 2014). Proteo-liposomes were dried onto two 5 mm x 5 mm platinum 
gauzes under vacuum for 1 h at RT. The gauzes were placed in parallel (5 mm distance) into a 
cuvette, submerged in a sucrose solution with a concentration matching the osmolality of the 
corresponding buffer used and an AC electric field with 10 Hz, 2.2 V was applied for 140 min followed 
by 2 Hz at 42°C for 20 min. An 8 well glass observation chamber (Chambered #1.0 Borosilicate 
Coverglass System, Lab-Tek) was blocked with 5 % (wt/vol) BSA in HEPES buffer (20 mM HEPES pH 
7.5, 150 mM NaCl, 1mM DTT) and washed with HEPES buffer. For each reaction 50 µl of freshly 
prepared GUVs were mixed with 150 µl HEPES buffer and placed into a well. Proteins added and 
buffers used for GUV preparation matched the osmotic pressure of the sucrose solution. The mixture 
was incubated for 5 min and imaged immediately at RT on an inverted Olympus Fluoview 1000 
confocal laser scanning system utilizing an UPlanSApo 60x/1.35 oil objective.  
 
Miscellaneous 
Nuclear assemblies, immunofluorescence, electron microscopy, generation of affinity resins, sperm 
heads and floated unlabeled or DiIC18-labeled membranes were carried out as described (Eisenhardt 
et al., 2014). Interphasic NPC assembly using dextran influx was performed as in (Vollmer et al., 
2012). Nuclear import assays using EGFP-NPM2 (importin /-dependent cargo), EGFP-Nplc-M9-M10 
(transportin-dependent cargo) and EGFP-LBR (aa146-258) as well as NPC counting are described in 
(Theerthagiri et al., 2010). AL were assembled in 15 µl Xenopus egg extract cytosol supplemented 
with 1.5 µl floated membranes, glycogen and an energy regenerating system (Eisenhardt et al., 
2014). After 4 h at 20ºC samples were processed for electron microscopy or diluted in 1 ml sucrose 
buffer. Membranes were pelleted by centrifugation (10 min at 15.000 g), washed in 1 ml sucrose 
buffer and analyzed by western blotting. Antibodies, protein expression and purification as well as 
the transfection experiments are described in detail in the supplemental material section. 
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 Figure Legends 
Figure 1: Nup153 interacts via its N-terminus directly with membranes 
A) 3 µM of the N-terminal domain (aa 1-149) of Xenopus Nup153 and the corresponding V50E 
mutant fragment, as well as a membrane interacting fragment of Nup133 and SUMO as 
positive and negative controls, respectively, were incubated with 2.5 mg/ml fluorescently 
labeled NE liposomes and floated through a sucrose gradient. The top gradient fraction and 
3% of the starting material were analyzed by SDS-PAGE and silver staining.  
B) Binding of the Nup153 N-terminus, the V50E mutant, SUMO and the Nup133 fragment to NE 
or DOPC liposomes of different sizes were analyzed by flotation experiments and quantified 
by western blotting (normalized to Nup153 binding to 30 nm liposomes, columns are the 
average bound quantities of three or four independent experiments, individual data points 
are indicated). 
C) Sequence alignment of the N-terminal region of vertebrate Nup153. 
D) Amino acid sequence of Xenopus Nup153 with the predicted amphipathic helix, seen in a 
helical wheel representation (generated with HeliQuest (Gautier et al., 2008)). Valine (V) was 
exchanged to glutamate (E) in the membrane binding mutant, indicated in red. 
E) NE lipid GUVs were incubated with 500 nM EGFP-tagged Nup153 N-terminus, the 
corresponding V50E mutant or EGFP alone. 
F) HeLa cells transfected with the EGFP-tagged Nup153 N-terminus, the V50E mutant or EGFP. 
Chromatin is stained with DAPI (blue in overlay). 
G) NE lipid GUVs were incubated with Oregon green labeled full-length human Nup153 and the 
corresponding V47E mutant. 
 
Bars: 10 µm. 
 
Figure 2: Nup153 membrane binding is not required for its NPC targeting 
A) HeLa cells were co-transfected with triple-EGFP human Nup153 or the corresponding V47E 
mutant and mCherry-Nup62 or mCherry-laminB and analyzed by live cell imaging. Insets 
show the nuclear surface at a 1.5 fold higher magnification. Bars: 5 µm 
B) HEK293 cells were mock transfected, transfected with triple-EGFP human Nup153 or the 
V47E mutant. Inputs and immunprecipitates from cell lysates were analyzed by western 
blotting. 
See also Figure S1 
 
Figure 3: Nup153 is not crucial for NPC assembly at the end of mitosis 
A)  Western blot of mock depleted, Nup153 depleted (Nup153), and Nup153 depleted extracts 
supplemented with recombinant wild type Nup153 or the membrane-binding mutant 
(Nup153 V47E). 
B) Nuclei assembled for 120 min in extracts generated as in (A) were analyzed by 
immunofluorescence for Nup153 (green) and mAB414 (red). DNA was stained with DAPI 
(blue) and membranes with DiIC18 (fourth row, red). The fifth row shows the surface 
rendering of confocal stacks of mAB414 labeled nuclei. 
C) Quantification of chromatin substrates with closed NEs. Columns are the average of six 
independent experiments. The means from individual experiments (each 100 randomly 
chosen chromatin substrates) are indicated. 
D) Quantification of nuclei with NPC clustering identified by mAB414 staining (six independent 
experiments with 100 chromatin substrates each). 
E) Immunofluorescence on nuclei assembled as in (B). Chromatin is stained with DAPI (blue). 
 
Bars: 10 µm. See also Figure S2 
 
 
Figure 4: Nup153 membrane interaction is not important for nuclear import efficiency but for 
interphasic NPC assembly 
A) Nuclei were assembled in mock, Nup153 depleted extracts or Nup153 depleted extracts 
supplemented with Nup153 or the V47E mutant. After closed NE formation, import rates for 
soluble M9 and cNLS cargos as well as for a transmembrane cargo were determined (average 
of two independent experiments, individual data points are indicated). 
B) Nuclei assembled as in (A) were fixed after 120 min and NPC numbers per nucleus counted 
based on mAB414 staining. Where indicated, interphasic NPC assembly was blocked by 
importin addition after 50 min (average from a total of 30 nuclei in 3 independent 
experiments, normalized to the mock control, error bars are SEM). 
C) Nuclei assembled as in (A) were supplemented with cytosol depleted of Nup153 and FG- 
nucleoporins. After a further 60 min incubation, FITC-labeled 70-kD dextran and Hoechst 
were added (average of three independent experiments each with 100 nuclei). 
 
Figure 5: Inner nuclear membrane tethering of the Y-complex bypasses the Nup153 necessity for 
interphasic NPC assembly 
A) Schematic representation of the Nup153 fusion constructs. The Y-complex (aa 210-338) and 
the ran interacting region (aa 658-890) (blue), flanked by EGFP (green) and the inner nuclear 
membrane protein BC08 (orange) yield EGFP-ycBD-BC08 or EGFP-ranBD-BC08, respectively. 
B) EGFP-ycBD-BC08 or EGFP-ranBD-BC08 was reconstituted into NE liposomes and incubated 
with Y-complex or ran. Start material (50% for the EGFP-ycBD-BC08 or EGFP-ranBD-BC08, 
30% for the Y-complex and ran) and top fractions were analyzed using EGFP, Nup160, 
Nup107, and ran antibodies.  
C) EGFP-ycBD-BC08 or EGFP-ranBD-BC08 were reconstituted into NE lipid GUVs and membrane 
recruitment of Alexa-546 labeled Y-complex or ran was analyzed. 
D) Nuclei were assembled in mock or Nup153 depleted extracts supplemented with empty, 
EGFP-ycBD-BC08 or EGFP-ranBD-BC08 containing liposomes. Samples were fixed after 120 
min and visualized using EGFP (green) and immunofluorescence for mAB414 (red). DNA was 
stained with DAPI (blue).  
E) NPC numbers in nuclei assembled as in (D) were determined using mAB414 staining (average 
from 30 nuclei from 3 independent experiments, normalized to the mock control, error bars 
are SEM). 
F) Nuclei assembled as in (B) and interphasic NPC assembly analyzed by dextran influx as in 
Figure 4C. 
 
Bars: 10 µm 
 
Figure 6: Nup153 membrane interaction is required for AL formation 
A) Mock, Nup153 depleted cytosol or Nup153 depleted cytosol supplemented with Nup153 or 
the V47E mutant were incubated for 4 h with membranes and where indicated with 
ranQ69L. 10% of the start material and the re-isolated membranes were analyzed. Reticulon 
4 (RTN4) serves as a ER marker. 
B) Quantification of Nup62 re-isolated with membranes (average Nup62 intensity value from 
three independent experiments performed as in (A), normalized to mock control in the 
absence of ranQ69L). 
C) Transmission electron microscopy of re-isolated membranes as in (A) in the presence of 10 
µM ranQ69L. Insets show a threefold higher magnification, bar 500 nm.  
 
Figure 7: Transportin regulates Nup153 membrane interaction and function in interphasic NPC 
assembly 
A) 3 µM of the Xenopus Nup153 N-terminus was, where indicated, pre-incubated with 5 µM 
transportin, 5 µM importin  or 5 µM transportin along with 15 µM ranQ69L. Proteins were 
incubated with fluorescently labeled NE liposomes and floated through a sucrose gradient. 
Top gradient fraction and 3% of the input material were analyzed by western blot (upper 
panel). For quantification from two independent experiments, liposome binding was 
normalized to the untreated Nup153 N-terminus. 
B) Model for transportin and Nup153 function in interphasic NPC assembly (left panel): 
Transportin binding to Nup153 in the cytoplasm prevents its membrane interaction and 
mediates its nuclear import. In the nucleus ranGTP releases transportin from Nup153, which 
becomes free to interact with the inner nuclear membrane and recruit the Y-complex for 
interphasic NPC assembly. In contrast, at the end of mitosis (right panel), MEL28/ELYS 
recruits the Y-complex to chromatin and NPC assembly sites without an essential 
contribution from Nup153. 
 
See also Figure S3 
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Figure S1, related to Figure 2 
 
Complete images of nuclear surface of HeLa cells co-transfected with triple-EGFP-tagged 
human Nup153 or the corresponding V47E mutant and mCherry-Nup62 or mCherry-lamin B 
which are shown as insets in Figure 2A. Bars: 5 µm 
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Figure S2, related to Figure 3 
Nuclei were assembled for 120 min in mock, Nup153 depleted (ΔNup153) and 
Nup153 depleted extracts supplemented with recombinant wild type protein (Nup153) 
or the membrane binding mutant (Nup153 V47E). Samples were analyzed by 
immunofluorescence for Nup107 and Nup133 (as nucleoporins of the Y-complex), 
Nup155 and Nup53 (as nucleoporins of the Nup93-complex) and Nup58 (as central 
channel nucleoporin). DNA was stained with DAPI (blue). Bar 10 µm 
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Figure S3, related to Figure 7 
GST-fusions of the RRM domain Xenopus Nup53 (aa 162-267) (Vollmer et al., 2012) 
as a control and of Xenopus Nup153 (aa-149), the corresponding membrane binding 
mutant (V50E) as well as Xenopus Nup153 (aa 395-608), known to bind Nup50 
(Makise et al., 2012), were incubated with cytosol from Xenopus egg extracts. Where 
indicated 10 µM ranQ69L was added to the incubation. Eluates were analyzed by 
western blotting with antibodies against transportin and importin β. Please note that 
transportin binding to Nup153 N-terminal fragment is not affected by the V50E 
mutation. The Nup153 aa 395-608 fragment binds transportin consistent with a 
previous report which mapped a transportin binding site to a partially overlapping 
Nup153 fragment (aa 440-720) (Shah and Forbes, 1998) 
 
  
sta
rt (
10
%)
sta
rt (
3%
)
GS
T-N
up
53
 16
2-2
67
GS
T-N
up
15
3 1
-14
9
GS
T-N
up
15
3 1
-14
9 V
50
E
GS
T-N
up
15
3 3
95
-60
6
116 kDa
65 kDa
116 kDa
65 kDa
GS
T-N
up
53
 16
2-2
67
GS
T-N
up
15
3 1
-14
9
GS
T-N
up
15
3 1
-14
9 V
50
E
GS
T-N
up
15
3 3
95
-60
6
+ + + + 10 µM ranQ69L
transportin
importin β
- - - -
Supplemental Movie 1 
 
3D reconstruction (generated with IMARIS) of confocal stack images of the HeLa cell 
transfected with EGFP-Nup153xl 1-149 shown in Figure 1F.   
Supplemental Experimental Procedures 
 
Antibodies 
Antibodies against Nup107 (Walther et al., 2003), GP210 (Antonin et al., 2005), NDC1 
(Mansfeld et al., 2006), Nup160 (Franz et al, 2007), Nup53 and LBR (Theerthagiri et al., 
2010) and Nup58 (Sachdev et al., 2012) have been described. mAB414 (Babco), transportin 
and ran (558660 and 610341, BD Bioscience), EGFP (11814460001, Roche), as well as TPR, 
human lamin A and B2 antibodies (ab58344, ab26300, ab151735 abcam) were purchased. 
Antibodies for POM121, RTN4, Nup153 and Nup133, were generated against recombinant 
fragments of the respective proteins (Xenopus POM121 aa 1-314, RTN4 aa 763-1043 and 
Nup153 aa 1-149, human Nup133 aa 67-514). Antibodies for Nup155, Nup50, importin β, 
lamin B (expressed as GFP-laminB3, kind gift from Rebecca Heald) are against the Xenopus 
full-length proteins, Xenopus importin α and BC08 antibodies are a kind gift from Iain Mattaj. 
 
Protein expression and purification 
Constructs for the Xenopus Nup153 N-terminus (aa 1-149) were generated from synthetic 
DNA optimized for codon usage in E. coli (Geneart), human full-length constructs from 
EGFP3-hNup153 (Rabut et al., 2004) and the corresponding V50E or V47E mutants by 
mutagenesis using QuikChange site-directed mutagenesis kit (Agilent). The Nup153 N-
terminus (wildtype and V50E mutant) was cloned into a modified pET28a vector with a yeast 
SUMO solubility tag followed by a TEV site or into a modified pET28a vector with EGFP 
upstream of Nup153. Proteins were expressed in E. coli and purified using Ni-agarose. His6- 
and SUMO-tags were cleaved using TEV protease and proteins were concentrated using 
VIVASPIN columns (Sartorius) and separated by gelfiltration (Superdex200 10/300 GL or 
Superdex200 PC 3.2/30, GE Healthcare) in HEPES buffer (20 mM HEPES pH 7.5, 150 mM 
NaCl, 1mM DTT). SUMO and EGFP were expressed and purified from the corresponding 
empty vectors. Human Nup133 (aa 67-514) was generated as described (Vollmer et al., 2012). 
Y-complex was purified from Xenopus egg extracts using TAP-tagged Nup98 (Walther et al., 
2003) and labelled using Alexa Fluor 546 carboxylic acid succinimidyl ester in 200 mM 
NaHCO3 pH 8.4. Human ranQ69L was expressed from a modified pET28a vector with a His6-
GST tag, which was cleaved of using TEV protease. The protein was separated from the tag 
after dialysis using Ni-agarose and further purified by gelfiltration (Superdex200 10/300 GL). 
Purified ranQ69L was labelled using Alexa Fluor 546 C5 Maleimide in HEPES buffer. Excess 
dye was removed by gelfiltration (Superdex200 PC 3.2/30). 
EGFP-ycBD-BC08 or EGFP-ranBD-BC08 where generated by insertion of human Nup153 
fragments (aa 210-338 or aa 658-890) into an BC08 reporter construct (Theerthagiri et al., 
2010) between EGFP and BC08. The corresponding constructs were expressed, purified and 
reconstituted into small unilamellar liposomes with a NE lipid composition previously 
described (Eisenhardt et al., 2014). 
 
Transfection experiments 
Plasmids encoding the Xenopus Nup153-N-Terminus and the corresponding V50E mutant 
(cloned into a modified pEGFP-C3 vector) were transfected into HeLa cells using Fugene 6 
(Roche) following the manufacturer’s instructions. After 24 h cells were fixed and analyzed 
by confocal microscopy. For immunoprecipitations, EGFP3-hNup153 constructs were 
transfected into HEK293 cells. 48 h post-transfection cells were harvested and lysed in lysis 
buffer (50 mM TRIS-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA 10% glycerol 0.1% Triton X-
100 supplemented with protease inhibitors (2 µg/ml leupeptin, 1 µg/ml pepstatin, 2 µg/ml 
aprotinin, 0.1 mg/ml AEBSF final concentration) for 10 min at 4°C. After centrifugation for 
15 min at 15.000 x g the supernatant was immunoprecipitated with GFP-Trap beads 
(Chromotek) for 2 h, washed 5x with lysis buffer, 2x with lysis buffer supplemented with 500 
mM NaCl, 2x with lysis buffer, and 1x with lysis buffer without Triton X-100 and finally 
eluted with SDS-sample buffer. Eluates and lysed cells (corresponding to 5% of the eluates) 
were analyzed. For colocalization experiments (Figure 2A), pEGFP3-Nup153hs or pEGFP3-
Nup153hsV47E were co-transfected with mCherry-hLMNB2 (kind gift of Martin Hetzer) or 
mCherry-Nup62xl using jetPRIME (Polyplus transfection). 24 hours after transfection live 
cells were imaged at 37°C with a confocal microscope LSM780 (Zeiss) equipped with 
incubation chamber and using an Apochromat 63x/1.40 Oil DIC M27 objective. 
 
GST Pulldown experiments 
Fragments used for the GST pulldown experiments were cloned into a modified pET28a 
vector with GST tag followed by a recognition site for TEV protease and purified via the N-
terminal His6 tag. 60 µl GSH–Sepharose (GE Healthcare) were incubated with 300 µg of the 
respective bait proteins, washed and blocked with 5% BSA in PBS. Beads were incubated 
with cytosol from Xenopus egg extracts (diluted 1:1 with PBS, and cleared by centrifugation 
for 30 min at 100,000 rpm in a TLA110 rotor (Beckman Coulter) for 2 h and washed six times 
with PBS. Bound proteins were eluted by cleavage with TEV protease (0.5 mg/ml) for 1 h at 
RT and analyzed by SDS-PAGE and Western blotting.  
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